Page last updated: 2024-08-24

adenosine and Benign Neoplasms

adenosine has been researched along with Benign Neoplasms in 411 studies

Research

Studies (411)

Timeframe	Studies, this research(%)	All Research%
pre-1990	29 (7.06)	18.7374
1990's	9 (2.19)	18.2507
2000's	23 (5.60)	29.6817
2010's	145 (35.28)	24.3611
2020's	205 (49.88)	2.80

Authors

Authors	Studies
Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J	1
Arellano, ML; Boggon, TJ; Brat, DJ; Chen, GZ; Chen, J; Chen, PR; DeBerardinis, RJ; Elf, S; Fan, J; Gu, TL; He, C; Hitosugi, T; Hurwitz, SJ; Ji, Q; Jiang, L; Kang, HB; Kang, S; Khoury, HJ; Khuri, FR; Lee, BH; Lei, Q; Li, Y; Lin, R; Lonial, S; Mao, H; Mitsche, M; Seo, JH; Shan, C; Sudderth, J; Tucker, M; Wang, D; Wu, S; Xie, J; Ye, K; Zhang, L; Zhang, S; Zhou, L	1
Džubák, P; Gurská, S; Hajdúch, M; Hejtmánková, K; Hocek, M; Lišková, B; Oždian, T; Pohl, R; Smoleń, S; Tichý, M; Tloušt'ová, E	1
Alvarez, CL; Espelt, MV; Troncoso, MF	1
Belaydi, O; Chen, J; Chen, M; Gong, G; Hu, J; Li, H; Liu, P; Ma, H; Ou, Z; Qiu, D; Quan, C; Ren, W; Sun, Y; Yi, Z; Yu, A; Zu, X	1
Cheng, M; Ding, C; Flavell, RA; Li, HB; Peng, H; Song, H; Song, J; Sun, R; Tian, S; Tian, Z; Wang, T; Wei, H; Zheng, M; Zhu, S	1
Chen, Y; Ji, C; Jia, Y; Liang, L; Sun, ZJ; Tan, J; Tan, W; Wang, W; Wang, X; Yang, LL; Yuan, Q; Zhang, L	1
Ashraf, MU; Bae, YS; Kang, MH; Kumar, S; Kumar, V; Mani, I; Sarthi, P	1
Džubák, P; Hajdúch, M; Kotulová, J	1
Whiteside, TL	3
Chen, J; Du, Y; Huang, Z; Liu, X; Qin, H; Zhao, Y	1
Chen, J; Chen, Z; Li, Y; Lin, J; Lin, Z; Shao, W; Tao, B; Yi, C; Zhang, B	1
Amiranda, S; Cotugno, G; D'Alise, AM; Finizio, A; Froechlich, G; Gentile, C; Nicosia, A; Sasso, E; Scarselli, E; Zambrano, N	1
Guo, L; Huang, L; Shi, Y; Yang, H; Zhang, J; Zhou, C	1
An, Y; Duan, H	1
Chen, P; Chen, Y; Han, X; Hu, J	1
Delgoffe, GM; Watson, MJ	1
Cai, Z; Cao, W; He, J; Hou, Y; Liu, Y; Qu, J; Yan, H; Zhang, E	1
Ge, R; Xu, P	1
David, A; Relier, S; Rivals, E	1
Hu, D; Li, H; Liu, J; Liu, L; Shao, W; Wang, Y; Yang, S; Zhang, J; Zhong, J	1
Augustin, RC; Bao, R; Fong, L; Leone, RD; Luke, JJ; Naing, A	1
Chen, JX; Chen, MF; Chen, ZS; Deng, LJ; Deng, WQ; Fan, SR; Lyu, WY; Qi, M; Qi, Q; Tiwari, AK; Zhang, DM	1
Liu, M; Lu, W; Wang, H; Wang, Y; Xie, Q; Yang, X; Yu, F; Ze, S; Zhu, C	1
Miao, Z; Wang, C; Wang, Y; Wu, Y; Ye, S; Zhang, H; Zhang, Y; Zhu, Y	1
Andreadou, M; Arapatzi, C; Chatzimike, M; Dushku, E; Gargani, S; Hatzis, P; Kontoyiannis, DL; Kostourou, V; Lourou, N; Ntafis, V; Saridaki, M; Sidiropoulos, ND; Tzanos, D	1
Deng, Y; Li, X; Ma, S; Yi, P; Yu, J	1
Calkhoven, CF; Zuidhof, HR	1
Cheng, Q; Dong, H; Gu, J; He, R; Li, Y; Liu, Y; Ruan, S; Xu, D; Yang, Y; Zang, J; Zhao, Y; Zheng, X	1
An, O; Chen, L; Han, J; Ke, XY; Leong, KW; Molias, FB; Ng, VHE; Pitcheshwar, P; Ren, X; Shen, H; Song, Y; Tan, KK; Tang, SJ; Tay, DJT; Yang, H	1
Cui, B; Ding, K; Du, Y; He, J; Jiang, K; Kong, X; Lai, L; Liao, W; Pan, J; Song, Y; Wang, H; Wang, Q; Xiong, J; Xue, M; Ye, H; Zheng, W; Zhu, J	1
Ignatev, K; Oleinik, E; Shibaev, M; Zhulai, G	1
Cai, J; Cai, M; Li, A; Li, J; Lv, Y; Ma, Q; Wu, W; Zhao, W	1
Chen, J; Chen, Y; Deng, X; Li, Y; Su, R	1
Dong, W; Jiang, H; Li, Y; Liu, Y	1
Hao, S; Sun, C; Wang, B	1
Chen, S; Deng, H; Duan, Y; Li, G; Li, M; Wei, J; Xiong, W; Xue, C; Zhan, Y; Zheng, L; Zhou, M	1
Li, Y; Liang, XJ; Liu, L; Lyu, M; Ni, Q; Timashev, P; Wu, L; Xia, L; Xie, W; Yuan, Y; Zhang, Q; Zhang, Y	1
Dai, Z; Huang, L; Liu, S; Songyang, Z; Weng, Z; Xiong, Y; Zhu, H	1
Baker, AR; Slack, FJ	1
Bao, Z; Chu, Q; Jiang, S; Li, L; Lu, J; Su, Y; Xue, C; Zheng, Q	1
Guo, S; Han, F; Zhu, W	1
Goncharov, AO; Kliuchnikova, AA; Kuznetsova, KG; Moshkovskii, SA; Shender, VO	1
de Waal, JJ; Heitman, LH; IJzerman, AP; Jespers, W; van Uden, L; van Westen, GJP; Wang, X; Wolff, KAN	1
Chen, J; Chen, X; Lu, Z; Mo, S; Yu, S; Zong, L	1
Guil, S; Ramesh-Kumar, D	1
Fu, J; Kucera, GL; Mao, C; Ming, X; Porosnicu, M; Thomas, A; Tian, S; Votanopoulos, KI; Yeh, S	1
Fuks, F; Penning, A; Primac, I	1
Cheng, P; He, S; Huang, J; Li, J; Pu, K; Zeng, Z; Zhang, C	1
Boison, D; Yegutkin, GG	2
Buytelaar, J; Heitman, LH; IJzerman, AP; Jespers, W; van Westen, GJP; Wang, X; Wolff, KAN	1
He, A; Jia, Y; Kong, G; Liu, R	1
Kumar, S; Kumari, S; Muthuswamy, S	1
Chen, J; Fang, Y; Sun, H; Xu, Y	1
Bao, X; Xie, L	1
Cao, Y; Gou, Y; Jiao, N; Li, Z; Liang, Z; Tan, J; Wang, H; Yu, Y; Zhang, Z	1
Lin, H; Long, F; Wang, P; Wang, T; Wang, Y	1
Danen, EHJ; Feng, C; Gorostiola González, M; Heitman, LH; Jespers, W; Liu, R; van Westen, GJP; Wang, X; Zamarbide Losada, SD	1
Li, DL; Li, Y; Tian, X; Wang, ZY; Zhang, CY	1
Gu, Y; Liu, Y; Ouyang, Y; Tang, F; Wang, W; Xiong, Y; Zeng, Z; Zhang, E; Zhang, S	1
Chen, F; Dong, L; He, L; Lamy, T; Lei, W; Luo, W; Zavialov, AV; Zhou, Q	1
Chandy, KG; Duggan, SP; Goh, RKJ; Grigoropoulos, NF; Poh, ZS; Shelat, VG; Udayakumar, A; Verma, NK; Verma, R; Wong, BHS	1
Aggad, WS; Almohaimeed, HM; Alshanwani, AR; Assiri, R; Hengwei, Y; Raza, SHA; Wenzhen, Z; Xinran, Y; Zan, L	1
Hu, C; Ji, D; Jiang, W; Li, Y; Liu, J; Liu, W; Ma, T	1
Cesaro, B; Fatica, A; Fernandez Rodriguez, G	1
Acunzo, M; Bagnoli, M; Croce, CM; Distefano, R; Fadda, P; Gasparini, P; Laganà, A; Ma, Q; Marceca, GP; Nigita, G; Rampioni Vinciguerra, GL; Tomasello, L; Xiang, Y	1
Huang, H; Huang, T; Jiang, J; Li, Y; Wu, S; Zhou, Y	1
Hao, Y; Li, W; Pang, D; Xu, S; Zhang, X	1
Abou-Aisha, K; Elsabbagh, RA; Gad, MZ; Rady, M; Watzl, C	1
Austin, JE; Boulares, AH; Carpino, N; Champhekar, AS; Ciccone, D; Csibi, F; Hossain, F; Huang, Z; Ibba, SV; Leit, S; Loh, C; Majumder, S; Miele, L; Monticone, G; Osborne, BA; Ucar, DA; Xu, K	1
Ditzel, HJ; Gammelgaard, OL; Gjerstorff, MF; Hamaker, O; Hansen, SW; Labrijn, AF; Müller, CE; Nielsen, AY; Parren, PW; Renn, C; Terp, MG; Vever, H	1
Fu, R; Liu, X; Liu, Z; Shen, H; Xu, X; Zhao, X	1
Adema, GJ; Bakker, GJ; Berends, AA; Friedl, P; Peters, E; Slaats, J; Smits, D; van Erp, M; Wagena, E; Weigelin, B	1
Cui, L; Feng, H; Lin, D; Liu, X; Peng, X; Wang, F; Wu, S; Yuan, X; Yuan, Y	1
Chen, XG; He, Z; Liu, Y; Meng, LY; Teng, Z; Yang, S; Yuan, CS	1
Li, F; Xu, YL; Yang, FF	1
Bai, Y; Liu, Z; Yang, Z; Zhang, X; Zheng, J	1
Bach, K; Hamoud, AR; Henkel, N; Kakrecha, O; McCullumsmith, RE; O'Donovan, SM; Wu, X	1
Andreu-Sanz, D; Benmebarek, MR; Briukhovetska, D; Cadilha, BL; Dhoqina, D; Dörr, J; Endres, S; Feinendegen, M; Gottschlich, A; Grünmeier, R; Jobst, J; Kobold, S; Lorenzini, T; Majed, L; Märkl, F; Obeck, H; Oner, A; Schindler, U; Seifert, M; Stock, S; Zhang, J	1
Desai, K; Govindarajan, R; Kaur, T; Mace, TA; Odom, H; Weadick, B	1
Bao, X; Chen, Z; Li, H; Luo, X; Ma, L; Ren, J; Teng, Y; Zhang, Y; Zhao, A; Zheng, J; Zuo, Z	1
Abad, C; Adriouch, S; Blandin, M; Demeules, M; Duan, Y; Gondé, H; Hardet, R; Koch-Nolte, F; Magnus, T; Mann, AM; Menzel, S; Rissiek, B; Scarpitta, A	1
Guo, T; Li, Y; Liu, R; Liu, Y; Yi, J; Zhou, Y	1
Han, J; Qiu, L; Xie, J; Zhang, L; Zhang, S; Zhang, Y; Zhou, Y	1
Matyśniak, D; Oslislok, M; Pomorski, P	1
Cheng, Z; Ding, J; Wei, Q; Xin, H; Zhang, L; Zhao, N	1
Hong, J; Lee, JH; Xu, K	1
Hou, J; Hu, Y; Pan, T; Wen, X; Xiao, W; Xiong, X; Yang, G; Zhou, S	1
Dang, Q; Han, X; Li, H; Liu, L; Liu, Z; Lv, J; Xu, H; Zhang, Y; Zhou, Z; Zou, H	1
Chen, J; Chen, X; Chen, Y; Guo, A; Hu, C; Lin, C; Xu, H; Yang, J	1
Hu, S; Hughes, BGM; Jones, WB; Luke, JJ; Mahabhashyam, S; Marron, T; Merchan, JR; Miller, RA; Willingham, SB	1
Chen, P; Cui, Z; Wu, S; Xie, T; Xu, J; Zhang, X	1
Cheng, L; Gao, L; Liu, Z; Lv, G; Sun, B; Tang, Q; Wang, G	1
Fu, L; To, KKW; Xia, C; Yin, S	1
Chen, S; Jia, X; Kang, C; Li, L; Li, R; Liu, J; Liu, L; Wu, C; Wu, X; Xie, W; Zeng, B; Zheng, H	1
Zhang, CY; Zhang, X; Zhang, Y; Zhao, NN; Zou, X	1
Ding, B; Fan, S; He, C; He, X; Lu, Y; Xiang, G; Zhang, X	1
Chai, X; Fang, M; Liu, M; Lu, W; Wang, H; Wang, Y; Xie, Q; Yang, X; Ze, S; Zhou, R; Zhu, C	1
Shen, H; Wang, S; Xu, X; Ye, H; Zhang, D; Zhao, J	1
Chen, G; Chen, L; Chen, X; He, Y; Liu, S; Ni, Z; Qi, S; Xie, T; Zhang, H; Zhao, S; Zhou, Y; Zhu, J	1
Baghaie, L; Chen, X; Clark, M; El-Diasty, M; Khoury, W; Szewczuk, MR; Trus, R	1
Chu, L; Fu, S; Ji, Q; Pu, X; Tang, H; Wan, M; Wang, X; Wu, Y; Xu, M; Zuo, H	1
Hodge, JW; Zahavi, D	1
Chen, J; Chen, W; Liu, X; Shen, Y; Xu, X; Xu, Y	1
Dai, X; Shi, J; Sun, M; Xiang, Y; Xie, L; Zhang, M	1
Bao, HJ; Chen, S; Wang, JL; Xu, L; Yuan, J; Zhao, Y	1
Chen, X; Du, C; Jiang, Z; Kang, W; Wu, T; You, Q; Zhang, W; Zhang, Y	1
Demaria, S; Golden, E; Stagg, J; Wennerberg, E	1
Chen, J; Meng, Q; Schatten, H; Zhou, Q	1
Chen, S; Cui, XL; Emch, MJ; Han, B; Hawse, JR; He, C; He, HH; Huang, H; Jimenez, R; Pan, Y; Sheng, H; Sun, R; Wang, L; Wei, J; Xia, S; Yin, K; Yue, Z; Zhang, J; Zou, Z	1
Bach, N; Brauneck, F; Fiedler, W; Tolosa, E; Winzer, R	1
Hong, LL; Li, P; Ling, ZQ; Liu, Z; Qi, YN	1
Liang, HF; Liu, HL; Luo, C; Su, HF; Yue, SW; Zhang, BX; Zhang, W	1
Li, Q; Li, W; Li, Y; Meng, J; Tang, L; Wang, D; Xu, J; Yang, F; Zhang, A; Zhang, Y	1
Li, N; Liu, H; Ma, F; Xu, Q; Zhang, CY; Zhang, L	1
Dong, J; Duan, B; Huang, K; Li, C; Li, J; Sun, M; Yang, R; Zhang, F; Zhi, F; Zhou, Z	1
Wang, J; Xing, J; Zhang, J	1
Desler, C; Madsen, HB; Peeters, MJ; Straten, PT	1
Antonioli, L; El-Far, AH; Fu, J	1
Gaber, M; Ghareeb, D; Hamed, A; Hamed, M; Mohamed, TM; Nofal, MS	1
Ding, L; Guo, H; Pan, X; Wang, L; Zhang, J; Zhang, W; Zheng, M	1
Haag, F; Magnus, T; Mittrücker, HW; Puig, B; Rissiek, A; Rissiek, B; Schneider, E; Tolosa, E; Winzer, R	1
Jaffrey, SR; Ries, RJ; Zaccara, S	1
Bai, J; Chen, X; Li, X; Li, Y; Qu, Y; Tian, Y; Wang, Q; Xiao, J; Xu, J; Zhang, Y	1
Ahmed, R; Caux, C; Coukos, G; Décombaz, L; Derré, L; Dormond, O; Ercolano, G; Gestermann, N; Harari, A; Ho, PC; Ianaro, A; Jandus, C; Jichlinski, P; Kandalaft, L; Lozano, LE; Mastelic-Gavillet, B; Ménétrier-Caux, C; Navarro Rodrigo, B; Nguyen-Ngoc, T; Romero, P; Speiser, DE; Tawadros, T; Valerio, M; Verdeil, G; Vigano, S; Wang, H	1
Allard, B; Allard, D; Hammami, A; Stagg, J	1
Barciszewski, J; Rolle, K; Wawrzyniak, D	1
Deb, PK	1
Ascierto, PA; Capone, M; Madonna, G; Morello, S; Pinto, A; Turiello, R	1
Allard, B; Cousineau, I; Spring, K; Stagg, J	1
Azambuja, JH; Braganhol, E; Ludwig, N; Whiteside, TL	1
Chen, C; Ji, X; Kan, Q; Liu, J; Ma, S; Sun, Z; Wang, G; Yuan, W; Zhou, Q	1
He, L; Li, H; Peng, Y; Shu, G; Wu, A; Yin, G	1
Gong, C; Hu, Y; Huang, Y; Liu, J; Wang, S; Xiao, Y; Yang, S	1
Armenia, J; Barrett, JC; Bauer, TM; Bendell, JC; Borodovsky, A; Dry, JR; Falchook, GS; Goodwin, K; Linghu, B; McEwen, R; Merchant, M; O'Connor, G; Patel, MR; Pouliot, G; Russell, DL; Sachsenmeier, K; Sidders, B; Woessner, R; Zhang, P	1
Chen, J; Melstrom, L	1
Haruehanroengra, P; Huang, Y; Sheng, J; Zheng, YY; Zhou, Y	1
Kawahara, Y; Nakahama, T	1
Chen, Q; Demaria, S; Formenti, SC; Gross, SS; Gruber, S; Lhuillier, C; Rudqvist, NP; Spada, S; Wennerberg, E; Zhang, F; Zhou, XK	1
Chen, L; Chen, Z; Liu, YP; Sun, W; Tang, Q; Tian, LF; Wu, W; Yan, XX	1
Bastid, J; Bensussan, A; Bonnefoy, N; Eliaou, JF; Gros, L; Paturel, C; Perrot, I	1
Shen, H; Shi, Y; Xie, W; Zhao, Y	1
Deng, H; Kidwell, RL; Liang, Z; Xie, Q	1
Boison, D; Jalkanen, S; Karikoski, M; Laurila, J; Losenkova, K; Yegutkin, GG; Zuccarini, M	1
Eisenberg, L; Eisenberg-Bord, M; Eisenberg-Lerner, A; Sagi-Eisenberg, R	1
Deng, S; Li, R; Li, X; Lin, D; Liu, X; Ye, Y; Zhang, H; Zheng, J; Zhu, K; Zuo, Z	1
Ju, S; Kong, S; Tao, M; Wang, T	1
Choe, J; Han, SH	1
Chen, Y; Gao, W; He, J; Lin, Y; Shu, Y	1
Feng, D; Han, J; Lu, Q; Lv, J; Wu, Q; Yang, H; Yang, X; Yu, H; Yuan, B; Zhou, Z	1
Allard, B; Allard, D; Buisseret, L; Stagg, J	1
Deng, D; Liu, W; Tian, W; Xiang, M; You, A	1
Chen, C; Guo, Y; Hou, C; Liu, J; Sun, Z; Yin, D; Yuan, W; Zhang, L	1
Cadassou, O; Cros-Perrial, E; Jordheim, LP; Strakhova, R	1
An, O; Chan, THM; Chen, L; Han, J; Hong, H; Lin, JS; Molias, FB; Ng, VHE; Pitcheshwar, P; Shen, H; Song, Y; Tan, HQ; Tang, SJ; Tay, DJT; Yang, H	1
Asada, K; Bolatkan, A; Hamamoto, R; Kaneko, S; Komatsu, M; Takasawa, K	1
Du, W; Duan, R; Guo, W	1
Cesarini, V; Cucina, L; Gallo, A; Scafidi, A; Silvestris, DA; Tassinari, V	1
Chen, XY; Yi, YC; Zhang, J; Zhu, JS	1
Helms, RS; Powell, JD	1
Jung, SH; Kim, T; Liao, Y	1
Halpin-Veszeleiova, K; Hatfield, SM	1
Beavis, PA; Darcy, PK; Kats, LM; Sek, K	1
Huang, W; Li, Y; Weng, H; Zeng, C	1
Sitkovsky, MV	1
Aasen, T; Abdul Moin, NI; Abdul Wafi, S; Aboukameel, A; Abu-Bakar, N; Acharya, A; Ackermans, L; Adaramoye, O; Adarsh, KV; Adeosun, WA; Ahmad, NH; Ahmadi, F; Akanni, O; Akbar, M; Akbulak, RO; Akev, N; Akkaya, Ö; Al-Rashed, S; AlAbbad, S; Alabi, O; Alappat, BJ; Alcalá, S; Alcoutlabi, M; Aleppo, G; Alexander Ross, JB; Alexander, JH; Alexander, R; Alias, A; Alimba, C; Alken, FA; Allan, R; Alpers, M; Alsbou, EM; Amarasiri, SS; An, T; Anastasiadis, F; Anastassiadou, M; Anderson, KC; Andronikos, P; Anheyer, D; Annapurna, K; Anorlu, RI; Anten, MM; Anthopoulos, TD; Araujo-Castillo, RV; Aravamudhan, S; Arawwawala, LDAM; Arulsamy, N; Arunamata, A; Asghar, A; Asiri, AM; Aslanidou, T; Astrakhantseva, IV; Astutik, E; Attanayake, AP; Atwater, BD; Audureau, E; Augusto, S; Bakare, A; Banach, M; Bandelier, P; Banerjee, S; Barral, M; Bascuñán, J; Bates, FS; Bauer, NJC; Bayrak, BB; Beck, RW; Beckervordersantforth, J; Beeri, R; Begum, R; Beldi-Ferchiou, A; Bellingham, G; Ben-Tal, N; Bendib, I; Bergenstal, RM; Berger, MF; Bernasconi, G; Berry, S; Beuvon, F; Bi, WJ; Bi, Z; Bianconi, V; Bibi, I; Blank, BR; Bliemeister, E; Bobkowski, W; Bode, AM; Booth, CM; Bose, U; Boyd, K; Brancato, A; Brenmoehl, J; Brogi, E; Bronzo, P; Brooks, T; Brown, D; Brown, DN; Bruce, D; Buan, MEM; Bueno-Hernández, F; Bugielski, B; Bulavaitė, A; Buscagan, TM; Buxton, R; Caffaro, MM; Cai, Q; Cai, X; Cai, Y; Calhoun, P; Callander, N; Cambier, S; Camparo, P; Canales-Vargas, EJ; Canham, K; Cantu, J; Cao, J; Cao, JW; Cao, P; Cao, T; Cao, X; Caravella, BA; Carcadea, E; Carè, J; Carmichael, P; Carrasco Cabrera, L; Carteaux, G; Carvalho, PDS; Casarez, E; Cazorla, M; Celestrin, CP; Chakraborty, NK; Chan, B; Chandarlapaty, S; Chandgude, AL; Chang, CC; Chang, JH; Chang, X; Chang, Y; Chankhanittha, T; Chantanis, S; Chapovetsky, A; Chavan, S; Chen, B; Chen, D; Chen, F; Chen, G; Chen, H; Chen, J; Chen, K; Chen, KJ; Chen, KP; Chen, L; Chen, MA; Chen, Q; Chen, S; Chen, W; Chen, WF; Chen, X; Chen, Y; Cheng, D; Cheng, J; Cheng, Q; Cheon, GJ; Chiu, SC; Cho, CH; Cho, J; Choi, H; Choi, JS; Choi, YH; Christie, P; Chu, CH; Chu, Y; Chung, DH; Chung, F; Cline, JP; Cohen, A; Cohen, AD; Cohen, NJ; Comen, E; Compter, I; Cong, J; Cong, Z; Cooper, A; Cornud, F; Costa, C; Costa, S; Covey, A; Cowan, AM; Cramer, H; Cruz-Rivera, C; Cui, J; Cui, M; Cui, Y; Cui, YH; Culquichicón, C; Cushman, T; D'Auria, SJ; da Silva, J; Dalgediene, I; Danenberg, HD; Das, S; Dasgupta, K; Daubit, IM; de Oliveira, PD; de Prost, N; De Ruysscher, D; Dearman, K; Decato, D; Delfau-Larue, MH; Deng, L; Dhakate, SR; Dharuman, V; Di Costanzo, N; Dickler, MN; Dinehart, EE; Ding, D; Dinh, TK; Divya, KP; Djifack Tadongfack, T; Do, T; Domínguez-Roldan, R; Domínguez-Zambrano, E; Dömling, A; Donato, MD; Dong, JH; Dong, W; Dong, X; Dong, XR; Dong, Y; Dong, Z; Downs, M; Drutskaya, MS; Du, B; Du, F; Du, H; Du, L; Du, X; Duan, Z; Duangthip, D; Dunstand-Guzmán, E; Duong, F; Eckert, DJ; Edelhäuser, BAH; Eekers, DBP; Efendi, F; Efraimidis, P; Ehrenberg, H; Ehsanbakhsh, Z; Eickholt, C; Eksterowicz, J; El Mobadder, M; El-Araby, IE; El-Magd, MA; El-Tarabany, MS; Elgorban, AM; Engelmann, D; English, KL; Esfandiari, H; Eslami, B; Espinosa-Cuevas, A; Eswara, S; Faber, E; Fan, XH; Fan, Y; Fang, J; Fang, Z; Fantin, VR; Fei, P; Feng, G; Feng, H; Feng, J; Feng, X; Feng, XJ; Fennell, TR; Fernández-Moreira, V; Ferraz, ABF; Ferreras, KN; Flores, K; Flores-Pérez, I; Flox, C; Fluharty, FL; Fokouong Tchoffo, E; Folefack, GO; Foroutan, T; Fort, D; Fourati, S; Fousas, S; Frapard, T; Freguia, S; Friedman, DJ; Friedman, LS; Fu, D; Fu, Q; Fu, Y; Fujinami, S; Furihata, K; Gal, RL; Gan, H; Gao, C; Gao, F; Gao, R; Gao, SS; Gao, W; Gao, XC; Gao, Y; Gao, Z; Garozi, L; Ge, J; Georgiopoulos, A; Gerakiou, K; Ghazimirsaeed, SM; Ghazimirsaeed, ST; Gimeno, MC; Gjestad, R; Glurich, I; Goetchius, E; Goland, S; Goldstein, S; Gonçalves, CM; Gonçalves, H; Gong, Q; Gonzalez, D; Goplen, FK; Gorshkova, EN; Gotsman, I; Govindasamy, V; Granger, CB; Greco, L; Grigoriadou-Skouta, E; Grigoropoulos, P; Grivicich, I; Gromov, NV; Gruber, S; Grytczuk, M; Grzech-Leśniak, K; Gu, L; Gu, S; Gu, Z; Guadagnini, D; Guan, H; Guilliams, M; Guo, J; Guo, L; Gupta, A; Gupta, SK; Gurzu, S; Gutleb, AC; Haban, A; Hablitz, JJ; Hadisuyatmana, S; Hahn, S; Haiges, R; Hallal-Calleros, C; Hamed, M; Hammad, N; Hammer, N; Han, C; Hao, Y; Harnett, J; Has, EMM; Hassanpour, K; Hatzopoulos, D; Hawaldar, R; He, X; He, Y; He, YY; He, Z; Heberman, D; Heckl, D; Hegde, H; Henson, MA; Hernández-Velázquez, VM; Herrera, E; Hijazi, Z; Hirayama, K; Hirth, JM; Hoeben, A; Hohnloser, SH; Hong, M; Hood, K; Hoplock, LB; Hopman, WM; Horlbogen, LM; Hossein Rashidi, B; Hou, G; Hou, H; Hou, J; Hou, Y; Hu, J; Hu, W; Hu, X; Hua, W; Huang, G; Huang, H; Huang, J; Huang, T; Huang, W; Huang, Y; Huang, YD; Huang, Z; Hudis, CA; Hue, S; Huo, J; Hussain, M; Hvas, AM; Ichii, T; Ide Zeuna, J; Ilyas, S; Inoue, T; Iranzo, A; Irfan, M; Iwasa, Y; Iwashita, Y; Izgorodina, EI; J R, A; Jaber, WA; Jaborek, JR; Jacobus, SJ; Jadeja, SD; Jafarabadi, M; Jalan, D; Jamil, MI; Jarrah, S; Jarvis, D; Jayatilaka, KAPW; Jemal-Turki, A; Jeon, YK; Jeong, N; Jeong, SH; Jeong, SY; Jermy, M; Jhaveri, K; Ji, H; Ji, K; Ji, RY; Jiang, F; Jiang, J; Jiang, X; Jiang, Y; Jiao, Q; Jilani, K; Jiménez-Guerrero, P; Jin, L; Jo, YH; Johnson, JG; Johnson, ML; Jones, WS; Jose, S; Jularic, M; Jung, I; Jung, YJ; Jungen, C; Junttila, MR; Kache, S; Kahanovitch, U; Kalantzi, KI; Kallio, T; Kamnoedboon, P; Kang, CH; Kang, H; Kang, J; Kang, KW; Kapoor, P; Karmakar, D; Kartalis, A; Kauranen, P; Kazocina, A; Keikha, F; Keltai, M; Kershaw, SV; Kettani, M; Khalvati, S; Khandhar, S; Khosla, N; Kiely, CJ; Kim, CC; Kim, H; Kim, MJ; Kim, Y; Kim, YH; Kim, YT; Kimoto, E; Kiyu, A; Klatt, N; Kobayashi, M; Koh, J; Köhler, R; Kondadasula, SV; Kong, H; Kong, W; Kong, X; Kotidis, A; Kotwal, A; Kouvari, M; Kozhinov, AN; Kruger, D; Kuang, S; Kuang, Y; Kubota, M; Kuklik, P; Kumar, P; Kumar, SK; Kuo, YF; Kurup, SP; Kusuhara, H; Kuswanto, H; Lacouture, ME; Lambin, P; Lang, CC; Langroudi, FH; Lanman, RB; Larsen, OH; Laskin, J; Le, VH; Leach, M; Lee, BG; Lee, DF; Lee, DS; Lee, HJ; Lee, SB; Lee, YA; Lei, Y; Lekashvili, O; Lelj, F; Lemin, AS; Lemoine, J; Leuschner, R; Li, B; Li, BT; Li, C; Li, D; Li, F; Li, G; Li, H; Li, HW; Li, J; Li, M; Li, P; Li, Q; Li, S; Li, W; Li, X; Li, XY; Li, Y; Li, Z; Lian, Y; Liang, C; Liao, J; Liao, W; Liao, Y; Lin, D; Lin, W; Lin, YL; Lindbäck, J; Lindsay, AP; Ling, J; Linser, PJ; Liu, C; Liu, H; Liu, JJ; Liu, L; Liu, Q; Liu, SF; Liu, X; Liu, Y; Liu, Z; Liu, ZM; Lo Sterzo, C; Lo, ECM; Lobchuk, MM; Lodge, TP; Logotheti, S; Lonial, S; Lopes, G; Lopes, RD; Lopez, J; Lopez, SA; López-Santos, AL; López-Sendón, JL; Loring, Z; Louis, C; Lovita, AND; Lu, DZ; Lu, H; Lu, J; Lu, K; Lu, TT; Lu, Y; Luengo, A; Lum, LG; Luna, JM; Luo, L; Luo, R; Luo, T; Luo, X; Luo, Z; Lv, B; Lymperopoulos, N; Lyras, A; Lyu, Y; M Kannan, A; Ma, H; Ma, M; Ma, Q; Ma, S; Ma, WY; Ma, Y; Maalouf, E; Machado, FA; Maeda, K; Magrans, JO; Maharani, A; Maia, G; Mainwaring, RD; Maji, TK; Majumdar, K; Mannarino, MR; Mansuri, MS; Marinescu, SC; Markatos, G; Marquardt, S; Marraiki, N; Martens, C; Martínez, TJ; Marumo, K; Maruyama, H; Marwani, HM; Marzo, I; Masrati, G; Matamba, P; Mathialagan, S; Matys, J; Mayatra, JM; Mboua, PC; McArthur, T; McCrimmon, RJ; McIntosh, S; McSpadden, S; Medina-Campos, ON; Medvedovsky, AT; Mei, Z; Mekontso-Dessap, A; Menezes, AMB; Meng, J; Meng, P; Meng, Y; Menter, A; Mets, MB; Mets-Halgrimson, R; Metzger, T; Metzler-Nolte, N; Meyer, C; Mi, Y; Michailoviene, V; Mikrogeorgiou, A; Militz, H; Miller Iii, TF; Minarowska, A; Mir, S; Miron, I; Miyake, T; Moayer, F; Modi, S; Moeller, SJ; Mohamad, MN; Mohammed, EHM; Mokhonov, VV; Mondal, A; Moore, J; Moravcova, M; Mordi, IR; Mordi, NA; Mortensen, NP; Moscariello, C; Moser, J; Moynahan, ME; Mu, J; Mu, W; Mudduwa, LKB; Mukherjee, S; Mukhtar, A; Mulkey, DK; Murr, N; Mushtaq, Z; Muthuswamy, N; Mutlu, O; Muto, C; Myroforou, I; Na, KJ; Nabi, M; Nagornov, KO; Nagy, RJ; Naik, A; Nakajima, K; Nam, KT; Nam, YW; Namburath, M; Nammour, S; Namour, A; Namour, M; Nanan, S; Natsume, H; Nave, S; Naveed, A; Nazir, H; Ndubaku, C; Nedospasov, SA; Neradilek, MB; Newcomb, C; Nguépy Keubo, FR; Nguyen, M; Ning, J; Ning, Q; Noguchi, S; Nordahl, SHG; Nordfalk, KF; Norton, L; Noupoue, EM; Nouri, SS; Nowak, JK; Núñez, K; Oakes, K; Odegaard, JI; Ogorodnikova, OL; Ogunsuyi, O; Oh, HK; Oh, HR; Oh, KH; Ohgi, K; Okunade, KS; Oliveira, AG; Olorunfemi, G; Olsen, ML; Olson, BA; Omari, KW; Ondruschka, B; Orfali, R; Orkopoulos, A; Orlowski, RZ; Oser, SM; Oser, TK; Özcan, M; Padilla, V; Paeng, JC; Pajuelo-Lozano, N; Pal, SK; Palmieri, S; Palomeque, E; Pan, W; Panagiotakos, DB; Pandey, M; Pang, D; Pang, Q; Pangarah, CA; Panny, A; Paparella, A; Papirio, S; Papouskova, K; Parang, K; Park, HJ; Park, IK; Park, S; Parker, TL; Parkhomenko, A; Parmon, VN; Parsons, B; Parsons, J; Patel, PR; Patil, S; Patsourakos, NG; Patterson, KC; Pavlidis, P; Pedernera, M; Pedersen, R; Pedraza-Chaverri, J; Pellegrini, M; Peña-Chora, G; Pereira, EDM; Pereira, MADS; Peretz, A; Perez-Padilla, R; Perlman, GY; Perona, R; Petras, C; Phuntsho, S; Picada, JN; Pinder, TA; Piper, LFJ; Pirozzi, F; Pirro, M; Pleckaityte, M; Ploutz-Snyder, LL; Ploutz-Snyder, R; Pogorzelski, A; Poles, L; Postma, AA; Prager, A; Prakash, J; Punn, R; Pützer, BM; Qi, J; Qi, MC; Qi, Y; Qian, J; Qian, Y; Qiang, L; Qiu, J; Qu, Y; Rabiu, KA; Rahighi, S; Rahman, MM; Rahmani, B; Rajkumar, SV; Ramanathan, R; Raras, TYM; Rashi, Y; Rasool, G; Rathore, MG; Ratnawati, R; Ratola, N; Raucci, U; Ray, SK; Razavi, P; Razazi, K; Razek, S; Razi, SS; Reback, M; Reddy, K; Rees, DC; Reginatto, FH; Reich, H; Reis-Filho, JS; Ren, X; Ren, Y; Renner, G; Rey, G; Reymen, B; Riaz, M; Ricci, A; Richardson, PG; Richter, C; Riga, M; Ritchie, C; Rivoal, S; Roberts, W; Robson, ME; Rocha, GZ; Rodrigues, AD; Rogach, AL; Rojas, A; Rosenberg, A; Rosenberg, E; Rosenheck, RA; Roslan, K; Rothenberger, C; Rouschop, KMA; Rubagumya, F; Ryan, CM; Ryder, JW; Saad, MJA; Sacan, O; Sacchi, A; Sahebkar, A; Saini, A; Sainz, B; Sajo, EA; Sakizadeh, J; Saleh, AA; Salgado Júnior, IB; Salvi, R; Samoylova, YV; Samuni, A; Sanchez, DM; Sanchez-Perez, I; Santos, M; Sarapulova, A; Sardot, T; Saud, N; Sauerbier, P; Scaltriti, M; Schaeffer, B; Schalk, DL; Scherschel, K; Schijven, MP; Schreuder, HWR; Schuhmacher, M; Schultz-Lebahn, A; Schwarzl, J; Scott, JM; Sebayang, SK; Seeger, ZL; Segabinazi Peserico, C; Selenica, P; Serio, A; Seruga, B; Shah, A; Shah, C; Shah, PD; Shahrokh Tehraninezhad, E; Shan, A; Shao, Z; Sharma, AMR; Sharma, RK; Shen, J; Shen, R; Shi, X; Shi, Y; Shi, ZE; Shih, YC; Shimohata, H; Shimpi, N; Shin, SH; Shon, HK; Shuvy, M; Siddique, AB; Siegbahn, A; Sikandar, M; Silvani, Y; Singh, A; Singh, AK; Singh, D; Singh, JS; Singh, KP; Singh, M; Situ, B; Skipper, MT; Skouloudi, M; Sloane, BF; Smyrnioudis, N; Snyder, MA; Söhnchen, C; Solis Condor, R; Solit, DB; Someya, S; Song, H; Song, J; Song, W; Song, Y; Sorokina, KN; Soshi, S; Soyer, P; Spitschak, A; Sreekrishnan, TR; Srinivasan, M; Staruschenko, A; Steel, A; Stefan-van Staden, RI; Stein, AM; Strayer, H; Struthers, AD; Su, H; Su, Q; Su, X; Sudore, RL; Sugimura, H; Sugiyama, Y; Sujuti, H; Sumner, SJ; Sun, B; Sun, D; Sun, H; Sun, J; Sun, JY; Sun, X; Sun, Y; Sun, Z; Sung, YC; Surenaud, M; Sutimantanapi, D; Suwandaratne, NS; Swaroop, S; Sychrova, H; Syed, A; Szczepanik, M; Szederjesi, J; Szodorai, R; Tacy, TA; Tadelle, RM; Takayasu, M; Tammeveski, K; Tan, H; Tan, M; Tang, HX; Tang, S; Tang, X; Tanokura, M; Tao, F; Tao, H; Tarafdari, A; Tarín-Carrasco, P; Tasson Tatang, C; Teixeira, JP; Thakur, A; Theobald, A; Thevenot, P; Thomaidis, K; Tian, J; Tillib, SV; Toma, C; Tomita, M; Tonchev, I; Tong, F; Toy, W; Trypuć, M; Tselepis, AD; Tsetseris, L; Tsikouri, GE; Tsikouris, EI; Tsoplifack, CB; Tsoumani, ME; Tsujimoto, R; Tsybin, YO; Tu, J; Tu, TM; Turco, M; Turkyilmaz, IB; Uddin, MJ; Ung, J; Unsihuay, D; Utsunomiya, T; Vagenende, B; Vaishnav, J; Valdes, C; Validad, MH; Valle, J; van Ginkel, MPH; van Grevenstein, WMU; Vanderpuye, V; Vasan, N; Vasilenko, EA; Vasques, GJ; Vavoulis, P; Verani, A; Veziroglu, E; Viegas, A; Vitali, MG; Vitsas, G; Voccio, JP; Vogiatzidis, C; Volow, A; Volpin, F; Vourvahis, M; Wagner, LI; Walkowiak, J; Wallace, R; Wallentin, L; Wan, D; Wan, L; Wan, T; Wang, C; Wang, F; Wang, FN; Wang, H; Wang, J; Wang, L; Wang, Q; Wang, S; Wang, T; Wang, W; Wang, X; Wang, XW; Wang, Y; Wang, YS; Wang, Z; Ward, J; Ward, L; Waseem, R; Watson, DF; Weber, P; Wehrmeister, FC; Wei, CH; Wei, H; Wei, L; Wei, Q; Wei, Y; Weinstock, RS; Weiss, M; Welborn, M; Wen, L; Wen, LM; Wen, Q; Wen, Z; Wesseling, P; Westerbergh, J; White, K; Wick, MP; Willems, S; Wiyasa, IWA; Wójciak, R; Wolkenhauer, O; Won, HH; Wong, J; Woo, YC; Wood, LS; Wu, CT; Wu, CY; Wu, D; Wu, G; Wu, J; Wu, K; Wu, M; Wu, Q; Wu, T; Wu, W; Wu, X; Wu, XT; Wu, Y; Xi, D; Xi, J; Xiang, W; Xiang, Y; Xiao, M; Xiao, Z; Xie, H; Xie, Q; Xie, S; Xie, X; Xing, M; Xing, YL; Xu, C; Xu, X; Xu, Y; Xu, Z; Xue, F; Xue, XD; Yaglioglu, HG; Yamada, H; Yamashita, M; Yan, W; Yan, Z; Yanardag, R; Yang, D; Yang, H; Yang, K; Yang, QQ; Yang, R; Yang, S; Yang, T; Yang, X; Yang, Y; Yao, H; Yao, Y; Yari, D; Yassin, MT; Ye, C; Ye, J; Ye, Q; Yildiz, EA; Ying, S; Yoon, H; Yu, D; Yu, K; Yu, N; Yu, PL; Yuan, C; Yuan, D; Yuan, LJ; Yuan, Z; Yuen, N; Zagatto, AM; Zakaria, Y; Zalewski, AM; Zamora, S; Zavorotinskaya, T; Zeid, JL; Zeinoun, T; Zeng, C; Zerby, HN; Zhan, X; Zhang, A; Zhang, D; Zhang, E; Zhang, F; Zhang, H; Zhang, J; Zhang, L; Zhang, M; Zhang, P; Zhang, Q; Zhang, QY; Zhang, RG; Zhang, S; Zhang, T; Zhang, X; Zhang, Y; Zhang, YY; Zhao, CK; Zhao, H; Zhao, J; Zhao, K; Zhao, Q; Zhao, S; Zhao, T; Zhao, XQ; Zhao, Y; Zhao, Z; Zheng, J; Zheng, L; Zheng, Y; Zhou, B; Zhou, G; Zhou, L; Zhou, T; Zhou, X; Zhu, C; Zhu, J; Zhu, Y; Zhu, ZQ; Zhuang, T; Zimmermannova, O; Zin, NNINM; Zisimos, K; Zoghebi, KA; Zonder, JA; Zou, C; Zwirner, J	1
Assaraf, YG; Chen, ZS; Huang, C; Jiang, J; Li, B; Xiao, H	1
Powell, JD; Thompson, EA	1
Fedoruk-Wyszomirska, A; Gurda-Wozna, D; Orlicka-Płocka, M; Wyszko, E	1
Cai, Y; Gao, M; Gong, Z; Guo, G; Huang, J; Peng, B; Wu, G; Xu, Z; Yan, Y; Zeng, S	1
Kumari, S; Muthusamy, S	1
Cekic, C	1
Huo, FC; Pei, DS; Zhu, ZM	1
Barderas, R; Campuzano, S; Gamella, M; Montero-Calle, A; Navarro-Villoslada, F; Pedrero, M; Pingarrón, JM; Povedano, E; Solís-Fernández, G; Torrente-Rodríguez, RM	1
Hatfield, SM; Steingold, JM	1
Antonioli, L; Blandizzi, C; D'Antongiovanni, V; Fornai, M; Haskó, G; Morello, S; Pellegrini, C; Turiello, R	1
Bao, Y; Gong, C; Hu, Y; Li, Z; Wang, S; Xiao, Y; Yang, C; Yang, H; Zhou, B	1
Beavis, PA; Hatfield, SM	1
Chen, J; He, Z; Ren, D; Tian, Y; Wang, L; Yan, X; Yuan, X; Zhang, Q; Zhang, T; Zhang, W	1
Yegutkin, GG	1
Ab-Rahim, S; Abdul Rahman, A; Mazlan, M; Naes, SM	1
Erdmann, EA; Hundley, HA; Mahapatra, A; Mukherjee, P; Yang, B	1
Cao, Y; Li, J; Yuan, X; Zhang, C	1
Cai, Y; Cao, J; Gao, P; Li, ST; Shen, S; Sun, L; Suo, C; Wang, N; Wang, Y; Wu, G; Yang, D; Yang, Y; Yang, YG; Zhang, H; Zhou, Y	1
Blanco, S; Miguel-López, B; Nombela, P	1
Cui, X; Cui, Y; Ji, G; Xu, Z	1
Ciccarelli, R; Di Iorio, P	1
Alizadeh, A; Arab, S; Asgharzade, S	1
Li, M; Wang, S; Zha, X	1
Bai, J; Cai, Y; Chang, Z; Li, D; Li, Y; Xu, J; Xu, K; Zhang, M; Zou, H	1
Chen, R; Hou, G; Huang, C; Jiang, B; Li, L; Liu, X; Lu, R; Wang, Y; Yang, Q; Yu, J; Zhao, X	1
Arcimowicz, Ł; Chruściel, E; Hupp, T; Keegan, L; Kowalski, J; Kurkowiak, M; Marek-Trzonkowska, N; O'Connell, M; Papak, I; Urban-Wójciuk, Z	1
Churov, A; Zhulai, G	1
Chen, Y; Duan, L; Jiang, X; Jin, Z; Liu, B; Nie, Z; Xiong, Q; Yang, C	1
Afroze, R; Bence, N; Bowman, D; Bump, N; Chau, R; Chuang, BC; Claiborne, C; Cohen, L; Connolly, K; Duffey, M; Durvasula, N; England, D; Freeze, S; Gallery, M; Galvin, K; Gaulin, J; Gershman, R; Greenspan, P; Grieves, J; Grossman, S; Gulavita, N; Guo, J; Hailu, S; He, X; Hoar, K; Hu, Y; Hu, Z; Ito, M; Kim, MS; Lane, SW; Langston, SP; Lok, D; Lublinsky, A; Mallender, W; McIntyre, C; Minissale, J; Mizutani, H; Mizutani, M; Molchinova, N; Ono, K; Patil, A; Pulukuri, SM; Qian, M; Riceberg, J; Shindi, V; Sintchak, MD; Song, K; Soucy, T; Wang, Y; Xu, H; Yang, X; Zawadzka, A; Zhang, J	1
Amin, SG; Belinsky, SA; Desai, DH; Do, K; Filipczak, PT; Hutt, JA; Juri, D; Picchi, MA; Tellez, CS	1
Cheng, X; Lu, Y; Ma, L; Man, S; Yin, L	1
Liu, F; Su, X	1
Paramasivam, A; Priyadharsini, JV	1
Jin, H; Li, Y; Shi, R; Wang, X; Ying, S; Zhu, L	1
Chen, F; Hu, Z; Jiang, Y; Li, Y; Lin, L; Liu, Z; Shen, H; Shen, S; Wei, Y; Zhang, R; Zhao, Y	1
Aras, M; Cekic, C; Clift, R; Cowell, J; Deaglio, S; Ersan, PG; Huang, L; LaBarre, MJ; Li, X; Linden, J; Londono, LM; Pei, H; Phan, KB; Saatci, O; Sahin, O; Serra, S; Shepard, HM; Thanos, CD; Wang, L; Zhao, Q	1
Gong, Z; Guo, C; He, Y; Li, G; Li, X; Li, Y; Shi, L; Tan, F; Wang, F; Wang, Y; Xiang, B; Xiong, F; Xiong, W; Zeng, Z; Zhang, S; Zhao, M; Zhou, M	1
Dong, S; Huang, H; Liu, Y; Weng, H; Wu, Y	1
Bissonnette, MB; Chang, R; Chen, C; Dong, L; Dougherty, U; Guo, P; Han, D; Lai, W; Li, J; Li, Y; Liang, G; Liu, J; Liu, Y; Shen, L; Sun, M; Wang, H; Wang, Z; Xu, MM; Zhang, Y	1
Chiarella, AM; Manji, GA; Rustgi, AK; Ryu, YK	1
Li, Z; Lin, C; Lu, Y; Shen, Z; Zhang, J	1
Fan, Z; Guo, J; Han, X	1
Barr, T; Caligiuri, MA; Chen, J; Chen, Z; Ma, S; Sun, JC; Wang, LS; Yan, J; Yu, J; Zhang, J	1
Capell, BC; Maldonado López, A	1
Bell, JL; Hüttelmaier, S; Lan, Q; Liu, PY; Liu, T; Wang, JY; Zhang, L; Zhang, XD	1
Lv, Y; Tang, M	1
Arasteh, A; Ghorbani, A; Hallaj, S; Jadidi-Niaragh, F; Lee, D; Mirza-Aghazadeh-Attari, M	1
Cai, Z; Jia, G; Song, P; Tayier, S	1
Jia, G; Qian, Y; Zhang, W	1
Borea, PA; Contri, C; Pasquini, S; Varani, K; Vincenzi, F	1
Guo, C; Li, Y; Liu, K; Ouyang, L; Zhang, C; Zhao, Q	1
Chen, TQ; Chen, YQ; Fang, K; Huang, W; Ye, H; Zeng, ZC	1
Gao, X; Han, B; Li, F; Li, Z; Wei, S; Zhang, J	1
Duan, Y; Mao, Y; Qin, S; Wang, H; Zhao, L	1
Farzaneh, F; Maher, J; Stambrook, PJ	1
Chen, H; Eterovic, AK; Han, L; Jeong, KJ; Li, J; Liang, H; Lu, Y; Mangala, LS; Mills, GB; Scott, KL; Sood, AK; Tsang, YH; Wang, Y; Xu, X; Yu, S; Yuan, Y; Zhou, Z	1
Li, H; Li, J; Ma, Z; Qiu, M; Sun, C; Wang, S; Xia, W; Xu, L; Xu, W; Xu, Y; Yin, R; Zhang, E	1
McCarty, OJT; Mitrugno, A	1
Chan, THM; Chen, L; Hong, H; Huang, XX; Lin, CH; Lin, JS; Maury, JJP; Ng, VHE; Qi, L; Song, Y; Tan, KT; Tang, SJ; Tay, DJT; Tenen, DG; Yang, H	1
Chen, J; Deng, X; Feng, X; Su, R; Wei, M	1
Smyth, MJ; Teng, MWL; Vijayan, D; Young, A	1
He, C; Hsu, PJ; Shi, H	1
Batista, PJ; Schmiechen, AC	1
Liang, H; Wang, Y; Xu, X	1
Fan, YG; Leng, RX; Li, LJ; Pan, HF; Ye, DQ	1
Ben-Asher, N; Ganem, NS; Lamm, AT	1
Buchumenski, I; Eisenberg, E; Levanon, EY; Pinto, Y	1
Chandrasekaran, B; Cherukupalli, S; Chinnam, S; Hampannavar, GA; Karpoormath, R; Kayamba, F; Reddy Aleti, R; Sayyad, N	1
Liang, H; Wang, Y	1
Beier, UH	1
Di Bella, G; Di Bella, L; Gualano, L	1
Dai, D; Jin, H; Wang, H; Wang, X; Zhu, L	1
Canzonetta, C; Costa, F; Ferretti, E; Horenstein, AL; Morandi, F	1
Akhtar, MH; Hussain, KK; Jung, DK; Kim, MH; Shim, YB	1
Eichmüller, SB; Kordaß, T; Osen, W	1
Cui, YH; He, YY; Robinson, M; Shah, P	1
Zhang, S	1
Allard, B; Allard, D; Chrobak, P; Messaoudi, N; Stagg, J	1
An, O; Bellido Molias, F; Chan, THM; Chen, L; Han, J; Hong, H; Kwok, HS; Lin, JS; Ng, VHE; Qi, L; Song, Y; Tang, SJ; Tay, DJT; Tenen, DG; Yang, H	1
Borea, PA; Gessi, S; Merighi, S; Varani, K; Vincenzi, F	1
Emens, LA; Leone, RD	1
Samanta, D; Semenza, GL	1
Chang, G; Huang, S; Leu, JS; Ma, L; Xie, K	1
Chai, P; Jia, R; Wang, S	1
He, L; Li, J; Wang, X; Xie, H; Xie, L; Yan, H; Ying, Y; Zheng, X	1
Matosevic, S; Wang, J	1
He, C; Li, Z; Liu, H; Luan, S; Luo, J	1
Chibalin, AV; Dolinar, K; Jan, V; Pavlin, M; Pirkmajer, S	1
Agarwal, DS; Sakhuja, R; Siva Krishna, V; Sriram, D; Yogeeswari, P	1
Borodovsky, A; Brown, GA; Congreve, M; Lamb, ML	1
Atallah Lanman, NM; Chambers, AM; Lupo, KB; Matosevic, S; Wang, J; Yu, H	1
Chen, J; Du, B	1
Chen, Z; Dai, Q; Li, J; Lu, Z; Luo, G; Qi, M; Shen, B; Wang, H; Wu, Y; Zheng, Z	1
Azizi, G; Ghalamfarsa, G; Hojjat-Farsangi, M; Jadidi-Niaragh, F; Kazemi, MH; Masjedi, A; Raoofi Mohseni, S; Yousefi, M	1
Andréasson, C; Fritzell, K; Öhman, M; Otrocka, M; Xu, LD	1
Chen, Y; Fan, XN; Gao, SJ; Huang, Y; Meng, J; Zhang, SW; Zhang, SY	1
Bi, Z; Liu, Q; Liu, Y; Wang, X; Wang, Y; Wu, R; Yao, Y; Zhao, Y	1
Joolharzadeh, P; St Hilaire, C	1
Bissonnette, MB; Chang, R; Chen, C; Dong, L; Dougherty, U; Han, D; He, C; Huang, X; Liu, J; Liu, Y; Shen, B; Wang, J; Weichselbaum, RR; Xu, MM	1
Ming, L; Sun, T; Wu, R	1
Chen, B; Li, Y; Song, R; Xu, F; Xue, C	2
Fan, Y; Gu, Z; Huang, Y; Lin, G; Shi, Y; Sun, Q; Zhai, G; Zhao, X	1
Buchi, M; Festag, J; Hinterwimmer, L; Jaschinski, F; Kallert, SM; Kashyap, AS; Klar, R; Michel, S; Schell, M; Thelemann, T; Zippelius, A	1
Kalkan, R; Tuncel, G	1
Bell, JL; Haase, J; Hüttelmaier, S; Lan, Q; Liu, PY; Liu, T	1
Harada, BT; He, C; Liu, J	1
Chen, SC; Lin, CH	1
Cao, M; Guo, M; Hu, Q; Pan, C; Wang, JZ; Wei, JF; Xu, Z; Yang, H; Zhu, W	1
Fu, J; Zhang, C; Zhou, Y	1
Gorzalczany, Y; Sagi-Eisenberg, R	1
Bolt, MJ; Fu, AQ; Gu, T; White, KP	1
Ishii, H; Konno, M; Taniguchi, M	1
Lang, F; Pei, Y; Robertson, ES; Singh, RK; Sun, K; Zhang, S	1
Alatzoglou, D; Caux, C; Coukos, G; Irving, M; Ménétrier-Caux, C; Romero, P; Vigano, S	1
Bhattamisra, SK; Choudhury, H; Gorain, B; Yee, GS	1
Borah, P; Deb, PK; Deka, S; Mailavaram, RP	1
Ashraf, M; Hussain, M; Javeed, A; Mukhtar, MM; Yuzhu, H	1
Au, SL; Lee, JM; Ng, IO; Wong, CC; Wong, CM	1
Antonioli, L; Blandizzi, C; Haskó, G; Pacher, P	1
Cheng, D; Gillespie, DG; Harasymczuk, M; Hong, CS; Jackson, EK; Lang, S; Mandapathil, M; Muller, L; Saze, Z; Schuler, PJ; Whiteside, TL	1
Leverkus, F	1
Muller, L; Muller-Haegele, S; Whiteside, TL	1
Antonioli, L; Blandizzi, C; Colucci, R; Fornai, M; Haskó, G	1
Mittal, D; Smyth, MJ; Stagg, J; Young, A	1
Creasy, CL; McCabe, MT	1
Abbott, R; Belikoff, B; Hatfield, SM; Jackson, EK; Karger, B; Kjaergaard, J; Kutok, JL; Lukashev, D; Ohta, A; Philbrook, P; Podack, ER; Ren, J; Rodig, S; Schreiber, TH; Sethumadhavan, S; Shujia, D; Sitkovsky, M; Thayer, M	1
Dong, K; Gao, ZW; Zhang, HZ	1
Chai, CL; Goh, YL; Hill, J; Jiang, X; Lee, PL; Li, Z; Lim, CZ; Nguyen, TM; Ong, EH; Santhanakrishnan, S; Tam, EK; Tan, TW; Wong, SY; Yang, H; Yu, Q	1
Chen, HY; Liu, Z; Shi, HW; Wu, MS; Xu, JJ	1
Du, X; Shi, J; Wu, D; Xu, B; Zhou, J; Zhou, N	1
Tsukamoto, H	1
Abbott, R; Belikoff, B; Cannici, R; Hatfield, SM; Jackson, EK; Karger, B; Kjaergaard, J; Ko, K; Kutok, JL; Lukashev, D; Ohta, A; Philbrook, P; Podack, ER; Rodig, S; Schreiber, TH; Sethumadhavan, S; Sitkovsky, MV; Thayer, M	1
Jiang, W; Li, W; Sun, J; Wang, L; Zhu, J	1
Jeengar, MK; Khan, W; Naidu, VG; Singh, I; Sistla, R; Swami, R	1
Abraham, EH; Rapaport, E; Salikhova, A	1
Chandra, G; Chang, TS; Choi, S; Jang, JY; Jeong, LS; Kim, G; Lee, SK; Lee, Y; Moon, YW; Mulamoottil, VA; Nayak, A; Noh, M; Oh, K; Sahu, PK; Song, J	1
Serebruany, VL	1
Agrofoglio, LA; Bessières, M; Chevrier, F; Roy, V	1
Bargonetti, J; Polotskaia, A; Rosso, M	1
Cheung, LWT; Diao, L; Eterovic, AK; Han, L; Jeong, KJ; Ju, Z; Li, J; Li, JB; Liang, H; Lu, Y; Mills, GB; Minelli, R; Nair, N; Roszik, J; Scott, KL; Tsang, YH; Werner, HMJ; Woodman, SE; Xu, X; Yang, Y; Yu, S; Yuan, Y; Zhang, R	1
Shipman, L	1
Cabrera-Fuentes, HA; Cherepanov, V; Kim, MH; Serebruany, VL	1
Das, B; Maity, A	1
Mayer, A; Vaupel, P	1
Allard, B; Allard, D; Chrobak, P; Gaudreau, PO; Stagg, J	1
Weinmann, H	1
Gooding, WE; Mitsuhashi, M; Muller, L; Simms, P; Whiteside, TL	1
Multhoff, G; Vaupel, P	1
Biller, SA; Blake, ML; Cameron, MJ; Choe, S; Clasquin, MF; Dorsch, M; Gross, S; Kernytsky, A; Konteatis, Z; Kunii, K; Mandley, E; Marjon, K; Marks, KM; McVay, M; Murtie, J; Quang, P; Travins, J	1
Allard, B; Beavis, PA; Darcy, PK; Stagg, J	1
Quintana, FJ; Robson, S; Takenaka, MC	1
Adinolfi, E; Di Virgilio, F; Falzoni, S; Giuliani, AL	1
Hatfield, SM; Sitkovsky, M	1
Di Virgilio, F; Pinton, P	1
Fuentes, E; Palomo, I; Sepúlveda, C	1
Jaffrey, SR; Kharas, MG	1
Smyth, MJ	1
Anvari, E; Ghalamfarsa, G; Hojjat-Farsangi, M; Jadidi-Niaragh, F; Kazemi, MH; Mohammadi, H; Raoofi Mohseni, S	1
Guo, X; Ji, S; Ji, X; Wei, W	1
Wang, M; Yu, N	1
Bonan, CD; Morsch, VM; Schetinger, MR; Wyse, AT	1
Kjaergaard, J; Lukashev, D; Ohta, A; Sitkovsky, MV	1
Franco, R	1
Afshar, S; Asai, T; Morrison, SL	1
Chen, G; Liu, BR; Xie, L	1
Fiserová, A; Kovárů, F; Kovárů, H; Kuldová, M; Svoboda, J; Vannucci, L	1
Lawrence, T; Rodriguez-Vita, J	1
Farajollahi, S; Maas, S	1
Smyth, MJ; Stagg, J	1
Sereda, MJ	1
Barciszewski, J; Dudzik, P; Dulińska-Litewka, J; Jędrychowska, P; Laidler, P; Opałka, M; Wyszko, E	1
Mandapathil, M; Whiteside, TL	1
Amariglio, N; Dominissini, D; Moshitch-Moshkovitz, S; Rechavi, G	1
Carmona, FJ; Esteller, M; Fernandez, AF; Imai, K; Jacinto, FV; Marquez, VE; Puertas, S; Shinomura, Y; Taniguchi, H; Villanueva, A; Yamamoto, H	1
Baldoli, E; Casati, S; Ciuffreda, P; Lopez, E; Maier, JA; Ottria, R	1
Mandapathil, M; Schuler, P; Whiteside, TL	1
Crea, F; Danesi, R; Marquez, VE; Paolicchi, E	1
Haskó, G; Pacher, P	1
Beavis, PA; Darcy, PK; Smyth, MJ; Stagg, J	1
Corriden, R; Insel, PA	1
Brüne, B; Hahn, C; Roberts, E; Sekar, D; Weigert, A	1
Kruger, WD; Tang, B; Testa, JR	1
de Giuseppe, PO; dos Santos, CR; Martins, NH; Meza, AN; Murakami, MT; Pereira, HD	1
Allard, B; Stagg, J; Turcotte, M	1
Bruchard, M; Chalmin, F; Ghiringhelli, F; Rébé, C	1
Kumar, V	1
Bernstein, SH; Deaglio, S; Longhi, MS; Robson, SC; Serra, S	1
Ohta, A; Sitkovsky, M	1
Ham, J; Rees, DA; Scanlon, MF	1
BOS, CJ; EMMELOT, P	1
EBERTS, FS; MAGEE, WE	1
BATTAGLIA, GB; GASPARRI, F; PERITI, P	1
CESTARI, A; DESSI, P; RIZZOLI, C	1
Baraldi, PG; Borea, PA; Gessi, S; Leung, E; Merighi, S; Mirandola, P; Tabrizi, MA; Varani, K	1
HACKBARTH, DE; KANOF, NB; MARKS, IE; SAWICKY, HH	1
LANDSCHUTZ, C	1
Baraldi, PG; Benini, A; Borea, PA; Gessi, S; Leung, E; MacLennan, S; Merighi, S; Mirandola, P; Varani, K	1
Abraham, EH; Cho, SY; Engles, JM; Hilton, J; Polster, J; Wahl, RL	1
Linden, J	1
Gorelik, E; Huang, X; Jackson, EK; Lokshin, A; Raskovalova, T	1
Lukashev, D; Ohta, A; Sitkovsky, M	1
Adamsky, K; Amariglio, N; Barbash, ZS; Ben-Dov, I; Brodie, C; Cazacu, S; Constantini, S; Eisenberg, E; Heimberger, AB; Hirschberg, A; Krupsky, M; Levanon, EY; Mikkelsen, T; Paz, N; Ram, Z; Rechavi, G; Safran, M	1
Colombo, MP; Piconese, S	1
Inai, K; Kohler, J; Mitchell, BS; Ostapkowicz, A; Rajfur, Z; Sadej, R; Skladanowski, AC; Spychala, J	1
Choi, BH; Kim, DC; Kim, KT; Kim, W; Tan, SN; Wang, QC; Yong, JW; Yoon, HS	1
Blay, J; Conrad, DM; Furlong, SJ; Hoskin, DW; Mader, JS	1
Goessens, G; Lepoint, A; Radoux, D	1
Hoffman, RM	1
Buhrow, SA; Cohen, S; Staros, JV	1
Akaoka, I; Fujimori, S; Kamatani, N; Kaneko, K	1
Tisdale, MJ	1
Carson, DA; Kamatani, N; Nelson-Rees, WA	1
Galletti, P; Seidenfeld, J; Williams-Ashman, HG	1
Fishman, RF; Gercel, C; Rapaport, E	1
Phillis, JW; Wu, PH	1
Keith, DE; Slavik, M; Vold, BS	1
Ishida, N; Ishiwata, S; Itoh, K; Mizugaki, M; Yamaguchi, T	1
el-Shakawi, S; Fielding, A; Langridge, JI; McClure, TD; Newton, RP; Schram, KH	1
Ammons, JR; Arbogast, JG; Bishop, RE; Gannett, PM; Shastri, PK; Tryfiates, GP	1
Umezawa, K	1
Bar-Yehuda, S; Fishman, P; Vagman, L	1
Honda, I; Itoh, K; Mizugaki, M; Sasaki, T	1
Bar-Yehuda, S; Barer, F; Fishman, P; Ohana, G	1
Bar-Yehuda, S; Barer, F; Fishman, P; Madi, L; Multani, AS; Pathak, S	1
Bar-Yehuda, S; Cohn, I; Fishman, P; Madi, L	1
Yamada, T	1
Smith, LH; Taylor, SA; Uziel, M	1
Dollinger, MR; Krakoff, IH	1
Akaoka, I; Fujimori, S; Kamatani, N; Kaneko, K; Kumakawa, T	1
Alderson, T	1
Akaoka, I; Fujii, H; Fujimori, S; Kamatani, N; Kanbayashi, T; Kaneko, K; Kumakawa, T; Miwa, S; Miyazawa, Y	1
Ishida, N; Itoh, K; Mizugaki, M	1
Carrera, CJ; Carson, DA; Kajander, EO; Kubota, M; Nobori, T; Yamanaka, H	1
Frost, P; Judde, JG	1
Hubbell, HR; Lee, C; Pequignot, EC; Suhadolnik, RJ; Willis, DH	1
Ishida, N	1
Meuwissen, HJ	1
Aketo, H; Nishihara, H	1
Agnello, V; Koffler, D; Kunkel, HG; Winchester, R	1
Bohuon, C; Caillard, L	1
Dzieza-Lalowicz, I; Haniewicz, J	1

Reviews

246 review(s) available for adenosine and Benign Neoplasms

Article	Year
6-Phosphogluconate dehydrogenase links oxidative PPP, lipogenesis and tumour growth by inhibiting LKB1-AMPK signalling. Nature cell biology, 2015, Volume: 17, Issue:11 Topics: AMP-Activated Protein Kinase Kinases; AMP-Activated Protein Kinases; Humans; Lipogenesis; Neoplasms; Oxidative Stress; Pentose Phosphate Pathway; Phosphogluconate Dehydrogenase; Protein Serine-Threonine Kinases; Ribulosephosphates; Signal Transduction	2015
Extracellular ATP and adenosine in tumor microenvironment: Roles in epithelial-mesenchymal transition, cell migration, and invasion. Journal of cellular physiology, 2022, Volume: 237, Issue:1 Topics: Adenosine; Adenosine Triphosphate; Cell Movement; Epithelial-Mesenchymal Transition; Humans; Neoplasms; Nucleotides; Tumor Microenvironment; Uracil Nucleotides	2022
N Frontiers in immunology, 2021, Volume: 12 Topics: Adenosine; Animals; Antineoplastic Agents; Gene Expression Regulation, Neoplastic; Humans; Immunotherapy; Molecular Targeted Therapy; Neoplasms; RNA, Neoplasm; Tumor Microenvironment	2021
Epitranscriptomic Approach: To Improve the Efficacy of ICB Therapy by Co-Targeting Intracellular Checkpoint CISH. Cells, 2021, 08-30, Volume: 10, Issue:9 Topics: Adenosine; Animals; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Immune Checkpoint Inhibitors; Molecular Targeted Therapy; Neoplasms; RNA Processing, Post-Transcriptional; Transcriptome	2021
Current Adenosinergic Therapies: What Do Cancer Cells Stand to Gain and Lose? International journal of molecular sciences, 2021, Nov-22, Volume: 22, Issue:22 Topics: Adenosine; Animals; Carcinogenesis; Humans; Immunotherapy; Molecular Targeted Therapy; Neoplasms; Receptors, Purinergic P1; Tumor Microenvironment	2021
The Role of Tumor-Derived Exosomes (TEX) in Shaping Anti-Tumor Immune Competence. Cells, 2021, 11-06, Volume: 10, Issue:11 Topics: Adenosine; Animals; Exosomes; Humans; Models, Biological; Neoplasms; Signal Transduction	2021
Insights into roles of METTL14 in tumors. Cell proliferation, 2022, Volume: 55, Issue:1 Topics: Adenosine; Animals; Genes, Tumor Suppressor; Humans; Methyltransferases; Neoplasms; Oncogenes; RNA	2022
N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy. Frontiers in immunology, 2021, Volume: 12 Topics: Adenosine; Animals; Humans; Immunotherapy; Methylation; Neoplasms; RNA; Tumor Microenvironment	2021
The role of m6A RNA methylation in cancer metabolism. Molecular cancer, 2022, 01-12, Volume: 21, Issue:1 Topics: Adenosine; Animals; Biomarkers; Disease Management; Disease Susceptibility; Energy Metabolism; Gene Expression Regulation, Neoplastic; Humans; Methylation; Mitochondria; Neoplasms; RNA; RNA Processing, Post-Transcriptional; RNA, Circular; RNA, Messenger; RNA, Untranslated; Signal Transduction; Transcription Factors	2022
Advances in the functional roles of N6-methyladenosine modification in cancer progression: mechanisms and clinical implications. Molecular biology reports, 2022, Volume: 49, Issue:6 Topics: Adenosine; Humans; Methylation; Neoplasms; RNA, Messenger	2022
Fighting in a wasteland: deleterious metabolites and antitumor immunity. The Journal of clinical investigation, 2022, 01-18, Volume: 132, Issue:2 Topics: Adenosine; Animals; Humans; Immunotherapy; Kynurenine; Lactic Acid; Neoplasms; Reactive Oxygen Species; Tumor Microenvironment	2022
RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential. Journal of hematology & oncology, 2022, 01-21, Volume: 15, Issue:1 Topics: Adenosine; AlkB Homolog 5, RNA Demethylase; Animals; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Models, Molecular; Neoplasms; RNA; RNA Processing, Post-Transcriptional	2022
Roles and drug development of METTL3 (methyltransferase-like 3) in anti-tumor therapy. European journal of medicinal chemistry, 2022, Feb-15, Volume: 230 Topics: Adenosine; Animals; Antineoplastic Agents; Drug Development; Humans; Methyltransferases; Neoplasms; Protein Biosynthesis	2022
Insights into N6-methyladenosine and programmed cell death in cancer. Molecular cancer, 2022, 01-28, Volume: 21, Issue:1 Topics: Adenosine; Apoptosis; Humans; Methylation; Neoplasms	2022
Next steps for clinical translation of adenosine pathway inhibition in cancer immunotherapy. Journal for immunotherapy of cancer, 2022, Volume: 10, Issue:2 Topics: Adenosine; Humans; Immunotherapy; Neoplasms	2022
m6A modification: recent advances, anticancer targeted drug discovery and beyond. Molecular cancer, 2022, 02-14, Volume: 21, Issue:1 Topics: Adenosine; Artificial Intelligence; Drug Discovery; Humans; Neoplasms; Prognosis	2022
Targeting the RNA m Molecular cancer, 2022, 03-16, Volume: 21, Issue:1 Topics: Adenosine; Humans; Immunotherapy; Neoplasms; RNA; Tumor Microenvironment	2022
Oncogenic and Tumor-Suppressive Functions of the RNA Demethylase FTO. Cancer research, 2022, 06-15, Volume: 82, Issue:12 Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Carcinogenesis; Humans; Neoplasms; Obesity; RNA; RNA, Messenger	2022
Adenosine-Metabolizing Enzymes, Adenosine Kinase and Adenosine Deaminase, in Cancer. Biomolecules, 2022, 03-08, Volume: 12, Issue:3 Topics: Adenosine; Adenosine Deaminase; Adenosine Kinase; Adenosine Monophosphate; Humans; Inosine; Neoplasms; Tumor Microenvironment	2022
N6-methyladenosine modification participates in neoplastic immunoregulation and tumorigenesis. Journal of cellular physiology, 2022, Volume: 237, Issue:7 Topics: Adenosine; Animals; Carcinogenesis; Cell Transformation, Neoplastic; Humans; Immunity; Inflammation; Neoplasms; Tumor Microenvironment	2022
FTO in cancer: functions, molecular mechanisms, and therapeutic implications. Trends in cancer, 2022, Volume: 8, Issue:7 Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Humans; Neoplasms; RNA; RNA, Messenger; Tumor Microenvironment	2022
Adenosine-A2A Receptor Pathway in Cancer Immunotherapy. Frontiers in immunology, 2022, Volume: 13 Topics: Adenosine; Animals; Humans; Immunotherapy; Immunotherapy, Adoptive; Neoplasms; Receptor, Adenosine A2A; Tumor Microenvironment	2022
The emerging roles of the interaction between m6A modification and c-Myc in driving tumorigenesis and development. Journal of cellular physiology, 2022, Volume: 237, Issue:7 Topics: Adenosine; Carcinogenesis; Gene Expression Regulation; Humans; Neoplasms; Proto-Oncogene Proteins c-myc	2022
ADAR1 and its implications in cancer development and treatment. Trends in genetics : TIG, 2022, Volume: 38, Issue:8 Topics: Adenosine; Adenosine Deaminase; Humans; Neoplasms; RNA Editing; RNA-Binding Proteins; RNA, Double-Stranded	2022
Role of main RNA modifications in cancer: N Signal transduction and targeted therapy, 2022, 04-28, Volume: 7, Issue:1 Topics: 5-Methylcytosine; Adenosine; Humans; Neoplasms; Pseudouridine; RNA Processing, Post-Transcriptional; RNA, Untranslated	2022
CD39 - A bright target for cancer immunotherapy. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 151 Topics: 5'-Nucleotidase; Adenosine; Adenosine Triphosphate; Apyrase; Humans; Immunotherapy; Neoplasms; Tumor Microenvironment	2022
Interplay between A-to-I Editing and Splicing of RNA: A Potential Point of Application for Cancer Therapy. International journal of molecular sciences, 2022, May-08, Volume: 23, Issue:9 Topics: Adenosine; Adenosine Deaminase; Antiviral Agents; Humans; Inosine; Neoplasms; RNA Splicing; RNA-Binding Proteins; RNA, Double-Stranded	2022
The IGF2BP family of RNA binding proteins links epitranscriptomics to cancer. Seminars in cancer biology, 2022, Volume: 86, Issue:Pt 3 Topics: Adenosine; Humans; Methylation; Neoplasms; RNA-Binding Proteins; RNA, Messenger	2022
Cancer epitranscriptomics in a nutshell. Current opinion in genetics & development, 2022, Volume: 75 Topics: Adenosine; DNA; Humans; Neoplasms; RNA; RNA, Messenger; Tumor Microenvironment	2022
ATP and Adenosine Metabolism in Cancer: Exploitation for Therapeutic Gain. Pharmacological reviews, 2022, Volume: 74, Issue:3 Topics: Adenosine; Adenosine Triphosphate; Humans; Neoplasms; Signal Transduction; Tumor Microenvironment	2022
Novel insights into roles of N6-methyladenosine reader YTHDF2 in cancer progression. Journal of cancer research and clinical oncology, 2022, Volume: 148, Issue:9 Topics: Adenosine; Disease Progression; Humans; Neoplasms; RNA; RNA-Binding Proteins; Transcription Factors	2022
RNA N6-methyladenosine modification in regulating cancer stem cells and tumor immune microenvironment and its implication for cancer therapy. Journal of cancer research and clinical oncology, 2023, Volume: 149, Issue:4 Topics: Adenosine; Neoplasms; Neoplastic Stem Cells; RNA; Signal Transduction; Tumor Microenvironment	2023
Role of m6A modification in female infertility and reproductive system diseases. International journal of biological sciences, 2022, Volume: 18, Issue:9 Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Female; Genitalia; Humans; Infertility, Female; Methyltransferases; Neoplasms	2022
Targeting purinergic pathway to enhance radiotherapy-induced immunogenic cancer cell death. Journal of experimental & clinical cancer research : CR, 2022, Jul-15, Volume: 41, Issue:1 Topics: Adenosine; Adenosine Triphosphate; Humans; Immunogenic Cell Death; Neoplasms; T-Lymphocytes, Regulatory; Tumor Microenvironment	2022
Mutual regulation between N6-methyladenosine (m6A) modification and circular RNAs in cancer: impacts on therapeutic resistance. Molecular cancer, 2022, 07-18, Volume: 21, Issue:1 Topics: Adenosine; Drug Resistance, Neoplasm; Humans; Methylation; Neoplasms; RNA, Circular	2022
Obstacles for T-lymphocytes in the tumour microenvironment: Therapeutic challenges, advances and opportunities beyond immune checkpoint. EBioMedicine, 2022, Volume: 83 Topics: Adenosine; Adenosine Triphosphate; Humans; Immune Checkpoint Proteins; Immunotherapy; Ligands; Neoplasms; T-Lymphocytes; Tumor Microenvironment	2022
Research progress of m Molecular and cellular probes, 2022, Volume: 65 Topics: Adenosine; Animals; Growth and Development; Humans; Methylation; Neoplasms; RNA; RNA, Messenger	2022
Multifaceted Roles of the Biomolecules, 2022, 07-28, Volume: 12, Issue:8 Topics: Adenosine; Humans; Methyltransferases; Neoplasms; RNA, Messenger; Tumor Microenvironment	2022
Multiple Roles of m6A RNA Modification in Translational Regulation in Cancer. International journal of molecular sciences, 2022, Aug-11, Volume: 23, Issue:16 Topics: Adenosine; Humans; Neoplasms; Proteomics; RNA; RNA, Messenger	2022
The Role of RNA m Current gene therapy, 2023, Volume: 23, Issue:1 Topics: Adenosine; Glycolysis; Humans; Methylation; Neoplasms; RNA; Tumor Microenvironment	2023
Targeting RNA N Molecular cancer, 2022, 09-07, Volume: 21, Issue:1 Topics: Adenosine; Humans; Immunotherapy; Neoplasms; RNA; Tumor Escape	2022
Impact of N6-methyladenosine (m Cell communication and signaling : CCS, 2022, 09-09, Volume: 20, Issue:1 Topics: Adenosine; Humans; Methylation; Methyltransferases; Neoplasms	2022
Adenosinergic axis and immune checkpoint combination therapy in tumor: A new perspective for immunotherapy strategy. Frontiers in immunology, 2022, Volume: 13 Topics: Adenosine; CTLA-4 Antigen; Cytokines; Humans; Immunotherapy; Neoplasms; Programmed Cell Death 1 Receptor; Receptors, Purinergic P1; Tumor Microenvironment	2022
Effects of writers, erasers and readers within miRNA-related m6A modification in cancers. Cell proliferation, 2023, Volume: 56, Issue:1 Topics: Adenosine; Carcinogenesis; Cell Transformation, Neoplastic; Humans; MicroRNAs; Neoplasms	2023
[Research Progress of m6A Methylation Modification in Hematological Tumors--Review]. Zhongguo shi yan xue ye xue za zhi, 2022, Volume: 30, Issue:5 Topics: Adenosine; Epigenesis, Genetic; Hematologic Neoplasms; Humans; Methylation; Neoplasms; RNA, Messenger	2022
Adenosine, Schizophrenia and Cancer: Does the Purinergic System Offer a Pathway to Treatment? International journal of molecular sciences, 2022, Oct-05, Volume: 23, Issue:19 Topics: Adenosine; Humans; Incidence; Neoplasms; Schizophrenia; Tumor Microenvironment	2022
Nucleoside transporters and immunosuppressive adenosine signaling in the tumor microenvironment: Potential therapeutic opportunities. Pharmacology & therapeutics, 2022, Volume: 240 Topics: Adenosine; Humans; Immunosuppressive Agents; Neoplasms; Nucleoside Transport Proteins; Nucleosides; Receptors, Purinergic P1; Tumor Microenvironment	2022
Translational Regulation by eIFs and RNA Modifications in Cancer. Genes, 2022, 11-06, Volume: 13, Issue:11 Topics: Adenosine; Humans; Neoplasms; Ribosomes; RNA Processing, Post-Transcriptional; RNA, Messenger	2022
P2X7 receptor in normal and cancer cells in the perspective of nucleotide signaling. Acta biochimica Polonica, 2022, Nov-11, Volume: 70, Issue:1 Topics: Adenosine; Adenosine Triphosphate; Neoplasms; Nucleotides; Receptors, G-Protein-Coupled; Receptors, Purinergic P2X7; Signal Transduction	2022
Immunosuppressive adenosine-targeted biomaterials for emerging cancer immunotherapy. Frontiers in immunology, 2022, Volume: 13 Topics: Adenosine; Biocompatible Materials; Humans; Immunotherapy; Neoplasms; Signal Transduction; Tumor Microenvironment	2022
Biological roles of the RNA m Experimental & molecular medicine, 2022, Volume: 54, Issue:11 Topics: Adenosine; Humans; Methylation; Neoplasms; RNA; RNA, Messenger	2022
Biological and pharmacological roles of m Molecular cancer, 2022, 12-14, Volume: 21, Issue:1 Topics: Adenosine; Drug Resistance, Neoplasm; Humans; Methyltransferases; Neoplasms; RNA; Tumor Microenvironment	2022
The Role of N Oxidative medicine and cellular longevity, 2022, Volume: 2022 Topics: Adenosine; Epigenesis, Genetic; Humans; Neoplasms; RNA	2022
The roles of N6-methyladenosine and its target regulatory noncoding RNAs in tumors: classification, mechanisms, and potential therapeutic implications. Experimental & molecular medicine, 2023, Volume: 55, Issue:3 Topics: Adenosine; Humans; Neoplasms; RNA; RNA, Untranslated	2023
CD39/CD73/A2AR pathway and cancer immunotherapy. Molecular cancer, 2023, 03-02, Volume: 22, Issue:1 Topics: Adenosine; Antibodies, Monoclonal; Cell Membrane; Humans; Immunotherapy; Neoplasms	2023
The adenosinergic machinery in cancer: In-tandem insights from basic mechanisms to therapy. Frontiers in immunology, 2023, Volume: 14 Topics: Adenosine; Adenosine Triphosphate; Humans; Neoplasms; Receptors, Purinergic P1; Receptors, Purinergic P2; Tumor Microenvironment	2023
Role of adenosine A2a receptor in cancers and autoimmune diseases. Immunity, inflammation and disease, 2023, Volume: 11, Issue:4 Topics: Adenosine; Autoimmune Diseases; Humans; Neoplasms; Receptor, Adenosine A2A; Signal Transduction	2023
The roles and mechanism of m Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 163 Topics: Adenosine; Humans; Methylation; Methyltransferases; Neoplasms; RNA; Tumor Microenvironment	2023
Parsimonious Effect of Pentoxifylline on Angiogenesis: A Novel Pentoxifylline-Biased Adenosine G Protein-Coupled Receptor Signaling Platform. Cells, 2023, 04-20, Volume: 12, Issue:8 Topics: Adenosine; Animals; Humans; Neoplasms; Pentoxifylline	2023
Mechanisms of N6‑methyladenosine modification in tumor development and potential therapeutic strategies (Review). International journal of oncology, 2023, Volume: 62, Issue:6 Topics: Adenosine; Animals; Ferroptosis; Humans; Immunotherapy; Mammals; Neoplasms; Tumor Microenvironment	2023
Targeting Immunosuppressive Adenosine Signaling: A Review of Potential Immunotherapy Combination Strategies. International journal of molecular sciences, 2023, May-17, Volume: 24, Issue:10 Topics: Adenosine; Humans; Immunosuppressive Agents; Immunotherapy; Neoplasms; Signal Transduction; Tumor Microenvironment	2023
Targeting IGF2BP3 in Cancer. International journal of molecular sciences, 2023, May-29, Volume: 24, Issue:11 Topics: Adenine; Adenosine; Eukaryota; Humans; Neoplasms; RNA	2023
Advances in CD73 inhibitors for immunotherapy: Antibodies, synthetic small molecule compounds, and natural compounds. European journal of medicinal chemistry, 2023, Oct-05, Volume: 258 Topics: 5'-Nucleotidase; Adenosine; Adenosine Triphosphate; Antibodies; Humans; Immunotherapy; Neoplasms; Tumor Microenvironment	2023
Biological roles of A-to-I editing: implications in innate immunity, cell death, and cancer immunotherapy. Journal of experimental & clinical cancer research : CR, 2023, Jun-17, Volume: 42, Issue:1 Topics: Adenosine; Humans; Immunity, Innate; Immunotherapy; Neoplasms; RNA, Double-Stranded	2023
Targeting m Bioorganic & medicinal chemistry, 2023, 07-15, Volume: 90 Topics: Adenosine; Animals; Carrier Proteins; Humans; Mammals; Neoplasms; RNA-Binding Proteins; RNA, Messenger; Transcription Factors	2023
The interplay between the DNA damage response and ectonucleotidases modulates tumor response to therapy. Science immunology, 2023, 07-14, Volume: 8, Issue:85 Topics: Adenosine; Adenosine Monophosphate; Adenosine Triphosphate; DNA Damage; Humans; Neoplasms; Tumor Microenvironment	2023
Crosstalk between m6A and coding/non-coding RNA in cancer and detection methods of m6A modification residues. Aging, 2023, 07-11, Volume: 15, Issue:13 Topics: Adenosine; Carcinogenesis; Humans; Neoplasms; RNA; RNA, Messenger	2023
The Clinical Significance of CD73 in Cancer. International journal of molecular sciences, 2023, Jul-21, Volume: 24, Issue:14 Topics: 5'-Nucleotidase; Adenosine; Clinical Relevance; Humans; Immunosuppression Therapy; Immunotherapy; Neoplasms	2023
Methyltransferase-like proteins in cancer biology and potential therapeutic targeting. Journal of hematology & oncology, 2023, 08-02, Volume: 16, Issue:1 Topics: Adenosine; Biology; Humans; Methylation; Methyltransferases; MicroRNAs; Neoplasms	2023
m6A-regulated tumor glycolysis: new advances in epigenetics and metabolism. Molecular cancer, 2023, 08-15, Volume: 22, Issue:1 Topics: Adenosine; Epigenesis, Genetic; Epigenomics; Glycolysis; Humans; Neoplasms; Tumor Microenvironment	2023
N6-methyladenosine (m6A) in cancer therapeutic resistance: Potential mechanisms and clinical implications. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2023, Volume: 167 Topics: Adenosine; Biological Products; Drug Resistance, Neoplasm; Humans; Neoplasms	2023
The Immune Regulatory Role of Adenosine in the Tumor Microenvironment. International journal of molecular sciences, 2023, Oct-05, Volume: 24, Issue:19 Topics: 5'-Nucleotidase; Adenosine; Adenosine Triphosphate; CD8-Positive T-Lymphocytes; Humans; Neoplasms; T-Lymphocytes, Regulatory; Tumor Microenvironment	2023
Nucleotide metabolism in the regulation of tumor microenvironment and immune cell function. Current opinion in biotechnology, 2023, Volume: 84 Topics: Adenosine; Adenosine Triphosphate; Humans; Neoplasms; Nucleotides; Tumor Microenvironment	2023
Inhibitory effect of adenosine on adaptive antitumor immunity and intervention strategies. Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2023, Sep-26, Volume: 52, Issue:5 Topics: Adaptive Immunity; Adenosine; Cytokines; Humans; Neoplasms; T-Lymphocytes; Tumor Microenvironment	2023
Generation and Function of Non-cell-bound CD73 in Inflammation. Frontiers in immunology, 2019, Volume: 10 Topics: 5'-Nucleotidase; Adenosine; Adenosine Triphosphate; Animals; Cell Communication; Cell Membrane; Extracellular Fluid; Extracellular Vesicles; Glycosylphosphatidylinositols; GPI-Linked Proteins; Humans; Inflammation; Lymphocyte Activation; Lymphocyte Subsets; Membrane Microdomains; Mice; Neoplasm Proteins; Neoplasms; Receptors, Purinergic P1; Solubility; Species Specificity; Tumor Microenvironment	2019
Reading, writing and erasing mRNA methylation. Nature reviews. Molecular cell biology, 2019, Volume: 20, Issue:10 Topics: Adenosine; Animals; Gene Expression Regulation, Neoplastic; Humans; Methylation; Neoplasms; RNA Processing, Post-Transcriptional; RNA, Messenger; RNA, Neoplasm	2019
Targeting the adenosine pathway for cancer immunotherapy. Seminars in immunology, 2019, Volume: 42 Topics: 5'-Nucleotidase; Adenosine; Animals; Antigens, CD; Apyrase; Humans; Immunotherapy; Neoplasms; Signal Transduction	2019
Biological activity of N6-furfuryladenosine Postepy biochemii, 2019, 06-06, Volume: 65, Issue:2 Topics: Adenosine; Apoptosis; Kinetin; Neoplasms; Plant Growth Regulators; Plants	2019
Inhibition of the Adenosinergic Pathway in Cancer Rejuvenates Innate and Adaptive Immunity. International journal of molecular sciences, 2019, Nov-14, Volume: 20, Issue:22 Topics: Adaptive Immunity; Adenosine; Adenosine Triphosphate; Animals; Disease Susceptibility; Exosomes; Humans; Immunity, Innate; Lymphocytes; Macrophages; Neoplasms; Receptors, Purinergic P1; Signal Transduction	2019
The interplay between m6A RNA methylation and noncoding RNA in cancer. Journal of hematology & oncology, 2019, 11-22, Volume: 12, Issue:1 Topics: Adenosine; Humans; Methylation; Methyltransferases; Neoplasms; RNA Processing, Post-Transcriptional; RNA, Neoplasm; RNA, Untranslated	2019
Functions of N6-methyladenosine and its role in cancer. Molecular cancer, 2019, 12-04, Volume: 18, Issue:1 Topics: Adenosine; Animals; Biomarkers; Disease Susceptibility; Gene Expression Regulation, Neoplastic; Humans; Methylation; Molecular Targeted Therapy; Neoplasms; Protein Binding; RNA, Messenger; Signal Transduction	2019
Adenosine Metabolism: Emerging Concepts for Cancer Therapy. Cancer cell, 2019, 12-09, Volume: 36, Issue:6 Topics: Adenosine; Adenosine Triphosphate; Animals; Humans; Immunotherapy; Neoplasms; Signal Transduction; Tumor Escape	2019
New sights in cancer: Component and function of N6-methyladenosine modification. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 122 Topics: Adenosine; Animals; Epigenesis, Genetic; Humans; Methylation; Neoplasms; RNA; RNA, Messenger	2020
RNA N Cancer gene therapy, 2020, Volume: 27, Issue:9 Topics: Adenosine; Epigenesis, Genetic; Humans; Neoplasms; RNA	2020
RNA modifications and cancer. RNA biology, 2020, Volume: 17, Issue:11 Topics: Adenosine; Animals; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Neoplasms; RNA; RNA Processing, Post-Transcriptional; RNA, Long Noncoding; RNA, Messenger; RNA, Ribosomal; RNA, Transfer; Transcriptome	2020
Adenosine-to-inosine RNA editing in the immune system: friend or foe? Cellular and molecular life sciences : CMLS, 2020, Volume: 77, Issue:15 Topics: Adenosine; Adenosine Deaminase; Animals; Autoimmune Diseases; Autoimmune Diseases of the Nervous System; Humans; Immune System; Inosine; Neoplasms; Nervous System Malformations; RNA Editing	2020
m Journal of hematology & oncology, 2020, 04-10, Volume: 13, Issue:1 Topics: Adenosine; Animals; Epigenesis, Genetic; Hematopoiesis; Humans; Neoplasms; Protein Binding; Proteins; RNA Processing, Post-Transcriptional; RNA, Messenger; Virus Diseases; Virus Physiological Phenomena; Viruses	2020
Epigenetic N6-methyladenosine modification of RNA and DNA regulates cancer. Cancer biology & medicine, 2020, 02-15, Volume: 17, Issue:1 Topics: Adenosine; Antineoplastic Agents; Carcinogenesis; Disease Progression; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Methyltransferases; Neoplasms; Oxidoreductases, N-Demethylating; RNA Processing, Post-Transcriptional; RNA Splicing Factors; RNA-Binding Proteins	2020
Metabolic alterations in the tumor microenvironment and their role in oncogenesis. Cancer letters, 2020, 08-01, Volume: 484 Topics: Adenosine; Adipocytes; Cancer-Associated Fibroblasts; Carcinogenesis; Glycolysis; Humans; Lysophospholipids; Neoplasms; Signal Transduction; Tumor Microenvironment	2020
The potential role of RNA N6-methyladenosine in Cancer progression. Molecular cancer, 2020, 05-12, Volume: 19, Issue:1 Topics: Adenosine; Animals; Biomarkers, Tumor; Disease Progression; DNA Methylation; Epigenesis, Genetic; Humans; Methyltransferases; Neoplasms	2020
Diverse molecular functions of m Experimental & molecular medicine, 2020, Volume: 52, Issue:5 Topics: Adenosine; Alternative Splicing; Animals; Gene Expression Regulation, Neoplastic; Humans; Methylation; Neoplasms; Nucleic Acid Conformation; Organ Specificity; RNA Processing, Post-Transcriptional; RNA Stability; RNA, Messenger; Structure-Activity Relationship	2020
Interaction between N Molecular cancer, 2020, 05-22, Volume: 19, Issue:1 Topics: Adenosine; Animals; Biomarkers, Tumor; Disease Progression; DNA Methylation; Epigenesis, Genetic; Humans; Methyltransferases; Neoplasms; RNA, Untranslated	2020
Mechanism of RNA modification N6-methyladenosine in human cancer. Molecular cancer, 2020, 06-08, Volume: 19, Issue:1 Topics: Adenosine; Biomarkers, Tumor; Disease Progression; DNA Methylation; Epigenesis, Genetic; Humans; Methyltransferases; Neoplasms	2020
The adenosine pathway in immuno-oncology. Nature reviews. Clinical oncology, 2020, Volume: 17, Issue:10 Topics: Adenosine; Antineoplastic Agents, Immunological; Cell Hypoxia; Clinical Trials as Topic; Combined Modality Therapy; Humans; Immune Checkpoint Inhibitors; Immunotherapy, Adoptive; Neoplasms; Signal Transduction; Tumor Escape	2020
The role of N Molecular cancer, 2020, 06-10, Volume: 19, Issue:1 Topics: Adenosine; Animals; Disease Progression; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Methyltransferases; Neoplasms; RNA, Circular	2020
Regulation of tumor infiltrated innate immune cells by adenosine. Purinergic signalling, 2020, Volume: 16, Issue:3 Topics: Adenosine; Animals; Humans; Immunity, Innate; Inflammation; Killer Cells, Natural; Macrophages; Mast Cells; Neoplasms; Tumor Microenvironment	2020
Critical Roles of Biomolecules, 2020, 07-17, Volume: 10, Issue:7 Topics: Adenosine; Animals; Epigenesis, Genetic; Humans; Neoplasms; RNA; RNA Folding; RNA Processing, Post-Transcriptional; RNA Stability; RNA Transport; Virus Diseases	2020
EZH2: a novel target for cancer treatment. Journal of hematology & oncology, 2020, 07-28, Volume: 13, Issue:1 Topics: Adenosine; Antineoplastic Agents; Benzamides; Biphenyl Compounds; Cell Cycle; Cell Transformation, Neoplastic; Clinical Trials as Topic; Combined Modality Therapy; Drug Resistance, Neoplasm; Enhancer of Zeste Homolog 2 Protein; Epigenetic Repression; Histone Code; Histones; Humans; Methylation; Morpholines; Multicenter Studies as Topic; Neoplasm Metastasis; Neoplasm Proteins; Neoplasms; Polycomb Repressive Complex 2; Pyridones; Structure-Activity Relationship; Transcriptional Activation; Tumor Microenvironment	2020
Novel insights into the interplay between m Molecular cancer, 2020, 08-07, Volume: 19, Issue:1 Topics: Adenosine; Animals; Carcinogenesis; Disease Susceptibility; Drug Resistance, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Methylation; MicroRNAs; Neoplasms; RNA Interference; RNA, Circular; RNA, Long Noncoding; RNA, Messenger; RNA, Untranslated	2020
Rethinking the adenosine-A Current opinion in pharmacology, 2020, Volume: 53 Topics: Adenosine; Animals; Homeostasis; Humans; Immunotherapy; Neoplasms; Receptor, Adenosine A2A	2020
A-to-I RNA editing as a tuner of noncoding RNAs in cancer. Cancer letters, 2020, 12-01, Volume: 494 Topics: Adenosine; Adenosine Deaminase; Humans; Inosine; Neoplasms; RNA Editing; RNA-Binding Proteins; RNA, Untranslated	2020
Oxygenation and A2AR blockade to eliminate hypoxia/HIF-1α-adenosinergic immunosuppressive axis and improve cancer immunotherapy. Current opinion in pharmacology, 2020, Volume: 53 Topics: 5'-Nucleotidase; Adenosine; Adenosine A2 Receptor Antagonists; Animals; Antigens, CD; Apyrase; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immune Tolerance; Immunotherapy; Neoplasms; Oxygen; Receptor, Adenosine A2A; Tumor Hypoxia	2020
Pharmacological and genetic strategies for targeting adenosine to enhance adoptive T cell therapy of cancer. Current opinion in pharmacology, 2020, Volume: 53 Topics: Adenosine; Animals; Gene Editing; Humans; Immunotherapy, Adoptive; Neoplasms; Receptors, Chimeric Antigen; T-Lymphocytes; Tumor Microenvironment	2020
Roles of METTL3 in cancer: mechanisms and therapeutic targeting. Journal of hematology & oncology, 2020, 08-27, Volume: 13, Issue:1 Topics: Adenosine; Antineoplastic Agents; Binding, Competitive; Carcinogens; Drug Design; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Humans; Methylation; Methyltransferases; Models, Molecular; Molecular Targeted Therapy; Neoplasm Proteins; Neoplasms; Oncogenes; Protein Conformation; Protein Domains; Recombinant Fusion Proteins; RNA Processing, Post-Transcriptional; RNA, Neoplasm; Substrate Specificity; Tumor Suppressor Proteins	2020
Sufficient numbers of anti-tumor T cells is a condition of maximal efficacy of anti-hypoxia-A2-adenosinergic drugs during cancer immunotherapy. Current opinion in pharmacology, 2020, Volume: 53 Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Humans; Immunotherapy; Neoplasms; Receptor, Adenosine A2A; T-Lymphocytes; Tumor Hypoxia	2020
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales medico-psychologiques, 2021, Volume: 179, Issue:2 Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses	2021
Surmounting cancer drug resistance: New insights from the perspective of N Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 2020, Volume: 53 Topics: Adenosine; Animals; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Disease Models, Animal; DNA Damage; DNA Repair; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Immune Checkpoint Inhibitors; Methylation; Neoplasms; Protein Kinase Inhibitors; RNA Processing, Post-Transcriptional; Treatment Outcome; Tumor Microenvironment	2020
Inhibition of the Adenosine Pathway to Potentiate Cancer Immunotherapy: Potential for Combinatorial Approaches. Annual review of medicine, 2021, 01-27, Volume: 72 Topics: Adenosine; Humans; Immunotherapy; Neoplasms	2021
N6-methyladenosine RNA modification in cancer therapeutic resistance: Current status and perspectives. Biochemical pharmacology, 2020, Volume: 182 Topics: Adenosine; Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Resistance, Neoplasm; Humans; Neoplasms; RNA	2020
SETD2 as a regulator of N6-methyladenosine RNA methylation and modifiers in cancer. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP), 2020, Volume: 29, Issue:6 Topics: Adenosine; Biomarkers, Tumor; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Histone-Lysine N-Methyltransferase; Humans; Mutation; Neoplasms; Prognosis	2020
Modulation of myeloid cells by adenosine signaling. Current opinion in pharmacology, 2020, Volume: 53 Topics: Adenosine; Animals; Autoimmune Diseases; Dendritic Cells; Humans; Infections; Myeloid Cells; Neoplasms; Receptors, Purinergic P1; Sepsis; Signal Transduction	2020
N Cell proliferation, 2020, Volume: 53, Issue:11 Topics: Adenosine; Animals; Disease Progression; Humans; Methylation; Methyltransferases; Neoplasms; RNA, Messenger	2020
Targeting Hypoxia-A2A Adenosinergic Immunosuppression of Antitumor T Cells During Cancer Immunotherapy. Frontiers in immunology, 2020, Volume: 11 Topics: Adenosine; Animals; Biomarkers; Humans; Hypoxia; Immunosuppression Therapy; Immunotherapy; Molecular Targeted Therapy; Neoplasms; Receptor, Adenosine A2A; Signal Transduction; T-Lymphocytes; Treatment Outcome	2020
The role of m Cell death & disease, 2020, 11-08, Volume: 11, Issue:11 Topics: Adenosine; Animals; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation; Humans; Mental Disorders; Metabolic Diseases; Neoplasms; RNA, Messenger	2020
Novel Insights Into the Role of N6-Methyladenosine RNA Modification in Bone Pathophysiology. Stem cells and development, 2021, 01-01, Volume: 30, Issue:1 Topics: Adenosine; Bone and Bones; Cartilage; Humans; Methylation; MicroRNAs; Neoplasms; RNA; RNA, Long Noncoding; RNA, Messenger	2021
Adenosine metabolism in the vascular system. Biochemical pharmacology, 2021, Volume: 187 Topics: 5'-Nucleotidase; Adenosine; Adenosine Triphosphate; Animals; Capillary Permeability; Humans; Neoplasms; Regional Blood Flow; Signal Transduction; Vascular Diseases; Vasoconstrictor Agents; Vasodilator Agents	2021
Equilibrative Nucleoside Transporter 2: Properties and Physiological Roles. BioMed research international, 2020, Volume: 2020 Topics: Adenosine; Animals; Antineoplastic Agents; Biological Transport; Biomarkers; Cell Cycle; Cell Line, Tumor; Cell Membrane; Equilibrative-Nucleoside Transporter 2; Glycosylation; Humans; Mice; Neoplasms; Nucleosides; Rabbits; Rats; Signal Transduction	2020
To protect and modify double-stranded RNA - the critical roles of ADARs in development, immunity and oncogenesis. Critical reviews in biochemistry and molecular biology, 2021, Volume: 56, Issue:1 Topics: Adenosine; Adenosine Deaminase; Animals; Carcinogenesis; Deamination; Humans; Immunity, Innate; Inosine; Neoplasms; RNA Editing; RNA-Binding Proteins; RNA, Double-Stranded	2021
The role of m Molecular cancer, 2021, 01-18, Volume: 20, Issue:1 Topics: 5-Methylcytosine; Adenosine; Humans; Neoplasms; Pseudouridine; RNA; RNA Processing, Post-Transcriptional	2021
The Impacts of Non-coding RNAs and N Current cancer drug targets, 2021, Volume: 21, Issue:5 Topics: Adenosine; Cell Differentiation; Drug Discovery; Gene Regulatory Networks; Humans; Neoplasms; RNA, Untranslated	2021
Adenine-Based Purines and Related Metabolizing Enzymes: Evidence for Their Impact on Tumor Extracellular Vesicle Activities. Cells, 2021, 01-19, Volume: 10, Issue:1 Topics: Adenosine; Adenosine Triphosphate; Biomarkers, Tumor; Cell Communication; Extracellular Vesicles; Neoplasms; Tumor Microenvironment	2021
Tumor-resident adenosine-producing mesenchymal stem cells as a potential target for cancer treatment. Clinical and experimental medicine, 2021, Volume: 21, Issue:2 Topics: 5'-Nucleotidase; Adenosine; Humans; Mesenchymal Stem Cells; Neoplasms; Tumor Microenvironment	2021
The role of N6-methyladenosine mRNA in the tumor microenvironment. Biochimica et biophysica acta. Reviews on cancer, 2021, Volume: 1875, Issue:2 Topics: Adenosine; Disease Progression; Gene Expression Regulation, Neoplastic; Humans; Neoplasms; Neoplastic Stem Cells; RNA, Messenger; Tumor Microenvironment	2021
The effects of RNA editing in cancer tissue at different stages in carcinogenesis. RNA biology, 2021, Volume: 18, Issue:11 Topics: Adenosine; Animals; Carcinogenesis; Humans; Inosine; Neoplasms; RNA Editing; RNA-Binding Proteins; RNA, Double-Stranded	2021
Targeting adenosine and regulatory T cells in cancer immunotherapy. Human immunology, 2021, Volume: 82, Issue:4 Topics: 5'-Nucleotidase; Adenosine; Animals; Antigens, CD; Antineoplastic Agents; Apyrase; Forkhead Transcription Factors; Humans; Immunotherapy; Molecular Targeted Therapy; Neoplasms; T-Lymphocytes, Regulatory; Tumor Microenvironment	2021
The role of m6A modification in the biological functions and diseases. Signal transduction and targeted therapy, 2021, 02-21, Volume: 6, Issue:1 Topics: Adenosine; Epigenesis, Genetic; Heterogeneous-Nuclear Ribonucleoprotein Group A-B; Humans; Methylation; Methyltransferases; Neoplasms; Nerve Tissue Proteins; RNA Processing, Post-Transcriptional; RNA Splicing Factors; RNA-Binding Proteins	2021
Potential and promising anticancer drugs from adenosine and its analogs. Drug discovery today, 2021, Volume: 26, Issue:6 Topics: Adenosine; Animals; Antineoplastic Agents; Drug Development; Humans; Neoplasms; Structure-Activity Relationship	2021
Effects of m6A modifications on signaling pathways in human cancer (Review). Oncology reports, 2021, Volume: 45, Issue:4 Topics: Adenosine; Cell Transformation, Neoplastic; Gene Expression Regulation, Neoplastic; Humans; Methylation; Neoplasms; RNA Processing, Post-Transcriptional; Signal Transduction	2021
Linking the YTH domain to cancer: the importance of YTH family proteins in epigenetics. Cell death & disease, 2021, 04-01, Volume: 12, Issue:4 Topics: Adenosine; Animals; Epigenesis, Genetic; Humans; Neoplasms; Nerve Tissue Proteins; RNA; RNA-Binding Proteins	2021
N6-methyladenosine-dependent signalling in cancer progression and insights into cancer therapies. Journal of experimental & clinical cancer research : CR, 2021, Apr-29, Volume: 40, Issue:1 Topics: Adenosine; Disease Progression; Humans; Neoplasms; Signal Transduction	2021
N Cancer communications (London, England), 2021, Volume: 41, Issue:7 Topics: Adenosine; Humans; Methylation; Neoplasms; RNA; RNA, Messenger	2021
Extracellular ATP and Adenosine in Cancer Pathogenesis and Treatment. Trends in cancer, 2021, Volume: 7, Issue:8 Topics: Adenosine; Adenosine Triphosphate; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Clinical Trials as Topic; Disease Models, Animal; Drug Resistance, Neoplasm; Humans; Immune Checkpoint Inhibitors; Neoplasms; Progression-Free Survival; Purinergic P1 Receptor Antagonists; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P1; Receptors, Purinergic P2; Signal Transduction; Xenograft Model Antitumor Assays	2021
Translation role of circRNAs in cancers. Journal of clinical laboratory analysis, 2021, Volume: 35, Issue:7 Topics: Adenosine; Animals; Humans; Models, Biological; Neoplasms; RNA Caps; RNA, Circular; Translational Research, Biomedical	2021
Interactions between m6A modification and miRNAs in malignant tumors. Cell death & disease, 2021, 06-09, Volume: 12, Issue:6 Topics: Adenosine; Animals; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Methylation; Methyltransferases; MicroRNAs; Neoplasms; RNA Processing, Post-Transcriptional	2021
The METTL3-m Genes, 2021, 06-30, Volume: 12, Issue:7 Topics: Adenosine; Cell Differentiation; Epigenesis, Genetic; Epithelial Cells; Gene Expression Regulation; Humans; Methyltransferases; Neoplasms; Transcriptome	2021
The Emerging Roles of RNA m Cancer research, 2021, 07-01, Volume: 81, Issue:13 Topics: Adenosine; Animals; Demethylation; Drug Resistance, Neoplasm; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Methylation; Neoplasms; RNA	2021
The Role of International journal of biological sciences, 2021, Volume: 17, Issue:9 Topics: Adenosine; Animals; Disease Progression; DNA Methylation; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Humans; Neoplasms; RNA, Circular	2021
Adenosine: The common target between cancer immunotherapy and glaucoma in the eye. Life sciences, 2021, Oct-01, Volume: 282 Topics: Adenosine; Animals; Eye; Glaucoma; Humans; Immunity; Immunotherapy; Neoplasms	2021
RNA methylation in mammalian development and cancer. Cell biology and toxicology, 2021, Volume: 37, Issue:6 Topics: Adenosine; Animals; Cell Differentiation; Methylation; Neoplasms; RNA	2021
The detection and functions of RNA modification m The Journal of biological chemistry, 2021, Volume: 297, Issue:2 Topics: Adenosine; Eukaryotic Cells; Humans; Methyltransferases; Neoplasms; RNA Processing, Post-Transcriptional; RNA, Messenger	2021
Adenosine and Inflammation: Here, There and Everywhere. International journal of molecular sciences, 2021, Jul-19, Volume: 22, Issue:14 Topics: Adenosine; Animals; Humans; Inflammation; Inflammatory Bowel Diseases; Ligands; Lung Diseases; Models, Biological; Models, Immunological; Neoplasms; Neuroimmunomodulation; Osteoarthritis; Receptors, Purinergic P1; Rheumatic Diseases	2021
N6-methyladenosine methyltransferases: functions, regulation, and clinical potential. Journal of hematology & oncology, 2021, 07-27, Volume: 14, Issue:1 Topics: Adenosine; Animals; Gene Expression Regulation, Neoplastic; Humans; Methyltransferases; Molecular Targeted Therapy; Neoplasms; Signal Transduction	2021
Decoding m Cancer letters, 2021, 10-10, Volume: 518 Topics: Adenosine; Animals; Gene Expression; Humans; Methylation; Neoplasms; Protein Domains; RNA Processing, Post-Transcriptional; RNA, Messenger	2021
The interplay between m6A modification and non-coding RNA in cancer stemness modulation: mechanisms, signaling pathways, and clinical implications. International journal of biological sciences, 2021, Volume: 17, Issue:11 Topics: Adenosine; Animals; Biomarkers, Tumor; Humans; Molecular Targeted Therapy; Neoplasms; RNA, Untranslated; Signal Transduction	2021
Cancer Immunotherapy: Whence and Whither. Molecular cancer research : MCR, 2017, Volume: 15, Issue:6 Topics: Adenosine; Cytokines; Humans; Immune Tolerance; Immunotherapy; Major Histocompatibility Complex; Mutation; Neoplasms; Receptors, Antigen, T-Cell; T-Lymphocytes; Tumor Microenvironment	2017
Targeting adenosine in cancer immunotherapy: a review of recent progress. Expert review of anticancer therapy, 2017, Volume: 17, Issue:6 Topics: Adenosine; Adenosine Triphosphate; Animals; Antibodies; Antineoplastic Agents; Humans; Immunotherapy; Neoplasms; Tumor Escape; Tumor Microenvironment	2017
Roles of RNA methylation by means of N Cancer letters, 2017, 11-01, Volume: 408 Topics: Adenosine; Gene Expression Regulation; Humans; Methylation; Methyltransferases; Neoplasms; RNA Processing, Post-Transcriptional	2017
Role of N Current opinion in genetics & development, 2018, Volume: 48 Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Gene Expression Regulation, Neoplastic; Neoplasms; RNA Processing, Post-Transcriptional; RNA, Messenger	2018
Targeting immunosuppressive adenosine in cancer. Nature reviews. Cancer, 2017, Volume: 17, Issue:12 Topics: Adenosine; Animals; Antibodies; Humans; Immunity, Cellular; Metabolic Networks and Pathways; Mice; Neoplasms; Purinergic P1 Receptor Antagonists; Tumor Microenvironment	2017
Epitranscriptomic influences on development and disease. Genome biology, 2017, 10-23, Volume: 18, Issue:1 Topics: Adenosine; Animals; Cell Differentiation; Growth and Development; Humans; Neoplasms; RNA Processing, Post-Transcriptional; RNA, Messenger; RNA, Transfer; Transcriptome	2017
The role of A-to-I RNA editing in cancer development. Current opinion in genetics & development, 2018, Volume: 48 Topics: Adenosine; Inosine; MicroRNAs; Neoplasms; RNA Editing	2018
Potential link between m Molecular immunology, 2018, Volume: 93 Topics: Adenosine; AlkB Homolog 5, RNA Demethylase; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Epigenesis, Genetic; Gene Expression Regulation; HIV Infections; Humans; Lupus Erythematosus, Systemic; Methyltransferases; Neoplasms; Nucleic Acid Conformation; Protein Biosynthesis; RNA Precursors; RNA Processing, Post-Transcriptional; RNA Splicing; RNA Stability; RNA-Binding Proteins	2018
In cancer, A-to-I RNA editing can be the driver, the passenger, or the mechanic. Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy, 2017, Volume: 32 Topics: Adenosine; Adenosine Deaminase; Alu Elements; Antineoplastic Agents; Biomarkers, Tumor; Carcinogenesis; Genetic Therapy; Humans; Inosine; Molecular Targeted Therapy; Neoplasms; Oncogenes; RNA Editing; RNA-Binding Proteins; RNA, Double-Stranded; RNA, Messenger; Tumor Suppressor Proteins	2017
An appraisal on synthetic and pharmaceutical perspectives of pyrazolo[4,3-d]pyrimidine scaffold. Bioorganic & medicinal chemistry, 2018, 01-15, Volume: 26, Issue:2 Topics: Adenosine; Anti-Infective Agents; Antineoplastic Agents; Cytokinins; Enzyme Inhibitors; Humans; Molecular Structure; Neoplasms; Phosphoric Diester Hydrolases; Pyrazoles; Pyrimidines	2018
When MicroRNAs Meet RNA Editing in Cancer: A Nucleotide Change Can Make a Difference. BioEssays : news and reviews in molecular, cellular and developmental biology, 2018, Volume: 40, Issue:2 Topics: Adenosine; Adenosine Deaminase; Animals; Humans; Inosine; MicroRNAs; Neoplasms; RNA Editing; RNA-Binding Proteins	2018
Melatonin with adenosine solubilized in water and stabilized with glycine for oncological treatment - technical preparation, effectivity and clinical findings. Neuro endocrinology letters, 2017, Volume: 38, Issue:7 Topics: Adenosine; Antineoplastic Agents; Drug Compounding; Humans; Melatonin; Neoplasms	2017
N6-methyladenosine links RNA metabolism to cancer progression. Cell death & disease, 2018, 01-26, Volume: 9, Issue:2 Topics: Adenosine; Animals; Disease Progression; DNA Damage; Humans; Neoplasms; RNA, Long Noncoding; RNA, Neoplasm	2018
Canonical and non-canonical adenosinergic pathways. Immunology letters, 2019, Volume: 205 Topics: Adenosine; Adenosine Triphosphate; Animals; Antigens, CD; Humans; Leukocytes; NAD; Neoplasms; Receptors, Purinergic P1; Signal Transduction	2019
Controlling the Immune Suppressor: Transcription Factors and MicroRNAs Regulating CD73/NT5E. Frontiers in immunology, 2018, Volume: 9 Topics: 5'-Nucleotidase; Adenosine; Animals; Gene Expression Regulation; Genes, cdc; GPI-Linked Proteins; Humans; Immunity, Cellular; Immunosuppressive Agents; Mice; MicroRNAs; Neoplasms; RNA Processing, Post-Transcriptional; RNA, Messenger; Transcription Factors	2018
The Role of Dynamic m Photochemistry and photobiology, 2019, Volume: 95, Issue:1 Topics: Adenosine; Circadian Clocks; DNA Damage; DNA Repair; Humans; Methylation; Neoplasms; RNA; Stem Cells; Ultraviolet Rays	2019
Mechanism of N Pharmacology & therapeutics, 2018, Volume: 189 Topics: Adenosine; Animals; Histone Demethylases; Humans; Methylation; Methyltransferases; Neoplasms; RNA; RNA Editing	2018
Targeting the CD73-adenosine axis in immuno-oncology. Immunology letters, 2019, Volume: 205 Topics: 5'-Nucleotidase; Adenosine; Animals; Antibodies, Neoplasm; Gene Expression Regulation, Neoplastic; Humans; Neoplasms; Purinergic Antagonists; Receptors, Purinergic P1; Signal Transduction	2019
Pharmacology of Adenosine Receptors: The State of the Art. Physiological reviews, 2018, 07-01, Volume: 98, Issue:3 Topics: Adenosine; Animals; Autoimmune Diseases; Cardiovascular Diseases; Humans; Molecular Structure; Neoplasms; Nervous System Diseases; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Signal Transduction	2018
Targeting adenosine for cancer immunotherapy. Journal for immunotherapy of cancer, 2018, 06-18, Volume: 6, Issue:1 Topics: Adenosine; Animals; Biomarkers, Tumor; Clinical Trials as Topic; Drug Evaluation, Preclinical; Humans; Immunomodulation; Immunotherapy; Neoplasms; Signal Transduction; Treatment Outcome; Tumor Escape	2018
Metabolic adaptation of cancer and immune cells mediated by hypoxia-inducible factors. Biochimica et biophysica acta. Reviews on cancer, 2018, Volume: 1870, Issue:1 Topics: Adenosine; Amino Acids; Aryl Hydrocarbon Receptor Nuclear Translocator; Basic Helix-Loop-Helix Transcription Factors; Cell Hypoxia; Fatty Acids; Glucose; Glycogen; Humans; Lipids; Neoplasms; T-Lymphocytes	2018
Methylation of RNA N Cytokine, 2019, Volume: 118 Topics: Adenosine; Animals; Carcinogenesis; Cytokines; Humans; Methylation; Neoplasms; RNA	2019
Novel insights on m Molecular cancer, 2018, 07-21, Volume: 17, Issue:1 Topics: Adenosine; Carcinogenesis; Disease Progression; Gene Regulatory Networks; Humans; Neoplasms; RNA, Messenger	2018
The dual role of N6-methyladenosine modification of RNAs is involved in human cancers. Journal of cellular and molecular medicine, 2018, Volume: 22, Issue:10 Topics: Adenosine; AlkB Homolog 5, RNA Demethylase; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Carcinogenesis; Disease Progression; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Genetic Therapy; Humans; Methylation; Methyltransferases; Molecular Targeted Therapy; Neoplasms; RNA Editing; RNA, Neoplasm	2018
Adenosinergic signaling as a target for natural killer cell immunotherapy. Journal of molecular medicine (Berlin, Germany), 2018, Volume: 96, Issue:9 Topics: Adenosine; Adenosine Deaminase; Animals; Biomarkers; Humans; Immunomodulation; Immunotherapy; Killer Cells, Natural; Neoplasms; Receptors, Purinergic P1; Signal Transduction	2018
Aberrant Regulation of mRNA m⁶A Modification in Cancer Development. International journal of molecular sciences, 2018, Aug-25, Volume: 19, Issue:9 Topics: Adenosine; Animals; Cell Transformation, Neoplastic; Gene Expression Regulation, Neoplastic; Humans; Methylation; Methyltransferases; Neoplasms; RNA, Messenger	2018
Targeting adenosine A Expert opinion on drug discovery, 2018, Volume: 13, Issue:11 Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Antineoplastic Agents; Drug Design; Humans; Neoplasms; Receptor, Adenosine A2A; Tumor Microenvironment	2018
Novel positioning from obesity to cancer: FTO, an m Journal of cancer research and clinical oncology, 2019, Volume: 145, Issue:1 Topics: 3' Untranslated Regions; Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Body Mass Index; Cell Proliferation; Demethylation; Disease Progression; Drug Resistance, Neoplasm; Epigenesis, Genetic; Gene Expression Regulation; Humans; Neoplasm Metastasis; Neoplasms; Obesity; Oncogenes; Polymorphism, Single Nucleotide; Prognosis; Radiation Tolerance	2019
CD73 as a potential opportunity for cancer immunotherapy. Expert opinion on therapeutic targets, 2019, Volume: 23, Issue:2 Topics: 5'-Nucleotidase; Adenosine; Animals; GPI-Linked Proteins; Humans; Immunotherapy; Molecular Targeted Therapy; Neoplasms; Tumor Microenvironment	2019
A dynamic reversible RNA N Journal of cellular physiology, 2019, Volume: 234, Issue:6 Topics: Adenosine; Epigenesis, Genetic; Humans; Lipid Metabolism; Methylation; Methyltransferases; Neoplasms; RNA Processing, Post-Transcriptional; RNA, Messenger	2019
CD73 (Cluster of Differentiation 73) and the Differences Between Mice and Humans. Arteriosclerosis, thrombosis, and vascular biology, 2019, Volume: 39, Issue:3 Topics: 5'-Nucleotidase; Adenosine; Adenosine Monophosphate; Animals; Clinical Trials as Topic; Disease Models, Animal; GPI-Linked Proteins; Humans; Inflammation; Joint Diseases; Mice, Knockout; Molecular Targeted Therapy; Neoplasms; Phenotype; Species Specificity; Thrombophilia; Tunica Media; Vascular Calcification; Vascular Diseases; Vascular Remodeling	2019
The role of m6A RNA methylation in cancer. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2019, Volume: 112 Topics: Adenosine; Animals; Humans; Methylation; Neoplasms; RNA	2019
Functions of RNA N6-methyladenosine modification in cancer progression. Molecular biology reports, 2019, Volume: 46, Issue:1 Topics: Adenosine; Animals; Disease Progression; Humans; Methylation; Neoplasms; RNA	2019
Inhibition of the adenosinergic pathway: the indispensable part of oncological therapy in the future. Purinergic signalling, 2019, Volume: 15, Issue:1 Topics: Adenosine; Animals; Humans; Immunotherapy; Neoplasms; Tumor Escape; Tumor Microenvironment	2019
Importance of m N Medical oncology (Northwood, London, England), 2019, Mar-16, Volume: 36, Issue:4 Topics: Adenosine; Animals; DNA Damage; Humans; Methylation; Neoplasms; RNA, Neoplasm	2019
The Critical Role of RNA m Cancer research, 2019, 04-01, Volume: 79, Issue:7 Topics: Adenosine; Demethylation; Humans; Methylation; Methyltransferases; Neoplasms; RNA; RNA-Binding Proteins	2019
Functions of RNA N6-methyladenosine modification in cancer progression. Molecular biology reports, 2019, Volume: 46, Issue:2 Topics: Adenosine; Disease Progression; Humans; Methylation; Methyltransferases; Neoplasms; RNA; RNA Processing, Post-Transcriptional	2019
Regulation of Gene Expression by N Trends in cell biology, 2019, Volume: 29, Issue:6 Topics: Adenosine; Animals; Gene Expression Regulation, Neoplastic; Humans; Neoplasms	2019
Detection of N6‑methyladenosine modification residues (Review). International journal of molecular medicine, 2019, Volume: 43, Issue:6 Topics: Adenosine; Animals; Biosensing Techniques; Blotting, Northern; Chromatography, High Pressure Liquid; Electrochemical Techniques; Humans; Immunoblotting; Immunoprecipitation; Methylation; Neoplasms; RNA; Sequence Analysis, RNA	2019
A Review in Research Progress Concerning m6A Methylation and Immunoregulation. Frontiers in immunology, 2019, Volume: 10 Topics: Active Transport, Cell Nucleus; Adenosine; Humans; Methylation; Methyltransferases; Neoplasms; RNA Processing, Post-Transcriptional; RNA Splicing; RNA, Messenger	2019
Role of Mast Cell-Derived Adenosine in Cancer. International journal of molecular sciences, 2019, May-27, Volume: 20, Issue:10 Topics: Adenosine; Animals; Humans; Mast Cells; Neoplasms; Receptors, Purinergic P1; Signal Transduction; Tumor Microenvironment	2019
Significant epitranscriptomes in heterogeneous cancer. Cancer science, 2019, Volume: 110, Issue:8 Topics: Adenosine; Animals; Eukaryota; Humans; Neoplasms; Precision Medicine; RNA, Messenger; Transcriptome	2019
Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function. Frontiers in immunology, 2019, Volume: 10 Topics: Adenosine; Biomarkers; Cyclic AMP; Humans; Immunity, Innate; Immunomodulation; Molecular Targeted Therapy; Neoplasms; Organ Specificity; Receptors, Purinergic P1; Signal Transduction; T-Lymphocytes; Tumor Microenvironment	2019
Adenosine Receptors as Novel Targets for the Treatment of Various Cancers. Current pharmaceutical design, 2019, Volume: 25, Issue:26 Topics: Adenosine; Endothelial Cells; Humans; Neoplasms; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Signal Transduction; Tumor Microenvironment	2019
P1 Receptor Agonists/Antagonists in Clinical Trials - Potential Drug Candidates of the Future. Current pharmaceutical design, 2019, Volume: 25, Issue:26 Topics: Adenosine; Asthma; Cardiovascular Diseases; Clinical Trials as Topic; Humans; Ligands; Neoplasms; Parkinson Disease; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Purines; Pyrazoles; Receptors, Purinergic P1	2019
Multilevel pharmacological manipulation of adenosine-prostaglandin E₂/cAMP nexus in the tumor microenvironment: a 'two hit' therapeutic opportunity. Pharmacological research, 2013, Volume: 73 Topics: Adenosine; Animals; Antineoplastic Agents; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dinoprostone; Humans; Neoplasms; Tumor Microenvironment	2013
Regulatory T cell subsets in human cancer: are they regulating for or against tumor progression? Cancer immunology, immunotherapy : CII, 2014, Volume: 63, Issue:1 Topics: Adenosine; Animals; CD4-Positive T-Lymphocytes; Chemoradiotherapy; Dinoprostone; Disease Progression; Gene Expression Regulation, Neoplastic; Humans; Immunotherapy; Inflammation; Lymphocyte Subsets; Neoplasms; T-Lymphocytes, Regulatory; Tumor Escape; Tumor Microenvironment	2014
Immunity, inflammation and cancer: a leading role for adenosine. Nature reviews. Cancer, 2013, Volume: 13, Issue:12 Topics: Adenosine; Animals; Cell Proliferation; Humans; Inflammation; Inflammation Mediators; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Neoplasm Metastasis; Neoplasms; Receptors, Purinergic P1; Tumor Microenvironment	2013
[Methodology for analysing quality-of-life data in the benefit assessment of pharmaceuticals]. Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen, 2014, Volume: 108, Issue:2-3 Topics: Adenosine; Clinical Trials, Phase III as Topic; Crizotinib; Drug Approval; Endpoint Determination; Humans; Kaplan-Meier Estimate; Neoplasms; Patient Outcome Assessment; Patient Satisfaction; Prescription Drugs; Protein Kinase Inhibitors; Pyrazoles; Pyridines; Quality of Life; Quality-Adjusted Life Years; Risk Assessment; Ticagrelor	2014
Immunoregulatory activity of adenosine and its role in human cancer progression. Expert review of clinical immunology, 2014, Volume: 10, Issue:7 Topics: Adenosine; Cell Proliferation; Humans; Neoplasms; Receptors, Purinergic P1; Signal Transduction	2014
Targeting cancer-derived adenosine: new therapeutic approaches. Cancer discovery, 2014, Volume: 4, Issue:8 Topics: 5'-Nucleotidase; Adenosine; Animals; Antigens, CD; Apyrase; GPI-Linked Proteins; Humans; Immunosuppressive Agents; Mice; Molecular Targeted Therapy; Neoplasms; Purinergic P1 Receptor Antagonists	2014
EZH2 as a potential target in cancer therapy. Epigenomics, 2014, Volume: 6, Issue:3 Topics: Adenosine; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Humans; Neoplasms; Neoplastic Stem Cells; Polycomb Repressive Complex 2; Small Molecule Libraries	2014
The roles of CD73 in cancer. BioMed research international, 2014, Volume: 2014 Topics: 5'-Nucleotidase; Adenosine; Adenosine Monophosphate; Animals; Carcinogenesis; Cell Proliferation; Gene Expression Regulation, Neoplastic; GPI-Linked Proteins; Humans; Mice; Neoplasms; Neovascularization, Pathologic	2014
[Immune regulation via the generation of extracellular adenosine by CD73]. Seikagaku. The Journal of Japanese Biochemical Society, 2014, Volume: 86, Issue:6 Topics: 5'-Nucleotidase; Adenosine; Adenosine Triphosphate; Animals; Graft vs Host Disease; Humans; Neoplasms; Receptors, Purinergic P1; T-Lymphocytes, Regulatory	2014
Recent progress for the synthesis of selected carbocyclic nucleosides. Future medicinal chemistry, 2015, Volume: 7, Issue:13 Topics: Adenosine; Animals; Antineoplastic Agents; Antiviral Agents; Drug Discovery; Guanine; Halogenation; Humans; Neoplasms; Nucleosides; Virus Diseases; Viruses	2015
Solid cancers after antiplatelet therapy: Confirmations, controversies, and challenges. Thrombosis and haemostasis, 2015, Nov-25, Volume: 114, Issue:6 Topics: Adenosine; Animals; Anticarcinogenic Agents; Aspirin; Blood Platelets; Carcinogenicity Tests; Clopidogrel; Colonic Neoplasms; Drug Therapy, Combination; Female; Humans; Lactones; Male; Mice; Multicenter Studies as Topic; Neoplasm Metastasis; Neoplasms; Neoplasms, Experimental; Neoplastic Cells, Circulating; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Pyridines; Randomized Controlled Trials as Topic; Rivaroxaban; Sex Factors; Species Specificity; Ticagrelor; Ticlopidine; Time Factors	2015
N6-methyladenosine modification in mRNA: machinery, function and implications for health and diseases. The FEBS journal, 2016, Volume: 283, Issue:9 Topics: Adenosine; Cell Differentiation; Eukaryotic Cells; Humans; Methylation; Methyltransferases; Neoplasms; Neurodegenerative Diseases; Oxidoreductases, N-Demethylating; RNA Splicing; RNA, Long Noncoding; RNA, Messenger; Signal Transduction; Transcription, Genetic	2016
CD73-adenosine: a next-generation target in immuno-oncology. Immunotherapy, 2016, Volume: 8, Issue:2 Topics: 5'-Nucleotidase; Adenosine; Adenosine A2 Receptor Antagonists; Animals; Clinical Trials, Phase I as Topic; GPI-Linked Proteins; Humans; Neoplasms; Receptor, Adenosine A2A	2016
Cancer Immunotherapy: Selected Targets and Small-Molecule Modulators. ChemMedChem, 2016, Mar-04, Volume: 11, Issue:5 Topics: Adenosine; Humans; Immunotherapy; Kynurenine; Neoplasms; Protein Serine-Threonine Kinases; Receptor, Transforming Growth Factor-beta Type I; Receptors, Transforming Growth Factor beta; Toll-Like Receptors; Transforming Growth Factor beta	2016
Adenosine can thwart antitumor immune responses elicited by radiotherapy : Therapeutic strategies alleviating protumor ADO activities. Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2016, Volume: 192, Issue:5 Topics: Adenosine; Cell Survival; Evidence-Based Medicine; Humans; Immunity, Innate; Immunologic Factors; Models, Immunological; Neoplasms; Radiotherapy; Treatment Outcome; Tumor Hypoxia	2016
Immunosuppressive activities of adenosine in cancer. Current opinion in pharmacology, 2016, Volume: 29 Topics: 5'-Nucleotidase; Adenosine; Animals; Antibodies; Antineoplastic Agents; Disease Progression; Drug Design; Humans; Neoplasms; Receptor, Adenosine A2A; Receptor, Adenosine A2B; Receptors, Purinergic	2016
Regulation of the T Cell Response by CD39. Trends in immunology, 2016, Volume: 37, Issue:7 Topics: 5'-Nucleotidase; Adenosine; Adenosine Monophosphate; Animals; Antigens, CD; Apyrase; Autoimmune Diseases; Autoimmunity; Gene-Environment Interaction; Humans; Immune Tolerance; Infections; Inflammation; Lymphocyte Activation; Neoplasms; T-Lymphocytes	2016
P2 receptors in cancer progression and metastatic spreading. Current opinion in pharmacology, 2016, Volume: 29 Topics: Adenosine; Adenosine Triphosphate; Animals; Disease Progression; Humans; Neoplasm Metastasis; Neoplasms; Receptors, Purinergic P2; Tumor Microenvironment	2016
A2A adenosine receptor antagonists to weaken the hypoxia-HIF-1α driven immunosuppression and improve immunotherapies of cancer. Current opinion in pharmacology, 2016, Volume: 29 Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Immune Tolerance; Immunotherapy; Killer Cells, Natural; Neoplasms; Signal Transduction; T-Lymphocytes; Tumor Microenvironment	2016
Role of adenosine A2b receptor overexpression in tumor progression. Life sciences, 2016, Dec-01, Volume: 166 Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Disease Progression; Gene Expression Regulation, Neoplastic; Humans; Immune Tolerance; Molecular Targeted Therapy; Neoplasms; Receptor, Adenosine A2B; Tumor Microenvironment; Up-Regulation	2016
Adenosine and adenosine receptors in the immunopathogenesis and treatment of cancer. Journal of cellular physiology, 2018, Volume: 233, Issue:3 Topics: 5'-Nucleotidase; Adenosine; Adenosine A1 Receptor Agonists; Adenosine A1 Receptor Antagonists; Adenosine A2 Receptor Agonists; Adenosine A2 Receptor Antagonists; Adenosine A3 Receptor Agonists; Adenosine A3 Receptor Antagonists; Adenosine Triphosphate; Animals; Antigens, CD; Apyrase; GPI-Linked Proteins; Humans; Mice; Neoplasms; Receptor, Adenosine A1; Receptor, Adenosine A3; Receptors, Adenosine A2; Signal Transduction; Tumor Escape	2018
Regulatory Role of N Journal of cellular biochemistry, 2017, Volume: 118, Issue:9 Topics: Adenosine; Animals; Diabetes Mellitus, Type 2; Enzyme Inhibitors; Humans; Methylation; Neoplasms; Obesity; RNA Processing, Post-Transcriptional; RNA, Neoplasm	2017
Anticancer drug discovery targeting DNA hypermethylation. Current medicinal chemistry, 2008, Volume: 15, Issue:14 Topics: 4-Aminobenzoic Acid; Adenosine; Animals; Antineoplastic Agents; Cytidine; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Drug Design; Enzyme Inhibitors; Humans; Hydrazines; Neoplasms; Oligonucleotides, Antisense; para-Aminobenzoates	2008
NTPDase and 5'-nucleotidase activities in physiological and disease conditions: new perspectives for human health. BioFactors (Oxford, England), 2007, Volume: 31, Issue:2 Topics: 5'-Nucleotidase; Adenosine; Adenosine Triphosphate; Animals; Antigens, CD; Apyrase; Atherosclerosis; Blood Coagulation; Blood Platelets; Cell Communication; Demyelinating Diseases; Epilepsy; Humans; Metabolism, Inborn Errors; Myocardial Infarction; Neoplasms; Platelet Activation; Platelet Aggregation; Seizures; Signal Transduction; Tamoxifen; Thrombosis	2007
Hypoxia-adenosinergic immunosuppression: tumor protection by T regulatory cells and cancerous tissue hypoxia. Clinical cancer research : an official journal of the American Association for Cancer Research, 2008, Oct-01, Volume: 14, Issue:19 Topics: Adenosine; Animals; Caffeine; CD8-Positive T-Lymphocytes; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Immunosuppressive Agents; Immunotherapy; Mice; Models, Biological; Neoplasms; Receptor, Adenosine A2A; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory	2008
[Coffee and cancer]. Medicina clinica, 2008, Nov-08, Volume: 131, Issue:16 Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Anticarcinogenic Agents; Caffeine; Cell Transformation, Neoplastic; Coffee; Female; Humans; Lymphocyte Activation; Male; Mice; Mice, Transgenic; Neoplasm Proteins; Neoplasms; Neovascularization, Pathologic; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Receptors, Adenosine A2; Theobromine; Theophylline	2008
[Stem cell-targeted therapy--a new strategy for cancer treatment]. Zhonghua zhong liu za zhi [Chinese journal of oncology], 2008, Volume: 30, Issue:11 Topics: Adenosine; Animals; Antineoplastic Agents; ATP-Binding Cassette Transporters; Biomarkers, Tumor; Cell Differentiation; Diketopiperazines; Heterocyclic Compounds, 4 or More Rings; Humans; Lapatinib; Neoplasms; Neoplastic Stem Cells; Protein Kinase Inhibitors; Pyrimidinones; Quinazolines; Signal Transduction; Triazines; Wnt Proteins	2008
The resolution of inflammation and cancer. Cytokine & growth factor reviews, 2010, Volume: 21, Issue:1 Topics: Adenosine; Animals; Cytokines; Humans; Inflammation; Inflammation Mediators; Lipids; Models, Immunological; Neoplasms	2010
Molecular diversity through RNA editing: a balancing act. Trends in genetics : TIG, 2010, Volume: 26, Issue:5 Topics: Adenosine; Animals; Deamination; Humans; Neoplasms; Nervous System Diseases; Proteins; RNA Editing	2010
Extracellular adenosine triphosphate and adenosine in cancer. Oncogene, 2010, Sep-30, Volume: 29, Issue:39 Topics: Adenosine; Adenosine Triphosphate; Extracellular Space; Humans; Immunity; Immunosuppression Therapy; Neoplasms; Receptors, Purinergic P1; Signal Transduction	2010
Targeting human inducible regulatory T cells (Tr1) in patients with cancer: blocking of adenosine-prostaglandin E₂ cooperation. Expert opinion on biological therapy, 2011, Volume: 11, Issue:9 Topics: Adenosine; Dinoprostone; Humans; Neoplasms; T-Lymphocytes, Regulatory	2011
Adenosine-to-inosine RNA editing meets cancer. Carcinogenesis, 2011, Volume: 32, Issue:11 Topics: Adenosine; Animals; Humans; Inosine; Neoplasms; RNA Editing	2011
The role of the adenosinergic pathway in immunosuppression mediated by human regulatory T cells (Treg). Current medicinal chemistry, 2011, Volume: 18, Issue:34 Topics: Adenosine; Animals; Dinoprostone; Humans; Immune Tolerance; Neoplasms; T-Lymphocytes, Regulatory; Tumor Microenvironment	2011
Polycomb genes and cancer: time for clinical application? Critical reviews in oncology/hematology, 2012, Volume: 83, Issue:2 Topics: Adenosine; Animals; Antineoplastic Agents; Gene Expression Regulation, Neoplastic; Humans; Neoplasms; Neoplastic Stem Cells; Polycomb Repressive Complex 2; Polycomb-Group Proteins	2012
Regulation of macrophage function by adenosine. Arteriosclerosis, thrombosis, and vascular biology, 2012, Volume: 32, Issue:4 Topics: Adenosine; Animals; Cell Differentiation; Humans; Inflammation; Macrophage Activation; Macrophages; Neoplasms; Neovascularization, Physiologic; Osteoclasts; Phagocytosis; Receptors, Purinergic P1; Signal Transduction; Vascular Diseases	2012
CD73: a potent suppressor of antitumor immune responses. Trends in immunology, 2012, Volume: 33, Issue:5 Topics: 5'-Nucleotidase; Adenosine; Animals; Disease Progression; Humans; Immune Tolerance; Neoplasms	2012
New insights regarding the regulation of chemotaxis by nucleotides, adenosine, and their receptors. Purinergic signalling, 2012, Volume: 8, Issue:3 Topics: Adenosine; Adenosine Triphosphate; Animals; Cell Movement; Chemotaxis; Chemotaxis, Leukocyte; Humans; Microglia; Neoplasms; Neutrophils; Nucleotides; Receptors, Cell Surface; Receptors, Purinergic P1	2012
CD73-generated adenosine: orchestrating the tumor-stroma interplay to promote cancer growth. Journal of biomedicine & biotechnology, 2012, Volume: 2012 Topics: 5'-Nucleotidase; Adenosine; Animals; Cell Proliferation; Humans; Neoplasms; Stromal Cells; T-Lymphocytes, Regulatory	2012
Production of adenosine by ectonucleotidases: a key factor in tumor immunoescape. Journal of biomedicine & biotechnology, 2012, Volume: 2012 Topics: 5'-Nucleotidase; Adenosine; Animals; Antineoplastic Agents; Humans; Immune Evasion; Molecular Targeted Therapy; Neoplasms	2012
Adenosine as an endogenous immunoregulator in cancer pathogenesis: where to go? Purinergic signalling, 2013, Volume: 9, Issue:2 Topics: Adenosine; Animals; Humans; Immunologic Factors; Neoplasms	2013
Biological functions of ecto-enzymes in regulating extracellular adenosine levels in neoplastic and inflammatory disease states. Journal of molecular medicine (Berlin, Germany), 2013, Volume: 91, Issue:2 Topics: Adenosine; Animals; Autoimmune Diseases; Humans; Hydrolases; Inflammation; Neoplasms; Reperfusion Injury; Respiratory Tract Diseases; Sepsis	2013
Targeting the hypoxia-adenosinergic signaling pathway to improve the adoptive immunotherapy of cancer. Journal of molecular medicine (Berlin, Germany), 2013, Volume: 91, Issue:2 Topics: Adenosine; Animals; Humans; Hypoxia; Immunotherapy, Adoptive; Neoplasms; Receptors, Adenosine A2; Signal Transduction; T-Lymphocytes; Tumor Microenvironment	2013
Adenosine signalling pathways in the pituitary gland: one ligand, multiple receptors. The Journal of endocrinology, 2003, Volume: 177, Issue:3 Topics: Adenosine; Cell Division; Humans; Inflammation; Interleukin-6; Neoplasms; Pituitary Gland, Anterior; Pituitary Hormones; Receptors, Purinergic P1; Signal Transduction	2003
A glance at adenosine receptors: novel target for antitumor therapy. Pharmacology & therapeutics, 2003, Volume: 100, Issue:1 Topics: Adenosine; Animals; Antineoplastic Agents; Apoptosis; Cell Division; Humans; Neoplasms; Neovascularization, Pathologic; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Receptors, Purinergic P1; Signal Transduction	2003
Adenosine-mediated inhibition of cytotoxic activity and cytokine production by IL-2/NKp46-activated NK cells: involvement of protein kinase A isozyme I (PKA I). Immunologic research, 2006, Volume: 36, Issue:1-3 Topics: Adenosine; Animals; Cyclic AMP-Dependent Protein Kinases; Cytokines; Cytotoxicity, Immunologic; Humans; Interleukin-2; Isoenzymes; Killer Cells, Natural; Membrane Glycoproteins; Natural Cytotoxicity Triggering Receptor 1; Neoplasms; Receptors, Adenosine A2; Receptors, Immunologic; Tumor Escape	2006
Hypoxia-dependent anti-inflammatory pathways in protection of cancerous tissues. Cancer metastasis reviews, 2007, Volume: 26, Issue:2 Topics: Adenosine; Cell Hypoxia; Humans; Inflammation; Neoplasms; Receptors, Purinergic P1; T-Lymphocytes	2007
Regulatory-T-cell inhibition versus depletion: the right choice in cancer immunotherapy. Nature reviews. Cancer, 2007, Volume: 7, Issue:11 Topics: Adenosine; Animals; Antibodies, Monoclonal; Cell Differentiation; Cell Division; Forkhead Transcription Factors; Humans; Indoleamine-Pyrrole 2,3,-Dioxygenase; Interleukin-2 Receptor alpha Subunit; Lymphocyte Depletion; Mice; Models, Immunological; Neoplasms; Neoplasms, Experimental; Receptors, OX40; Self Tolerance; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory; Thymus Gland	2007
Inhibition of T cell and natural killer cell function by adenosine and its contribution to immune evasion by tumor cells (Review). International journal of oncology, 2008, Volume: 32, Issue:3 Topics: Adenosine; Adenosine Deaminase; Animals; Humans; Immunotherapy; Killer Cells, Natural; Lymphocyte Activation; Models, Biological; Neoplasms; Receptors, Purinergic P1; T-Lymphocytes; Tumor Escape	2008
Altered methionine metabolism, DNA methylation and oncogene expression in carcinogenesis. A review and synthesis. Biochimica et biophysica acta, 1984, Volume: 738, Issue:1-2 Topics: Adenosine; Animals; Azacitidine; Carcinogens; Cell Line; Cell Transformation, Neoplastic; Cell Transformation, Viral; Choline; DNA; DNA (Cytosine-5-)-Methyltransferases; DNA, Viral; Ethionine; Gene Expression Regulation; Homocysteine; Humans; Methionine; Methylation; Methyltransferases; Neoplasms; Oncogenes; Oncogenic Viruses; S-Adenosylhomocysteine; S-Adenosylmethionine; Simian virus 40	1984
Trends in the biochemical pharmacology of 5'-deoxy-5'-methylthioadenosine. Biochemical pharmacology, 1982, Feb-01, Volume: 31, Issue:3 Topics: Adenosine; Animals; Deoxyadenosines; Female; Humans; Male; Neoplasms; Purine-Nucleoside Phosphorylase; Rats; Ribosemonophosphates; S-Adenosylmethionine; Spermidine; Spermine; Thioglycosides; Thionucleosides	1982
Adenosine may regulate the vascular supply and thus the growth and spread of neoplastic tissues: a proposal. General pharmacology, 1981, Volume: 12, Issue:5 Topics: Adenosine; Animals; Dipyridamole; Humans; Neoplasm Metastasis; Neoplasms	1981
Differential effect of adenosine on tumor and normal cell growth: focus on the A3 adenosine receptor. Journal of cellular physiology, 2001, Volume: 186, Issue:1 Topics: Adenosine; Animals; Cell Division; Humans; Neoplasms; Receptor, Adenosine A3; Receptors, Purinergic P1; Reference Values; Signal Transduction	2001
A3 adenosine receptor as a target for cancer therapy. Anti-cancer drugs, 2002, Volume: 13, Issue:5 Topics: Adenosine; Administration, Oral; Animals; Antineoplastic Agents, Alkylating; Granulocyte Colony-Stimulating Factor; Humans; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasms; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Purinergic P1 Receptor Agonists; Receptor, Adenosine A3; Receptors, Purinergic P1; Signal Transduction	2002
Control mechanisms in cell-type conversion in newt lens regeneration. Monographs in developmental biology, 1977, Volume: 13 Topics: Adenosine; Animals; Cell Differentiation; Cell Division; Cell Membrane; Cells, Cultured; Cyclic AMP; DNA; Epithelial Cells; Extremities; Iris; Lens, Crystalline; Neoplasms; Organ Culture Techniques; Pigmentation; Regeneration; Retina; RNA; Salamandridae; Urodela	1977
New targets for cancer chemotherapy--poly(ADP-ribosylation) processing and polyisoprene metabolism. Biological reviews of the Cambridge Philosophical Society, 1990, Volume: 65, Issue:4 Topics: Adenosine; Animals; Butadienes; Drug Design; GTP-Binding Proteins; Hemiterpenes; Humans; Neoplasms; Nuclear Proteins; Pentanes; Poly Adenosine Diphosphate Ribose; Protein Processing, Post-Translational	1990
Methylthioadenosine (MeSAdo) phosphorylase deficiency in malignancy. Advances in experimental medicine and biology, 1988, Volume: 250 Topics: Adenosine; Animals; Deoxyadenosines; Humans; Neoplasms; Pentosyltransferases; Purine-Nucleoside Phosphorylase; Thionucleosides	1988
[Isolation of factors responsible for the immunosuppression found in tumor-bearing animals]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 1985, Volume: 105, Issue:2 Topics: Adenosine; Animals; Glycoproteins; Humans; Immune Tolerance; Macrophage Activation; Macrophages; Mice; Molecular Weight; Neoplasm Proteins; Neoplasms; Nucleosides; RNA, Transfer; Uracil; Uric Acid	1985

Trials

4 trial(s) available for adenosine and Benign Neoplasms

Article	Year
Anti-CD73 antibody activates human B cells, enhances humoral responses and induces redistribution of B cells in patients with cancer. Journal for immunotherapy of cancer, 2022, Volume: 10, Issue:12 Topics: Adenosine; Animals; Antibodies, Monoclonal; Antigens, Viral; B-Lymphocytes; Epitopes; Humans; Immunity, Humoral; Mice; Neoplasms	2022
Adenosine Signaling Is Prognostic for Cancer Outcome and Has Predictive Utility for Immunotherapeutic Response. Clinical cancer research : an official journal of the American Association for Cancer Research, 2020, 05-01, Volume: 26, Issue:9 Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Biomarkers, Tumor; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Databases, Genetic; Female; Humans; Immunotherapy; Mice; Mice, Inbred C57BL; Neoplasms; Prognosis; Random Allocation; Receptors, Adenosine A2; Signal Transduction; Survival Rate; Transcriptome	2020
Psychological distress among health care professionals of the three COVID-19 most affected Regions in Cameroon: Prevalence and associated factors. Annales medico-psychologiques, 2021, Volume: 179, Issue:2 Topics: 3' Untranslated Regions; 5'-Nucleotidase; A549 Cells; Accidental Falls; Acetylcholinesterase; Acrylic Resins; Actinobacillus; Acute Disease; Acute Kidney Injury; Adaptor Proteins, Signal Transducing; Adenosine; Adenosine Triphosphate; Administration, Inhalation; Administration, Oral; Adolescent; Adult; Advance Care Planning; Africa, Northern; Age Factors; Aged; Aged, 80 and over; Air Pollutants; Air Pollution; Air Pollution, Indoor; Albendazole; Aluminum Oxide; Anastomosis, Surgical; Ancylostoma; Ancylostomiasis; Androstadienes; Angiogenesis Inhibitors; Angiotensin II; Animals; Anti-Bacterial Agents; Anti-Infective Agents; Antibodies, Bispecific; Antibodies, Viral; Anticoagulants; Antihypertensive Agents; Antinematodal Agents; Antineoplastic Agents; Antineoplastic Agents, Immunological; Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Antiporters; Antiviral Agents; Apoptosis; Aptamers, Nucleotide; Aromatase Inhibitors; Asian People; Astrocytes; Atrial Fibrillation; Auditory Threshold; Aurora Kinase B; Australia; Autophagy; Autophagy-Related Protein 5; Autotrophic Processes; Bacillus cereus; Bacillus thuringiensis; Bacterial Proteins; Beclin-1; Belgium; Benzene; Benzene Derivatives; Benzhydryl Compounds; beta Catenin; beta-Arrestin 2; Biliary Tract Diseases; Biofilms; Biofuels; Biomarkers; Biomarkers, Tumor; Biomass; Biomechanical Phenomena; Bioreactors; Biosensing Techniques; Biosynthetic Pathways; Bismuth; Blood Platelets; Bone and Bones; Bone Regeneration; Bortezomib; Botulinum Toxins, Type A; Brain; Brain Injuries; Brain Ischemia; Brain Neoplasms; Breast Neoplasms; Breath Tests; Bronchodilator Agents; Calcium Phosphates; Cannabis; Carbon Dioxide; Carbon Isotopes; Carcinogenesis; Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cardiac Resynchronization Therapy; Cardiac Resynchronization Therapy Devices; Cardiomyopathies; Cardiovascular Diseases; Cariostatic Agents; Case Managers; Case-Control Studies; Catalysis; Cation Transport Proteins; CD8-Positive T-Lymphocytes; Cecropia Plant; Cell Adhesion; Cell Count; Cell Differentiation; Cell Division; Cell Line; Cell Line, Tumor; Cell Membrane; Cell Movement; Cell Proliferation; Cell Self Renewal; Cell Survival; Cells, Cultured; Cellular Reprogramming; Cellulose; Charcoal; Chemical and Drug Induced Liver Injury; Chemical Phenomena; Chemokines; Chemoradiotherapy; Chemoreceptor Cells; Child; Child Abuse; Child, Preschool; China; Chlorogenic Acid; Chloroquine; Chromatography, Gas; Chronic Disease; Clinical Competence; Coated Materials, Biocompatible; Cochlea; Cohort Studies; Color; Comorbidity; Computer Simulation; Computer-Aided Design; Contraception; Contraceptive Agents, Female; Contrast Media; COP-Coated Vesicles; Coronavirus Infections; Cost of Illness; Coturnix; COVID-19; Creatinine; Cross-Over Studies; Cross-Sectional Studies; Culex; Curriculum; Cyclic N-Oxides; Cytokines; Cytoplasm; Cytotoxicity, Immunologic; Cytotoxins; Databases, Factual; Deep Learning; Delivery, Obstetric; Denitrification; Dental Caries; Denture, Complete; Dexamethasone; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dielectric Spectroscopy; Diet, High-Fat; Dietary Fiber; Disease Models, Animal; Disease Progression; DNA; DNA Copy Number Variations; DNA, Mitochondrial; Dog Diseases; Dogs; Dopaminergic Neurons; Double-Blind Method; Down-Regulation; Doxorubicin; Drug Carriers; Drug Design; Drug Interactions; Drug Resistance, Bacterial; Drug Resistance, Neoplasm; Drug-Related Side Effects and Adverse Reactions; Drugs, Chinese Herbal; Dry Powder Inhalers; Dust; E2F1 Transcription Factor; Ecosystem; Education, Nursing; Education, Nursing, Baccalaureate; Electric Impedance; Electricity; Electrocardiography; Electrochemical Techniques; Electrochemistry; Electrodes; Electrophoresis, Polyacrylamide Gel; Endoplasmic Reticulum; Endothelial Cells; Environmental Monitoring; Enzyme Inhibitors; Epithelial Cells; Epithelial-Mesenchymal Transition; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Estrogen Receptor Modulators; Europe; Evoked Potentials, Auditory, Brain Stem; Exosomes; Feasibility Studies; Female; Ferricyanides; Ferrocyanides; Fibrinogen; Finite Element Analysis; Fistula; Fluorescent Dyes; Fluorides, Topical; Fluorodeoxyglucose F18; Fluticasone; Follow-Up Studies; Food Contamination; Food Microbiology; Foods, Specialized; Forensic Medicine; Frail Elderly; France; Free Radicals; Fresh Water; Fungi; Fungicides, Industrial; Galactosamine; Gastrointestinal Neoplasms; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Frequency; Genetic Predisposition to Disease; Genotype; Gingival Hemorrhage; Glioblastoma; Glioma; Glomerular Filtration Rate; Glomerulosclerosis, Focal Segmental; Glucose; Glucose Transport Proteins, Facilitative; Glucosides; Glutamine; Glycolysis; Gold; GPI-Linked Proteins; Gram-Negative Bacteria; Gram-Positive Bacteria; Graphite; Haplotypes; HCT116 Cells; Healthy Volunteers; Hearing Loss; Heart Failure; Hedgehog Proteins; HEK293 Cells; HeLa Cells; Hemodynamics; Hemorrhage; Hepatocytes; Hippo Signaling Pathway; Histone Deacetylases; Homeostasis; Hospital Mortality; Hospitalization; Humans; Hydantoins; Hydrazines; Hydrogen Peroxide; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Hydroxylamines; Hypoglycemic Agents; Immunity, Innate; Immunoglobulin G; Immunohistochemistry; Immunologic Factors; Immunomodulation; Immunophenotyping; Immunotherapy; Incidence; Indazoles; Indonesia; Infant; Infant, Newborn; Infarction, Middle Cerebral Artery; Inflammation; Injections, Intramuscular; Insecticides; Insulin-Like Growth Factor I; Insurance, Health; Intention to Treat Analysis; Interleukin-1 Receptor-Associated Kinases; Interleukin-6; Intrauterine Devices; Intrauterine Devices, Copper; Iron; Ischemia; Jordan; Keratinocytes; Kidney; Kidney Diseases; Kir5.1 Channel; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Laparoscopy; Lasers; Lasers, Semiconductor; Lenalidomide; Leptin; Lethal Dose 50; Levonorgestrel; Limit of Detection; Lipid Metabolism; Lipid Metabolism Disorders; Lipogenesis; Lipopolysaccharides; Liquid Biopsy; Liver; Liver Abscess, Pyogenic; Liver Cirrhosis; Liver Diseases; Liver Neoplasms; Longevity; Lung Neoplasms; Luteolin; Lymph Nodes; Lymphocyte Activation; Macaca fascicularis; Macrophages; Mad2 Proteins; Magnetic Resonance Imaging; Male; Mammary Glands, Human; Manganese; Manganese Compounds; MAP Kinase Signaling System; Materials Testing; Maternal Health Services; MCF-7 Cells; Medicaid; Medicine, Chinese Traditional; Melanoma; Membrane Proteins; Mental Health; Mercury; Metal Nanoparticles; Metals, Heavy; Metformin; Methionine Adenosyltransferase; Mice; Mice, Inbred BALB C; Mice, Inbred C3H; Mice, Inbred C57BL; Mice, Inbred CBA; Mice, Knockout; Mice, Nude; Microalgae; Microbial Sensitivity Tests; Microglia; MicroRNAs; Microscopy, Atomic Force; Microscopy, Electron, Scanning; Middle Aged; Mitochondria; Mitochondrial Proteins; Mitral Valve; Mitral Valve Insufficiency; Models, Anatomic; Molecular Structure; Molybdenum; Monocarboxylic Acid Transporters; Moths; MPTP Poisoning; Multigene Family; Multiparametric Magnetic Resonance Imaging; Multiple Myeloma; Muscle, Skeletal; Mutagens; Mutation; Myeloid Cells; Nanocomposites; Nanofibers; Nanomedicine; Nanoparticles; Nanowires; Neoadjuvant Therapy; Neomycin; Neoplasm Grading; Neoplasm Recurrence, Local; Neoplasms; Neoplastic Stem Cells; Neostriatum; Neovascularization, Pathologic; Netherlands; Neuromuscular Agents; Neurons; NF-E2-Related Factor 2; NF-kappa B; Nickel; Nitrogen Oxides; Non-alcoholic Fatty Liver Disease; Nucleosides; Nucleotidyltransferases; Nutritional Status; Obesity, Morbid; Ofloxacin; Oils, Volatile; Oligopeptides; Oncogene Protein v-akt; Optical Imaging; Organic Cation Transport Proteins; Organophosphonates; Osteoarthritis; Osteoarthritis, Hip; Osteoarthritis, Knee; Osteoblasts; Osteogenesis; Oxidation-Reduction; Oxidative Stress; Oxides; Oxygen Isotopes; Pancreas; Pancreaticoduodenectomy; Pandemics; Particle Size; Particulate Matter; Patient Acceptance of Health Care; Patient Compliance; PC-3 Cells; Peptide Fragments; Peptides; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Periodontitis; Peroxides; Peru; Pest Control, Biological; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phylogeny; Pilot Projects; Piperidines; Plant Bark; Plant Extracts; Plant Leaves; Plasmids; Platelet Function Tests; Pneumonia, Viral; Podocytes; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Polyethylene Terephthalates; Polymers; Polymorphism, Single Nucleotide; Porosity; Portugal; Positron-Emission Tomography; Postoperative Complications; Postural Balance; Potassium Channels, Inwardly Rectifying; Povidone; Powders; Precancerous Conditions; Precision Medicine; Predictive Value of Tests; Pregnancy; Prenatal Care; Prognosis; Promoter Regions, Genetic; Prospective Studies; Prostatectomy; Prostatic Neoplasms; Proteasome Inhibitors; Protective Agents; Protein Binding; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Protein Transport; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-akt; Psychiatric Nursing; PTEN Phosphohydrolase; Pulmonary Embolism; Pyrimethamine; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Rats, Wistar; Reactive Oxygen Species; Receptor, ErbB-2; Receptor, IGF Type 1; Receptors, Estrogen; Receptors, G-Protein-Coupled; Recombinational DNA Repair; Recovery of Function; Regional Blood Flow; Renal Dialysis; Renin; Renin-Angiotensin System; Reperfusion Injury; Reproducibility of Results; Republic of Korea; Respiratory Distress Syndrome; Retrospective Studies; Rhodamines; Risk Assessment; Risk Factors; RNA, Long Noncoding; RNA, Messenger; Running; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Salinity; Salmeterol Xinafoate; Sarcoma; Seasons; Shoulder Injuries; Signal Transduction; Silicon Dioxide; Silver; Sirtuin 1; Sirtuins; Skull Fractures; Social Determinants of Health; Sodium; Sodium Fluoride; Sodium Potassium Chloride Symporter Inhibitors; Sodium-Glucose Transporter 2 Inhibitors; Soil; Soil Pollutants; Spain; Spectrophotometry; Spectroscopy, Fourier Transform Infrared; Staphylococcal Protein A; Staphylococcus aureus; Stem Cells; Stereoisomerism; Stomach Neoplasms; Streptomyces; Strontium; Structure-Activity Relationship; Students, Nursing; Substance-Related Disorders; Succinic Acid; Sulfur; Surface Properties; Survival Rate; Survivin; Symporters; T-Lymphocytes; Temozolomide; Tensile Strength; Thiazoles; Thiobacillus; Thiohydantoins; Thiourea; Thrombectomy; Time Factors; Titanium; Tobacco Mosaic Virus; Tobacco Use Disorder; Toll-Like Receptor 4; Toluene; Tomography, X-Ray Computed; TOR Serine-Threonine Kinases; Toxicity Tests, Acute; Toxicity Tests, Subacute; Transcriptional Activation; Treatment Outcome; Troponin I; Tumor Cells, Cultured; Tumor Escape; Tumor Hypoxia; Tumor Microenvironment; Tumor Necrosis Factor Inhibitors; Tumor Necrosis Factor-alpha; Tyrosine; Ubiquitin-Protein Ligases; Ubiquitination; Ultrasonic Waves; United Kingdom; United States; United States Department of Veterans Affairs; Up-Regulation; Urea; Uric Acid; Urinary Bladder Neoplasms; Urinary Bladder, Neurogenic; Urine; Urodynamics; User-Computer Interface; Vemurafenib; Verbenaceae; Veterans; Veterans Health; Viral Load; Virtual Reality; Vitiligo; Water Pollutants, Chemical; Wildfires; Wnt Signaling Pathway; Wound Healing; X-Ray Diffraction; Xenograft Model Antitumor Assays; Xylenes; Young Adult; Zinc; Zinc Oxide; Zinc Sulfate; Zoonoses	2021
Continuous intravenous infusion of ATP in humans yields large expansions of erythrocyte ATP pools but extracellular ATP pools are elevated only at the start followed by rapid declines. Purinergic signalling, 2015, Volume: 11, Issue:2 Topics: Adenosine; Adenosine Triphosphate; Adult; Erythrocytes; Extracellular Space; Female; Humans; Infusions, Intravenous; Middle Aged; Neoplasms; Purinergic Agents; Time Factors	2015

Other Studies

162 other study(ies) available for adenosine and Benign Neoplasms

Article	Year
Chemical genetics reveals a complex functional ground state of neural stem cells. Nature chemical biology, 2007, Volume: 3, Issue:5 Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells	2007
Synthesis and Cytostatic and Antiviral Profiling of Thieno-Fused 7-Deazapurine Ribonucleosides. Journal of medicinal chemistry, 2017, 03-23, Volume: 60, Issue:6 Topics: Antineoplastic Agents; Antiviral Agents; Cell Line, Tumor; Hepacivirus; Hepatitis C; Humans; Neoplasms; Purines; Ribonucleosides	2017
METTL3-mediated m Nature communications, 2021, 09-17, Volume: 12, Issue:1 Topics: Adenosine; Animals; Carcinogenesis; Cell Line, Tumor; Gene Deletion; Homeostasis; Interleukin-15; Killer Cells, Natural; Lymphocytes, Tumor-Infiltrating; Methylation; Methyltransferases; Mice, Inbred C57BL; Mice, Knockout; Neoplasms; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Proto-Oncogene Proteins c-akt; RNA; Signal Transduction; Tumor Microenvironment	2021
Calcium Phosphate-Reinforced Metal-Organic Frameworks Regulate Adenosine-Mediated Immunosuppression. Advanced materials (Deerfield Beach, Fla.), 2021, Volume: 33, Issue:45 Topics: Adenosine; Adenosine Kinase; Animals; Calcium Phosphates; Catalytic Domain; Cell Line, Tumor; Humans; Immunity; Immunosuppression Therapy; Immunosuppressive Agents; Metal-Organic Frameworks; Mice; Neoplasms; Phosphorylation; T-Lymphocytes, Regulatory; Transplantation, Heterologous; Tumor Microenvironment	2021
m Molecular cancer, 2021, 12-20, Volume: 20, Issue:1 Topics: Adenosine; Biomarkers, Tumor; Circulating MicroRNA; Computational Biology; Diagnosis, Differential; Gene Expression Profiling; Humans; Liquid Biopsy; MicroRNAs; Neoplasms; Prognosis; Reproducibility of Results; ROC Curve	2021
Generation of a Retargeted Oncolytic International journal of molecular sciences, 2021, Dec-16, Volume: 22, Issue:24 Topics: Adenosine; Adenosine Deaminase; Antigens, CD; Cell Line; Herpesviridae; Humans; Immunotherapy; Neoplasms; Oncolytic Virotherapy; Oncolytic Viruses; THP-1 Cells; Tumor Microenvironment	2021
The multifaceted functions of the Fat mass and Obesity-associated protein (FTO) in normal and cancer cells. RNA biology, 2022, Volume: 19, Issue:1 Topics: Adenosine; Adipose Tissue; Adiposity; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Catalysis; Disease Susceptibility; Epigenesis, Genetic; Gene Expression Regulation; Homeostasis; Humans; Neoplasms; Organ Specificity; RNA Processing, Post-Transcriptional; RNA-Binding Proteins; RNA, Messenger; RNA, Small Nuclear; RNA, Transfer; Substrate Specificity	2022
Design, Synthesis, and Bioevaluation of 2-Aminopteridin-7(8 Journal of medicinal chemistry, 2022, 03-10, Volume: 65, Issue:5 Topics: Adenosine; Adenosine A2 Receptor Antagonists; Adenosine-5'-(N-ethylcarboxamide); Immunotherapy; Neoplasms; Receptor, Adenosine A2A	2022
Discovery and optimization of betulinic acid derivatives as novel potent CD73 inhibitors. Bioorganic & medicinal chemistry, 2022, 04-01, Volume: 59 Topics: 5'-Nucleotidase; Adenosine; Betulinic Acid; Humans; Immunotherapy; Neoplasms; Pentacyclic Triterpenes	2022
Inactivation of AUF1 in Myeloid Cells Protects From Allergic Airway and Tumor Infiltration and Impairs the Adenosine-Induced Polarization of Pro-Angiogenic Macrophages. Frontiers in immunology, 2022, Volume: 13 Topics: Adenosine; Animals; Hypersensitivity; Inflammation; Lung; Macrophages; Mice; Myeloid Cells; Neoplasms; RNA, Messenger	2022
Targeting the Negative Feedback of Adenosine-A2AR Metabolic Pathway by a Tailored Nanoinhibitor for Photothermal Immunotherapy. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2022, Volume: 9, Issue:14 Topics: Adenosine; Feedback; Humans; Immunotherapy; Metabolic Networks and Pathways; Neoplasms; Receptor, Adenosine A2A; Tumor Microenvironment	2022
ADARs act as potent regulators of circular transcriptome in cancer. Nature communications, 2022, 03-21, Volume: 13, Issue:1 Topics: Adenosine; Adenosine Deaminase; Heterogeneous-Nuclear Ribonucleoproteins; Humans; Neoplasms; Polypyrimidine Tract-Binding Protein; RNA Editing; RNA, Circular; RNA, Double-Stranded; Transcriptome	2022
Lactylation-driven METTL3-mediated RNA m Molecular cell, 2022, 05-05, Volume: 82, Issue:9 Topics: Adenosine; Animals; Humans; Immunosuppression Therapy; Methyltransferases; Mice; Myeloid Cells; Neoplasms; RNA; Tumor Microenvironment	2022
Bibliometric analysis of N6-methyladenosine in cancer: landscapes, highlights and trending topics. Future oncology (London, England), 2022, Volume: 18, Issue:17 Topics: Adenosine; Bibliometrics; China; Humans; Neoplasms	2022
Biomimetic Nanocarriers Guide Extracellular ATP Homeostasis to Remodel Energy Metabolism for Activating Innate and Adaptive Immunity System. Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2022, Volume: 9, Issue:17 Topics: Adaptive Immunity; Adenosine; Adenosine Triphosphate; Apyrase; Biomimetics; Energy Metabolism; Homeostasis; Humans; Neoplasms; Tumor Microenvironment	2022
REIA: A database for cancer A-to-I RNA editing with interactive analysis. International journal of biological sciences, 2022, Volume: 18, Issue:6 Topics: Adenosine; Humans; Inosine; Neoplasms; RNA; RNA Editing	2022
Cancer-related somatic mutations alter adenosine A FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2022, Volume: 36, Issue:6 Topics: Adenosine; Animals; Cell Line; Humans; Mammals; Mutation; Neoplasms; Receptor, Adenosine A1; Saccharomyces cerevisiae	2022
A Novel Signature Based on m6A RNA Methylation Regulators Reveals Distinct Prognostic Subgroups and Associates with Tumor Immunity of Patients with Pancreatic Neuroendocrine Neoplasms. Neuroendocrinology, 2022, Volume: 112, Issue:12 Topics: Adenosine; Humans; Methylation; Multivariate Analysis; Neoplasms; Prognosis; RNA	2022
Delivery of an ectonucleotidase inhibitor with ROS-responsive nanoparticles overcomes adenosine-mediated cancer immunosuppression. Science translational medicine, 2022, 06-08, Volume: 14, Issue:648 Topics: Adenosine; Adenosine Triphosphate; Animals; Cell Line, Tumor; Esters; Humans; Immunosuppression Therapy; Mice; Nanoparticles; Neoplasms; Reactive Oxygen Species; Tumor Microenvironment	2022
Catalytical nano-immunocomplexes for remote-controlled sono-metabolic checkpoint trimodal cancer therapy. Nature communications, 2022, 06-16, Volume: 13, Issue:1 Topics: Adenosine; CD8-Positive T-Lymphocytes; Humans; Immunotherapy; Neoplasms; Tumor Microenvironment	2022
Cancer-Related Somatic Mutations in Transmembrane Helices Alter Adenosine A1 Receptor Pharmacology. Molecules (Basel, Switzerland), 2022, Jun-10, Volume: 27, Issue:12 Topics: Adenosine; Animals; Humans; Mammals; Mutation; Neoplasms; Protein Structure, Secondary; Receptor, Adenosine A1; Saccharomyces cerevisiae	2022
FTO-dependent N(6)-Methyladenosine regulates the progression of endometriosis via the ATG5/PKM2 Axis. Cellular signalling, 2022, Volume: 98 Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Autophagy-Related Protein 5; Endometriosis; Female; Humans; Neoplasms; RNA, Messenger	2022
Cancer-Associated Mutations of the Adenosine A Molecules (Basel, Switzerland), 2022, Jul-22, Volume: 27, Issue:15 Topics: Adenosine; Adenosine-5'-(N-ethylcarboxamide); HEK293 Cells; Humans; Ligands; Mutation; Neoplasms; Receptor, Adenosine A2A; Tumor Microenvironment	2022
Single-Molecule Counting of FTO in Human Breast Tissues Based on a Rolling Circle Transcription Amplification-Driven Clustered Regularly Interspaced Short Palindromic Repeat─Cas12a. Analytical chemistry, 2022, 08-16, Volume: 94, Issue:32 Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; CRISPR-Cas Systems; Humans; Mammals; Neoplasms; Obesity	2022
Identification of the crosstalk among four types of adenosine-related RNA modification in pan-cancer. Cancer science, 2022, Volume: 113, Issue:10 Topics: Adenosine; Humans; Neoplasms; Prognosis; RNA; Tumor Microenvironment	2022
ELISA based assays to measure adenosine deaminases concentration in serum and saliva for the diagnosis of ADA2 deficiency and cancer. Frontiers in immunology, 2022, Volume: 13 Topics: Adenosine; Adenosine Deaminase; Agammaglobulinemia; Enzyme-Linked Immunosorbent Assay; Humans; Intercellular Signaling Peptides and Proteins; Neoplasms; Polyarteritis Nodosa; Saliva; Severe Combined Immunodeficiency	2022
Pan-Cancer Analysis of Canonical and Modified miRNAs Enhances the Resolution of the Functional miRNAome in Cancer. Cancer research, 2022, 10-17, Volume: 82, Issue:20 Topics: Adenosine; Adult; Biomarkers, Tumor; Child; Humans; Inosine; MicroRNAs; Neoplasms	2022
Targeting the Cbl-b-Notch1 axis as a novel immunotherapeutic strategy to boost CD8+ T-cell responses. Frontiers in immunology, 2022, Volume: 13 Topics: Adenosine; CD8-Positive T-Lymphocytes; Humans; Immunotherapy; Lymphoma; Neoplasms; Receptor, Notch1	2022
Targeting two distinct epitopes on human CD73 with a bispecific antibody improves anticancer activity. Journal for immunotherapy of cancer, 2022, Volume: 10, Issue:9 Topics: Adenosine; Animals; Antibodies, Bispecific; Epitopes; Humans; Mice; Neoplasms	2022
Adenosine A2a Receptor Antagonism Restores Additive Cytotoxicity by Cytotoxic T Cells in Metabolically Perturbed Tumors. Cancer immunology research, 2022, 12-02, Volume: 10, Issue:12 Topics: Adenosine; Adenosine A2 Receptor Antagonists; Cytotoxicity, Immunologic; Humans; Neoplasms; Receptor, Adenosine A2A; T-Lymphocytes, Cytotoxic; Tumor Microenvironment	2022
Reshaping hypoxia and silencing CD73 via biomimetic gelatin nanotherapeutics to boost immunotherapy. Journal of controlled release : official journal of the Controlled Release Society, 2022, Volume: 351 Topics: Adenosine; Animals; B7-H1 Antigen; Biomimetics; Cell Line, Tumor; Gelatin; Hypoxia; Immune Checkpoint Inhibitors; Immunotherapy; Mice; Neoplasms; Oxygen; Tumor Microenvironment	2022
Overcoming high level adenosine-mediated immunosuppression by DZD2269, a potent and selective A2aR antagonist. Journal of experimental & clinical cancer research : CR, 2022, Oct-14, Volume: 41, Issue:1 Topics: Adenosine; Animals; Clinical Trials, Phase I as Topic; Cyclic AMP Response Element-Binding Protein; Cytokines; Humans; Immune Checkpoint Inhibitors; Immunosuppression Therapy; Immunosuppressive Agents; Leukocytes, Mononuclear; Mice; Neoplasms; Receptor, Adenosine A2A; Tumor Microenvironment	2022
Impact of the selective A2 British journal of cancer, 2022, Volume: 127, Issue:12 Topics: Adenosine; Animals; Cytokines; Mice; Neoplasms; T-Lymphocytes; Tumor Microenvironment	2022
RM2Target: a comprehensive database for targets of writers, erasers and readers of RNA modifications. Nucleic acids research, 2023, 01-06, Volume: 51, Issue:D1 Topics: Adenosine; Animals; Databases, Nucleic Acid; Humans; Mice; Neoplasms; RNA; RNA Processing, Post-Transcriptional; RNA-Binding Proteins	2023
Evaluation of nanobody-based biologics targeting purinergic checkpoints in tumor models Frontiers in immunology, 2022, Volume: 13 Topics: Adenosine; Adenosine Triphosphate; Animals; Mice; Neoplasms; Oxaliplatin; Tumor Microenvironment	2022
Integrative Transcriptomic Analysis Identify Potential m6A Pathway-Related Drugs That Inhibit Cancer Cell Proliferation. Genes, 2022, 11-02, Volume: 13, Issue:11 Topics: Adenosine; Cell Proliferation; Gene Expression Profiling; Humans; Methylation; Neoplasms; Transcriptome	2022
A macrophage membrane-coated mesoporous silica nanoplatform inhibiting adenosine A2AR via in situ oxygen supply for immunotherapy. Journal of controlled release : official journal of the Controlled Release Society, 2023, Volume: 353 Topics: Adenosine; CD8-Positive T-Lymphocytes; Doxorubicin; Humans; Immunotherapy; Macrophages; Nanoparticles; Neoplasms; Oxygen; Receptor, Adenosine A2A; Silicon Dioxide; Tumor Microenvironment	2023
Multi-omics analysis of N6-methyladenosine reader IGF2BP3 as a promising biomarker in pan-cancer. Frontiers in immunology, 2023, Volume: 14 Topics: Adenosine; Biomarkers; Biomarkers, Tumor; Glioma; Humans; Multiomics; Neoplasms; Tumor Microenvironment	2023
Controllable assembly of dendritic DNA nanostructures for ultrasensitive detection of METTL3-METTL14 m Biosensors & bioelectronics, 2023, May-15, Volume: 228 Topics: Adenosine; Biosensing Techniques; DNA; Humans; Methyltransferases; Nanostructures; Neoplasms	2023
HIF-1 inhibitor-based one-stone-two-birds strategy for enhanced cancer chemodynamic-immunotherapy. Journal of controlled release : official journal of the Controlled Release Society, 2023, Volume: 356 Topics: Adenosine; Cell Line, Tumor; Copper; Humans; Hydrogen Peroxide; Hypoxia-Inducible Factor 1; Immunotherapy; Neoplasms; Oleic Acid; Reactive Oxygen Species; Tumor Microenvironment	2023
Discovery of Pyridinone Derivatives as Potent, Selective, and Orally Bioavailable Adenosine A Journal of medicinal chemistry, 2023, 04-13, Volume: 66, Issue:7 Topics: Adenosine; Adenosine A2 Receptor Antagonists; Animals; Immunotherapy; Mice; Neoplasms; Receptor, Adenosine A2A	2023
A lncRNA from the FTO locus acts as a suppressor of the m Molecular cell, 2023, 08-03, Volume: 83, Issue:15 Topics: Adenosine; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Animals; Male; Methyltransferases; Mice; Neoplasms; RNA, Long Noncoding; RNA, Messenger; Tumor Suppressor Protein p53	2023
Label-free and sensitive detection of N6-methyladenosine demethylase activity in crude cell extracts and clinical cancer tissues based on demethylation-triggered exponential signal amplification. Analytica chimica acta, 2023, Oct-16, Volume: 1278 Topics: Adenosine; Cell Extracts; Demethylation; Fluorescent Dyes; Humans; Neoplasms; RNA	2023
"Dominolike" Barriers Elimination with an Intratumoral Adenosine-Triphosphate-Supersensitive Nanogel to Enhance Cancer Chemoimmunotherapy. ACS nano, 2023, 10-10, Volume: 17, Issue:19 Topics: Adenosine; Adenosine Triphosphate; Cell Line, Tumor; Humans; Immunotherapy; Nanogels; Neoplasms; Tumor Microenvironment	2023
Editorial: Adenosine pathways in cancer immunity and immunotherapy. Frontiers in immunology, 2023, Volume: 14 Topics: Adenosine; Humans; Immunotherapy; Neoplasms	2023
Caffeine-folic acid-loaded-chitosan nanoparticles combined with methotrexate as a novel HepG2 immunotherapy targeting adenosine A2A receptor downstream cascade. BMC complementary medicine and therapies, 2023, Oct-27, Volume: 23, Issue:1 Topics: Adenosine; Caffeine; Chitosan; Folic Acid; Humans; Immunotherapy; Methotrexate; Molecular Docking Simulation; Nanoparticles; Neoplasms; Receptor, Adenosine A2A; Tumor Microenvironment	2023
Molecular characterization and clinical relevance of m Molecular cancer, 2019, 09-14, Volume: 18, Issue:1 Topics: Adenosine; Computational Biology; DNA Methylation; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Genetic Variation; Humans; Methylation; Neoplasms; Prognosis; Signal Transduction	2019
Adenosine mediates functional and metabolic suppression of peripheral and tumor-infiltrating CD8 Journal for immunotherapy of cancer, 2019, 10-10, Volume: 7, Issue:1 Topics: Adenosine; Adult; Aged; Aged, 80 and over; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cyclic AMP-Dependent Protein Kinases; Disease Progression; Female; Humans; Lymphocytes, Tumor-Infiltrating; Male; Mechanistic Target of Rapamycin Complex 1; Middle Aged; Neoplasms; Primary Cell Culture; Receptor, Adenosine A2A; Signal Transduction; Tumor Escape; Tumor Microenvironment	2019
Therapeutic Potentials of Adenosine Receptors: The State of The Art. Current pharmaceutical design, 2019, Volume: 25, Issue:26 Topics: Adenosine; Adenosine A1 Receptor Agonists; Adenosine A2 Receptor Agonists; Arthritis, Rheumatoid; Central Nervous System Diseases; Humans; Neoplasms; Receptor, Adenosine A1; Receptor, Adenosine A2A; Signal Transduction	2019
Enzyme activity of circulating CD73 in human serum. Methods in enzymology, 2019, Volume: 629 Topics: 5'-Nucleotidase; Adenosine; Antineoplastic Agents, Immunological; Cell Line, Tumor; Disease Progression; Enzyme Assays; GPI-Linked Proteins; Humans; Neoplasms; Patient Selection; Receptors, Purinergic P1; T-Lymphocytes	2019
Measurement of CD73 enzymatic activity using luminescence-based and colorimetric assays. Methods in enzymology, 2019, Volume: 629 Topics: 5'-Nucleotidase; Adenosine; Antineoplastic Agents, Immunological; Cell Line, Tumor; Colorimetry; Coloring Agents; Enzyme Assays; Feasibility Studies; GPI-Linked Proteins; High-Throughput Screening Assays; Humans; Luciferases; Luminescence; Neoplasms; Receptors, Purinergic P1; Recombinant Proteins; Rosaniline Dyes; Signal Transduction	2019
CD73 Blockade Promotes Dendritic Cell Infiltration of Irradiated Tumors and Tumor Rejection. Cancer immunology research, 2020, Volume: 8, Issue:4 Topics: 5'-Nucleotidase; Adenosine; Animals; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Dendritic Cells; Female; Humans; Interferon Type I; Mice; Mice, Inbred BALB C; Mice, Knockout; Neoplasms	2020
Structural basis of nucleic acid recognition and 6mA demethylation by human ALKBH1. Cell research, 2020, Volume: 30, Issue:3 Topics: Adenosine; AlkB Homolog 1, Histone H2a Dioxygenase; DNA; DNA Demethylation; Humans; Neoplasms; Protein Binding; Protein Structural Elements	2020
[A new generation of immunotherapies targeting the CD39/CD73/adenosine pathway to promote the anti-tumor immune response]. Medecine sciences : M/S, 2020, Volume: 36, Issue:2 Topics: 5'-Nucleotidase; Adaptive Immunity; Adenosine; Antigens, CD; Apyrase; Humans; Immunotherapy; Molecular Targeted Therapy; Neoplasms; Signal Transduction	2020
Compartmentalization of adenosine metabolism in cancer cells and its modulation during acute hypoxia. Journal of cell science, 2020, 05-29, Volume: 133, Issue:10 Topics: Adenosine; Adenosine Diphosphate; Adenosine Triphosphate; Adenylate Kinase; Animals; Hypoxia; Male; Mice; Neoplasms; Nucleotides	2020
M6A2Target: a comprehensive database for targets of m6A writers, erasers and readers. Briefings in bioinformatics, 2021, 05-20, Volume: 22, Issue:3 Topics: Adenosine; Databases, Genetic; Humans; Mutation; Neoplasms; Reproducibility of Results	2021
RNA N-6-methyladenosine enzymes and resistance of cancer cells to chemotherapy and radiotherapy. Epigenomics, 2020, Volume: 12, Issue:9 Topics: Adenosine; AlkB Homolog 5, RNA Demethylase; Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Cell Cycle Proteins; Drug Resistance, Neoplasm; Humans; Methylation; Methyltransferases; Neoplasms; Radiation Tolerance; RNA; RNA Splicing Factors	2020
Suppression of adenosine-to-inosine (A-to-I) RNA editome by death associated protein 3 (DAP3) promotes cancer progression. Science advances, 2020, Volume: 6, Issue:25 Topics: Adenosine; Adenosine Deaminase; Apoptosis Regulatory Proteins; Humans; Inosine; Neoplasms; RNA; RNA-Binding Proteins	2020
MicroRNA Editing Detection and Function: A Combined In Silico and Experimental Approach for the Identification and Validation of Putative Oncogenic Targets. Methods in molecular biology (Clifton, N.J.), 2021, Volume: 2181 Topics: Adenosine; Animals; Carcinogenesis; Computational Biology; Humans; Inosine; MicroRNAs; Neoplasms; Oncogenes; RNA Editing; Sequence Analysis, DNA; Validation Studies as Topic	2021
Circumventing the Crabtree effect: forcing oxidative phosphorylation (OXPHOS) via galactose medium increases sensitivity of HepG2 cells to the purine derivative kinetin riboside. Apoptosis : an international journal on programmed cell death, 2020, Volume: 25, Issue:11-12 Topics: Adenosine; Adenosine Triphosphate; Antineoplastic Agents; Apoptosis; Culture Media; Galactose; Glucose; Glycolysis; Hep G2 Cells; Humans; Kinetin; Membrane Potential, Mitochondrial; Neoplasms; Oxidative Phosphorylation	2020
Magnetic microbeads-based amperometric immunoplatform for the rapid and sensitive detection of N6-methyladenosine to assist in metastatic cancer cells discrimination. Biosensors & bioelectronics, 2021, Jan-01, Volume: 171 Topics: Adenosine; Biosensing Techniques; Hydrogen Peroxide; Limit of Detection; Magnetic Phenomena; Microspheres; Neoplasms	2021
Adenosine Signaling in the Tumor Microenvironment. Advances in experimental medicine and biology, 2021, Volume: 1270 Topics: 5'-Nucleotidase; Adenosine; Humans; Neoplasms; Receptors, G-Protein-Coupled; Signal Transduction; Tumor Microenvironment	2021
Editorial overview: Cancer 2020 current mechanistic insights into the hypoxia-adenosine-A2A adenosinergic immunosuppressive axis in cancer immunotherapies. Current opinion in pharmacology, 2020, Volume: 53 Topics: Adenosine; Humans; Hypoxia; Immune Checkpoint Inhibitors; Immune Tolerance; Immunotherapy; Neoplasms; Receptor, Adenosine A2A	2020
Molecular Characteristics of N1-Methyladenosine Regulators and Their Correlation with Overall Cancer Survival. DNA and cell biology, 2021, Volume: 40, Issue:3 Topics: Adenosine; Disease-Free Survival; Epigenesis, Genetic; Female; Gene Expression Regulation, Neoplastic; Humans; Male; Neoplasms; Survival Rate	2021
MYC promotes cancer progression by modulating m EMBO reports, 2021, 03-03, Volume: 22, Issue:3 Topics: Adenosine; AlkB Homolog 5, RNA Demethylase; Gene Expression Regulation, Neoplastic; Humans; Neoplasms; RNA, Messenger	2021
Pan-cancer characterization of expression and clinical relevance of m Molecular cancer, 2021, 02-08, Volume: 20, Issue:1 Topics: Adenosine; Epigenesis, Genetic; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Humans; Methylation; Neoplasm Staging; Neoplasms; Organ Specificity; Prognosis; RNA, Long Noncoding	2021
SUMOylation of YTHDF2 promotes mRNA degradation and cancer progression by increasing its binding affinity with m6A-modified mRNAs. Nucleic acids research, 2021, 03-18, Volume: 49, Issue:5 Topics: Adenosine; Animals; Cell Hypoxia; Cell Line; Disease Progression; Humans; Lysine; Male; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Oxidative Stress; RNA Stability; RNA-Binding Proteins; RNA, Messenger; Small Ubiquitin-Related Modifier Proteins; Sumoylation; Transcriptome; Ubiquitination	2021
Discovery of TAK-981, a First-in-Class Inhibitor of SUMO-Activating Enzyme for the Treatment of Cancer. Journal of medicinal chemistry, 2021, 03-11, Volume: 64, Issue:5 Topics: Adenosine; Animals; Antineoplastic Agents; Cell Line, Tumor; Enzyme Inhibitors; Humans; Mice; Molecular Structure; Neoplasms; Protein Binding; Protein Processing, Post-Translational; Structure-Activity Relationship; Sulfonic Acids; Sumoylation; Ubiquitin-Activating Enzymes; Xenograft Model Antitumor Assays	2021
Chromatin remodeling by the histone methyltransferase EZH2 drives lung pre-malignancy and is a target for cancer prevention. Clinical epigenetics, 2021, 02-25, Volume: 13, Issue:1 Topics: Adenosine; Adenosylhomocysteinase; Animals; Benzamides; Biphenyl Compounds; Cell Proliferation; Chromatin Assembly and Disassembly; CpG Islands; DNA Methylation; Enhancer of Zeste Homolog 2 Protein; Enzyme Inhibitors; Epigenesis, Genetic; Epithelial Cells; Female; Histone Code; Histone Methyltransferases; Histone-Lysine N-Methyltransferase; Histones; Humans; Lung Neoplasms; Mice; Morpholines; Neoplasms; Phenotype; Pyridones; Transcriptome	2021
RNA N6-methyladenosine: a new player in autophagy-mediated anti-cancer drug resistance. British journal of cancer, 2021, Volume: 124, Issue:10 Topics: Adenosine; Autophagy; Disease Progression; Drug Resistance, Neoplasm; Humans; Methylation; Methyltransferases; Neoplasms; RNA; RNA Processing, Post-Transcriptional	2021
Comprehensive analyses of m6A regulators and interactive coding and non-coding RNAs across 32 cancer types. Molecular cancer, 2021, 04-13, Volume: 20, Issue:1 Topics: Adenosine; Biomarkers, Tumor; Epigenesis, Genetic; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Methylation; Neoplasms; Organ Specificity; RNA, Messenger; RNA, Untranslated	2021
Targeting Adenosine with Adenosine Deaminase 2 to Inhibit Growth of Solid Tumors. Cancer research, 2021, 06-15, Volume: 81, Issue:12 Topics: Adenosine; Adenosine Deaminase; Animals; Apoptosis; Cell Proliferation; Female; Humans; Intercellular Signaling Peptides and Proteins; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Neoplasms; Prognosis; Survival Rate; Tumor Cells, Cultured; Xenograft Model Antitumor Assays	2021
The loss of RNA N Cancer cell, 2021, 07-12, Volume: 39, Issue:7 Topics: Adenosine; Animals; Carcinoma, Lewis Lung; CD8-Positive T-Lymphocytes; Colorectal Neoplasms; Cytokines; Female; Humans; Lymphocyte Activation; Melanoma, Experimental; Methyltransferases; Mice; Mice, Inbred C57BL; Mice, Knockout; Minor Histocompatibility Antigens; Neoplasms; Receptors, Cytokine; Tumor Microenvironment; Tumor-Associated Macrophages	2021
The RNA m6A reader YTHDF2 controls NK cell antitumor and antiviral immunity. The Journal of experimental medicine, 2021, 08-02, Volume: 218, Issue:8 Topics: Adenosine; Animals; Antiviral Agents; Cell Proliferation; Cell Survival; Cytomegalovirus Infections; Disease Progression; DNA-Binding Proteins; Homeostasis; Immunity; Interleukin-15; Killer Cells, Natural; Mice, Inbred C57BL; Neoplasms; RNA; RNA-Binding Proteins; Transcriptome	2021
The role of YTH domain containing 2 in epigenetic modification and immune infiltration of pan-cancer. Journal of cellular and molecular medicine, 2021, Volume: 25, Issue:18 Topics: Adenosine; Gene Expression Regulation, Neoplastic; Humans; Neoplasms; Prognosis; RNA Helicases	2021
Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers. Genome research, 2017, Volume: 27, Issue:7 Topics: Adenosine; Female; Genes, Tumor Suppressor; Humans; Inosine; Leukemia Inhibitory Factor Receptor alpha Subunit; Male; MicroRNAs; Neoplasm Invasiveness; Neoplasm Proteins; Neoplasms; RNA Editing; RNA, Neoplasm; Zinc Finger E-box Binding Homeobox 2; Zinc Finger E-box-Binding Homeobox 1	2017
Ticagrelor breaks up the tumor-platelet party. Blood, 2017, 09-07, Volume: 130, Issue:10 Topics: Adenosine; Blood Platelets; Humans; Neoplasms; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Ticagrelor	2017
An RNA editing/dsRNA binding-independent gene regulatory mechanism of ADARs and its clinical implication in cancer. Nucleic acids research, 2017, Oct-13, Volume: 45, Issue:18 Topics: 3' Untranslated Regions; Adenosine; Adenosine Deaminase; Animals; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; HEK293 Cells; Humans; Inosine; Neoplasms; RNA Editing; RNA-Binding Proteins; RNA, Double-Stranded; Tumor Cells, Cultured	2017
An epitranscriptomic vulnerability in myeloid malignancies. Nature medicine, 2017, 11-07, Volume: 23, Issue:11 Topics: Adenosine; Hematopoietic Stem Cell Transplantation; Humans; Leukemia; Methyltransferases; Myeloproliferative Disorders; Neoplasms	2017
Human cancer tissues exhibit reduced A-to-I editing of miRNAs coupled with elevated editing of their targets. Nucleic acids research, 2018, 01-09, Volume: 46, Issue:1 Topics: 3' Untranslated Regions; Adenosine; Binding Sites; Gene Expression Regulation, Neoplastic; Humans; Inosine; MicroRNAs; Neoplasms; RNA Editing; Survival Analysis	2018
Apoptotic Regulatory T Cells Retain Suppressive Function through Adenosine. Cell metabolism, 2018, 01-09, Volume: 27, Issue:1 Topics: Adenosine; Apoptosis; Autoimmunity; Humans; Immune Tolerance; Neoplasms; Oxidative Stress; T-Lymphocytes, Regulatory	2018
Performance comparison between multienzymes loaded single and dual electrodes for the simultaneous electrochemical detection of adenosine and metabolites in cancerous cells. Biosensors & bioelectronics, 2018, Jun-30, Volume: 109 Topics: A549 Cells; Adenosine; Adenosine Deaminase; Biosensing Techniques; Electrodes; Humans; Hypoxanthine; Inosine; Limit of Detection; Metabolomics; Neoplasms; Purine-Nucleoside Phosphorylase; Xanthine Oxidase	2018
Bidirectional regulation of adenosine-to-inosine (A-to-I) RNA editing by DEAH box helicase 9 (DHX9) in cancer. Nucleic acids research, 2018, 09-06, Volume: 46, Issue:15 Topics: Adenosine; Adenosine Deaminase; Animals; Antibiotics, Antineoplastic; Cell Line, Tumor; DEAD-box RNA Helicases; Deamination; Doxorubicin; HEK293 Cells; Humans; Inosine; Mice, Inbred NOD; Mice, Knockout; Mice, SCID; Neoplasm Proteins; Neoplasms; RNA Editing; RNA Interference; RNA-Binding Proteins; Xenograft Model Antitumor Assays	2018
Nucleosides block AICAR-stimulated activation of AMPK in skeletal muscle and cancer cells. American journal of physiology. Cell physiology, 2018, 12-01, Volume: 315, Issue:6 Topics: Adenosine; Aminoimidazole Carboxamide; AMP-Activated Protein Kinase Kinases; Ascorbic Acid; Cell Line, Tumor; Culture Media; Diabetes Mellitus, Type 2; Energy Metabolism; Glucose; Humans; Muscle, Skeletal; Neoplasms; Nucleosides; Protein Kinases; Ribonucleotides; Thioctic Acid; Vitamin B 12	2018
Clickable conjugates of bile acids and nucleosides: Synthesis, characterization, in vitro anticancer and antituberculosis studies. Steroids, 2018, Volume: 139 Topics: Adenosine; Antineoplastic Agents; Antitubercular Agents; Bile Acids and Salts; Click Chemistry; Deoxycholic Acid; HEK293 Cells; Humans; MCF-7 Cells; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Neoplasms; Nucleosides; Spectroscopy, Fourier Transform Infrared; Structure-Activity Relationship	2018
Adenosinergic Signaling Alters Natural Killer Cell Functional Responses. Frontiers in immunology, 2018, Volume: 9 Topics: Adenosine; CD56 Antigen; Cell Differentiation; Cell Proliferation; Cells, Cultured; Cytokines; Cytotoxicity, Immunologic; Humans; Immunotherapy, Adoptive; Killer Cells, Natural; Lymphocyte Activation; Neoplasms; NK Cell Lectin-Like Receptor Subfamily K; Signal Transduction; TOR Serine-Threonine Kinases	2018
Transfer RNA demethylase ALKBH3 promotes cancer progression via induction of tRNA-derived small RNAs. Nucleic acids research, 2019, 03-18, Volume: 47, Issue:5 Topics: Adenosine; AlkB Homolog 3, Alpha-Ketoglutarate-Dependent Dioxygenase; Animals; Apoptosis; Cell Movement; Cell Proliferation; Cytidine; Disease Progression; HeLa Cells; Humans; Mice; Neoplasm Invasiveness; Neoplasms; Ribonuclease, Pancreatic; RNA, Transfer; Xenograft Model Antitumor Assays	2019
Sensitive ADAR editing reporter in cancer cells enables high-throughput screening of small molecule libraries. Nucleic acids research, 2019, 02-28, Volume: 47, Issue:4 Topics: Adenosine; Adenosine Deaminase; Apoptosis; Autoimmune Diseases of the Nervous System; Gene Editing; Genes, Reporter; HeLa Cells; High-Throughput Screening Assays; Humans; Inosine; Interferons; Luciferases; Luminescent Measurements; Nanoparticles; Neoplasms; Nervous System Malformations; RNA-Binding Proteins; Small Molecule Libraries; Transcriptome	2019
Global analysis of N6-methyladenosine functions and its disease association using deep learning and network-based methods. PLoS computational biology, 2019, Volume: 15, Issue:1 Topics: Adenosine; Algorithms; Computational Biology; Deep Learning; Genetic Markers; Humans; Neoplasms; Protein Interaction Maps; Software	2019
Anti-tumour immunity controlled through mRNA m Nature, 2019, Volume: 566, Issue:7743 Topics: Adenosine; Animals; Antigen Presentation; Antigens, Neoplasm; B7-H1 Antigen; Binding Sites; Cathepsins; CD8-Positive T-Lymphocytes; Cross-Priming; Dendritic Cells; Female; Humans; Methylation; Mice; Mice, Inbred C57BL; Neoplasms; Protein Biosynthesis; Proteins; RNA-Binding Proteins; RNA, Messenger; Transcriptome	2019
Antisense oligonucleotide targeting CD39 improves anti-tumor T cell immunity. Journal for immunotherapy of cancer, 2019, 03-12, Volume: 7, Issue:1 Topics: Adenosine; Adenosine Triphosphate; Animals; Antineoplastic Agents, Immunological; Apyrase; Biomarkers, Tumor; CD8-Positive T-Lymphocytes; Cell Line, Tumor; Cells, Cultured; Disease Models, Animal; Gene Silencing; Humans; Immunity; Lymphocyte Activation; Mice; Neoplasms; Oligonucleotides, Antisense; T-Lymphocyte Subsets; Xenograft Model Antitumor Assays	2019
The Cancer Editome Atlas: A Resource for Exploratory Analysis of the Adenosine-to-Inosine RNA Editome in Cancer. Cancer research, 2019, 06-01, Volume: 79, Issue:11 Topics: Adenosine; Computational Biology; Datasets as Topic; Humans; Inosine; MicroRNAs; Neoplasms; RNA Editing	2019
Clinical Relevance of Noncoding Adenosine-to-Inosine RNA Editing in Multiple Human Cancers. JCO clinical cancer informatics, 2019, Volume: 3 Topics: 3' Untranslated Regions; Adenosine; Biomarkers, Tumor; Computational Biology; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Humans; Inosine; MicroRNAs; Neoplasms; Prognosis; RNA Editing; RNA, Untranslated	2019
EBV epitranscriptome reprogramming by METTL14 is critical for viral-associated tumorigenesis. PLoS pathogens, 2019, Volume: 15, Issue:6 Topics: Adenosine; Animals; Cell Line, Tumor; Cell Transformation, Viral; Epstein-Barr Virus Infections; Epstein-Barr Virus Nuclear Antigens; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Gene Expression Regulation, Viral; HEK293 Cells; Herpesvirus 4, Human; Humans; Male; Methyltransferases; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Proteins; Neoplasms	2019
EZH2-Mediated H3K27me3 Is Involved in Epigenetic Repression of Deleted in Liver Cancer 1 in Human Cancers. PloS one, 2013, Volume: 8, Issue:6 Topics: Actin Cytoskeleton; Adenosine; Antineoplastic Agents; Cell Line, Tumor; Cell Movement; Enhancer of Zeste Homolog 2 Protein; Epigenetic Repression; Gene Expression Regulation, Neoplastic; GTPase-Activating Proteins; Histones; Humans; Methylation; Neoplasms; Promoter Regions, Genetic; RNA, Messenger; Tumor Suppressor Proteins	2013
Human CD4+ CD39+ regulatory T cells produce adenosine upon co-expression of surface CD73 or contact with CD73+ exosomes or CD73+ cells. Clinical and experimental immunology, 2014, Volume: 177, Issue:2 Topics: 5'-Nucleotidase; Adenosine; Antigens, CD; Apyrase; Cell Line; Cell Membrane; Cells, Cultured; Exosomes; Gene Expression; Humans; Immunophenotyping; Leukocytes, Mononuclear; Lymphocyte Activation; Neoplasms; Phenotype; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory	2014
Adenosine pathway and cancer: where do we go from here? Expert opinion on therapeutic targets, 2014, Volume: 18, Issue:9 Topics: 5'-Nucleotidase; Adenosine; Animals; Antineoplastic Agents; Disease Progression; Drug Design; Humans; Molecular Targeted Therapy; Neoplasms; Receptors, Purinergic P1; Signal Transduction; Tumor Microenvironment	2014
Systemic oxygenation weakens the hypoxia and hypoxia inducible factor 1α-dependent and extracellular adenosine-mediated tumor protection. Journal of molecular medicine (Berlin, Germany), 2014, Volume: 92, Issue:12 Topics: Adenosine; Animals; Cell Hypoxia; Cell Line, Tumor; Female; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Mice, Inbred C57BL; Neoplasms; Oxygen; Tumor Microenvironment	2014
3-Deazaneplanocin A and neplanocin A analogues and their effects on apoptotic cell death. ChemMedChem, 2015, Volume: 10, Issue:1 Topics: Adenosine; Adenosylhomocysteinase; Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; HCT116 Cells; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasms; Structure-Activity Relationship; Transplantation, Heterologous	2015
Visual electrochemiluminescence detection of cancer biomarkers on a closed bipolar electrode array chip. Analytical chemistry, 2015, Jan-06, Volume: 87, Issue:1 Topics: Adenosine; Antibodies, Monoclonal; Aptamers, Nucleotide; Biomarkers, Tumor; Biosensing Techniques; Electrochemistry; Electrodes; Humans; Luminescent Measurements; Metal Nanoparticles; Microfluidics; Neoplasms; Silicon Dioxide; Tumor Cells, Cultured	2015
The first CD73-instructed supramolecular hydrogel. Journal of colloid and interface science, 2015, Jun-01, Volume: 447 Topics: 5'-Nucleotidase; Adenosine; Adenosine Monophosphate; Cell Survival; GPI-Linked Proteins; HeLa Cells; Hep G2 Cells; Humans; Hydrogels; MCF-7 Cells; Nanofibers; Neoplasms	2015
Immunological mechanisms of the antitumor effects of supplemental oxygenation. Science translational medicine, 2015, Mar-04, Volume: 7, Issue:277 Topics: Adenosine; Animals; Antineoplastic Agents; Cell Line, Tumor; Disease Models, Animal; Female; Humans; Hyperoxia; Hypoxia; Immunosuppression Therapy; Killer Cells, Natural; Mice, Inbred BALB C; Mice, Inbred C57BL; Neoplasm Metastasis; Neoplasms; Oxygen; Remission Induction; Respiration; T-Lymphocytes, Regulatory; Tumor Microenvironment	2015
Label-free fluorescence dual-amplified detection of adenosine based on exonuclease III-assisted DNA cycling and hybridization chain reaction. Biosensors & bioelectronics, 2015, Aug-15, Volume: 70 Topics: Adenosine; Aptamers, Nucleotide; Biomarkers, Tumor; Biosensing Techniques; DNA; Equipment Design; Equipment Failure Analysis; Exodeoxyribonucleases; Humans; In Situ Hybridization, Fluorescence; Neoplasms; Nucleic Acid Amplification Techniques; Reproducibility of Results; Sensitivity and Specificity; Staining and Labeling	2015
Adenosine conjugated lipidic nanoparticles for enhanced tumor targeting. International journal of pharmaceutics, 2015, Volume: 486, Issue:1-2 Topics: Adenosine; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Docetaxel; Humans; Lipids; Mice; Nanoparticles; Neoplasms; Taxoids	2015
Structure-Activity Relationships of Neplanocin A Analogues as S-Adenosylhomocysteine Hydrolase Inhibitors and Their Antiviral and Antitumor Activities. Journal of medicinal chemistry, 2015, Jun-25, Volume: 58, Issue:12 Topics: Adenine; Adenosine; Adenosylhomocysteinase; Animals; Antineoplastic Agents; Antiviral Agents; Cell Line, Tumor; Chlorocebus aethiops; Enzyme Inhibitors; Humans; Molecular Docking Simulation; Neoplasms; Structure-Activity Relationship; Vero Cells; Virus Diseases; Viruses	2015
Ticagrelor shift from PLATO to PEGASUS: Vanished mortality benefit, excess cancer deaths, massive discontinuations, and overshooting target events. International journal of cardiology, 2015, Dec-15, Volume: 201 Topics: Acute Coronary Syndrome; Adenosine; Aspirin; Clopidogrel; Follow-Up Studies; Hemorrhage; Humans; Mortality; Neoplasms; Platelet Aggregation Inhibitors; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Sepsis; Ticagrelor; Ticlopidine	2015
Homozygous mdm2 SNP309 cancer cells with compromised transcriptional elongation at p53 target genes are sensitive to induction of p53-independent cell death. Oncotarget, 2015, Oct-27, Volume: 6, Issue:33 Topics: Adenosine; Antineoplastic Agents; Blotting, Western; Cell Death; Cell Line, Tumor; Chromatin Immunoprecipitation; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Humans; Neoplasms; Polymorphism, Single Nucleotide; Proto-Oncogene Proteins c-mdm2; Real-Time Polymerase Chain Reaction; Transcriptional Activation; Tumor Suppressor Protein p53	2015
The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers. Cancer cell, 2015, Oct-12, Volume: 28, Issue:4 Topics: Adenosine; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Genome, Human; Humans; Inosine; Neoplasms; RNA Editing	2015
Cancer genomics: The relevance of extensive editing in tumour transcriptomes. Nature reviews. Cancer, 2015, Volume: 15, Issue:12 Topics: Adenosine; Humans; Inosine; Neoplasms; RNA Editing	2015
Hypoxia-Driven Adenosine Accumulation: A Crucial Microenvironmental Factor Promoting Tumor Progression. Advances in experimental medicine and biology, 2016, Volume: 876 Topics: Adenosine; Cell Hypoxia; Disease Progression; Humans; Neoplasms; Tumor Microenvironment	2016
Tumor-derived exosomes regulate expression of immune function-related genes in human T cell subsets. Scientific reports, 2016, Feb-04, Volume: 6 Topics: Adenosine; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Apyrase; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cells, Cultured; Culture Media, Conditioned; Down-Regulation; Exosomes; Humans; Lectins, C-Type; Microscopy, Electron, Transmission; Microscopy, Fluorescence; Neoplasms; Real-Time Polymerase Chain Reaction; RNA, Messenger; T-Lymphocyte Subsets; T-Lymphocytes, Regulatory; Up-Regulation	2016
MTAP Deletions in Cancer Create Vulnerability to Targeting of the MAT2A/PRMT5/RIOK1 Axis. Cell reports, 2016, Apr-19, Volume: 15, Issue:3 Topics: Adenosine; Antigens, Neoplasm; Gene Deletion; Genomics; HCT116 Cells; Humans; Methionine Adenosyltransferase; Multiprotein Complexes; Neoplasms; Protein Serine-Threonine Kinases; Protein-Arginine N-Methyltransferases; Purine-Nucleoside Phosphorylase; RNA, Small Interfering; Signal Transduction; Thionucleosides	2016
Editorial overview: Cancer. Current opinion in pharmacology, 2016, Volume: 29 Topics: Adenosine; Calcium; Humans; Inflammasomes; Neoplasms; Signal Transduction; Tumor Microenvironment	2016
Emerging links between m Genome medicine, 2017, 01-12, Volume: 9, Issue:1 Topics: Adenosine; Animals; Humans; Methylation; Neoplasms; RNA Processing, Post-Transcriptional; RNA, Messenger	2017
Multiple approaches to immunotherapy - the new pillar of cancer treatment. Immunology and cell biology, 2017, Volume: 95, Issue:4 Topics: Adenosine; Animals; Antibodies; Cancer Vaccines; Extracellular Space; Genetic Engineering; Humans; Immunotherapy; Neoplasms; Tumor Microenvironment	2017
Humanized ADEPT comprised of an engineered human purine nucleoside phosphorylase and a tumor targeting peptide for treatment of cancer. Molecular cancer therapeutics, 2009, Volume: 8, Issue:1 Topics: Adenosine; Antibodies; Cell Line, Tumor; Cell Proliferation; Guanosine; Humans; Kinetics; Molecular Mimicry; Mutation; Neoplasms; Peptides; Prodrugs; Protein Engineering; Purine-Nucleoside Phosphorylase; Receptor, ErbB-2; Recombinant Proteins; Substrate Specificity	2009
NK cell-mediated cytotoxicity modulation by A(2) adenosine receptor agonist in different mammalian species. Folia microbiologica, 2009, Volume: 54, Issue:4 Topics: Adenosine; Adenosine A2 Receptor Agonists; Animals; Cells, Cultured; Cytotoxicity, Immunologic; Female; Goats; Humans; Killer Cells, Natural; Male; Mice; Mice, Inbred C57BL; Neoplasms; Rats; Rats, Wistar; Receptors, Adenosine A2; Rodentia; Swine	2009
Purines 2010: Adenine Nucleosides and Nucleotides in Biomedicine. IDrugs : the investigational drugs journal, 2010, Volume: 13, Issue:8 Topics: Adenine Nucleotides; Adenosine; Anemia, Sickle Cell; Bone and Bones; Cystic Fibrosis; Drug Design; Drugs, Investigational; Humans; Neoplasms; Neurodegenerative Diseases; Pain; Pulmonary Fibrosis; Receptors, Purinergic; Signal Transduction	2010
Effects of kinetin riboside on proliferation and proapoptotic activities in human normal and cancer cell lines. Journal of cellular biochemistry, 2011, Volume: 112, Issue:8 Topics: Adenosine; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Caspase 8; Cell Line, Tumor; Cell Proliferation; Cytochromes c; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Kinetin; Neoplasms	2011
Silencing of Kruppel-like factor 2 by the histone methyltransferase EZH2 in human cancer. Oncogene, 2012, Apr-12, Volume: 31, Issue:15 Topics: Adenosine; Animals; Breast Neoplasms; DNA-Binding Proteins; Enhancer of Zeste Homolog 2 Protein; Female; Humans; Kruppel-Like Transcription Factors; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Polycomb Repressive Complex 2; Prostatic Neoplasms; RNA Interference; Transcription Factors; Transfection	2012
Effects of cytokinins, cytokinin ribosides and their analogs on the viability of normal and neoplastic human cells. Anticancer research, 2011, Volume: 31, Issue:10 Topics: Adenosine; Cell Line, Tumor; Cell Survival; Cisplatin; Cytokinins; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Isopentenyladenosine; Neoplasms; Neutral Red; Ribonucleosides; Tumor Stem Cell Assay; Zeatin	2011
Apoptotic tumor cells induce IL-27 release from human DCs to activate Treg cells that express CD69 and attenuate cytotoxicity. European journal of immunology, 2012, Volume: 42, Issue:6 Topics: Adenosine; Antigens, CD; Antigens, Differentiation, T-Lymphocyte; Apoptosis; Apyrase; Cell Line, Tumor; Cytotoxicity, Immunologic; Dendritic Cells; Female; Forkhead Transcription Factors; Humans; Interleukins; Lectins, C-Type; Lymphocyte Activation; Neoplasms; Receptors, Lysosphingolipid; T-Lymphocytes, Regulatory	2012
Increasing the therapeutic index of 5-fluorouracil and 6-thioguanine by targeting loss of MTAP in tumor cells. Cancer biology & therapy, 2012, Volume: 13, Issue:11 Topics: Adenosine; Animals; Cell Line; Cell Line, Tumor; Disease Models, Animal; Fibrosarcoma; Fluorouracil; Humans; Mesothelioma; Mice; Mice, Inbred C57BL; Neoplasms; Purine-Nucleoside Phosphorylase; Thioguanine; Thionucleosides	2012
Insights into phosphate cooperativity and influence of substrate modifications on binding and catalysis of hexameric purine nucleoside phosphorylases. PloS one, 2012, Volume: 7, Issue:9 Topics: Acyclovir; Adenosine; Bacillus subtilis; Catalysis; Catalytic Domain; Crystallography, X-Ray; Ganciclovir; Genetic Therapy; Humans; Ligands; Models, Molecular; Molecular Conformation; Neoplasms; Phosphates; Prodrugs; Protein Structure, Quaternary; Purine-Nucleoside Phosphorylase; Serine; Threonine; Tubercidin	2012
Studies on isolated tumour mitochondria; phosphate release from adenosine di- and triphosphates. British journal of cancer, 1957, Volume: 11, Issue:1 Topics: Adenosine; Adenosine Triphosphate; Mitochondria; Neoplasms; Nucleotides; Phosphates; Polyphosphates	1957
Studies with psicofuranine in the tumor-bearing rat. Cancer research, 1961, Volume: 21 Topics: Adenosine; Animals; Antineoplastic Agents; Neoplasms; Rats	1961
[HISTOCHEMICAL CHANGES IN THE NUCLEIC ACIDS, 5-NUCLEOTIDASES, ALKALINE PHOSPHATASE AND ADENOSINE TRIPHOSPHORIC ACID IN UTERINE CERVICAL CARCINOMA AFTER TREATMENT WITH TRIETHYLENIMINOBENZOQUINONE]. Bollettino della Societa italiana di biologia sperimentale, 1963, Dec-31, Volume: 39 Topics: 5'-Nucleotidase; Adenosine; Adenosine Triphosphate; Alkaline Phosphatase; Antineoplastic Agents; Carcinoma, Squamous Cell; DNA; DNA, Neoplasm; Female; Humans; Neoplasms; Nucleic Acids; Nucleotidases; Polyphosphates; RNA; RNA, Neoplasm; Uterine Cervical Neoplasms	1963
[ACTION OF PSICOFURANINE ON HUMAN TUMORAL ELEMENTS IN CONTINUOUS CULTURE]. Archivio italiano di scienze farmacologiche, 1963, Volume: 13 Topics: Adenosine; Anti-Bacterial Agents; Antibiotics, Antitubercular; Antineoplastic Agents; Neoplasms; Pharmacology; Research; Tissue Culture Techniques	1963
Therapeutic assays of the skin and cancer unit of the New York University Hospital. Assay VI. Adenosine-5-monophosphate (MY-B-DEN) for the relief of pruritus. The Journal of investigative dermatology, 1951, Volume: 17, Issue:5 Topics: Adenosine; Adenosine Monophosphate; Hospitals, University; Humans; Neoplasms; New York; Pruritus; Skin	1951
[Cytochemical determination of adenosinetriphosphatase (ATP-ase) in the cells of an ascites tumor in the mouse]. Experientia, 1950, Jun-15, Volume: 6, Issue:6 Topics: Adenosine; Adenosine Triphosphatases; Adenosine Triphosphate; Animals; Ascites; Carcinoma, Ehrlich Tumor; Enzymes; Mice; Neoplasms	1950
A3 adenosine receptors modulate hypoxia-inducible factor-1alpha expression in human A375 melanoma cells. Neoplasia (New York, N.Y.), 2005, Volume: 7, Issue:10 Topics: Adenosine; Angiopoietin-2; Blotting, Western; Cell Line, Tumor; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Melanoma; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Neoplasms; Oxygen; p38 Mitogen-Activated Protein Kinases; Receptor, Adenosine A3; Reverse Transcriptase Polymerase Chain Reaction; RNA Interference; RNA, Small Interfering; Time Factors; Transfection; Up-Regulation	2005
In vitro evaluation of adenosine 5'-monophosphate as an imaging agent of tumor metabolism. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2006, Volume: 47, Issue:5 Topics: 5'-Nucleotidase; Adenosine; Adenosine Monophosphate; Caffeine; Carbon Radioisotopes; Cell Line, Tumor; Female; Humans; Immunophenotyping; In Vitro Techniques; Models, Biological; Neoplasm Metastasis; Neoplasms; Positron-Emission Tomography; Time Factors	2006
Adenosine metabolism and cancer. Focus on "Adenosine downregulates DPPIV on HT-29 colon cancer cells by stimulating protein tyrosine phosphatases and reducing ERK1/2 activity via a novel pathway". American journal of physiology. Cell physiology, 2006, Volume: 291, Issue:3 Topics: Adenosine; Adenosine Deaminase; Animals; Dipeptidyl Peptidase 4; Down-Regulation; HT29 Cells; Humans; Neoplasms; Neovascularization, Pathologic; Receptors, Purinergic P1; Tumor Escape	2006
Altered adenosine-to-inosine RNA editing in human cancer. Genome research, 2007, Volume: 17, Issue:11 Topics: Adenosine; Adenosine Deaminase; Alu Elements; Animals; Base Sequence; Cell Line, Tumor; Cell Proliferation; Cells, Cultured; Computational Biology; Humans; Inosine; Mice; Molecular Sequence Data; Neoplasms; RNA Editing; RNA Precursors; RNA-Binding Proteins; RNA, Untranslated	2007
Tenascin C interacts with ecto-5'-nucleotidase (eN) and regulates adenosine generation in cancer cells. Biochimica et biophysica acta, 2008, Volume: 1782, Issue:1 Topics: 5'-Nucleotidase; Adenosine; Cell Adhesion; Cell Line, Tumor; Cell Movement; Extracellular Matrix; Humans; Neoplasms; Protein Binding; Solubility; Substrate Specificity; Tenascin	2008
Kinetin riboside preferentially induces apoptosis by modulating Bcl-2 family proteins and caspase-3 in cancer cells. Cancer letters, 2008, Mar-08, Volume: 261, Issue:1 Topics: Adenosine; Animals; Apoptosis; bcl-Associated Death Protein; Caspase 3; Cattle; Cell Line; Cell Line, Tumor; Cytochromes c; Fibroblasts; Humans; Kinetin; Membrane Potential, Mitochondrial; Mice; Neoplasms; Proto-Oncogene Proteins c-bcl-2	2008
[Cytological study of nucleoli and nucleolar organizers during inhibition of RNA synthesis]. Bulletin de l'Association des anatomistes, 1980, Volume: 64, Issue:185 Topics: Adenosine; Animals; Cell Nucleolus; Cells, Cultured; Chick Embryo; Fibroblasts; Microscopy, Electron; Neoplasms; Nucleolus Organizer Region; RNA	1980
Affinity labeling of the protein kinase associated with the epidermal growth factor receptor in membrane vesicles from A431 cells. The Journal of biological chemistry, 1982, Apr-25, Volume: 257, Issue:8 Topics: Adenosine; Affinity Labels; Cell Line; Cell Membrane; Epidermal Growth Factor; ErbB Receptors; Humans; Kinetics; Molecular Weight; Neoplasms; Protein Kinase Inhibitors; Protein Kinases; Receptors, Cell Surface	1982
5'-Methylthioadenosine in urine from normal subjects and cancer patients. Biochimica et biophysica acta, 1984, Nov-28, Volume: 802, Issue:2 Topics: Adenosine; Chromatography, High Pressure Liquid; Deoxyadenosines; Female; Gas Chromatography-Mass Spectrometry; Humans; Male; Neoplasms; Thionucleosides	1984
Methionine synthesis from 5'-methylthioadenosine by tumour cells. Biochemical pharmacology, 1983, Oct-01, Volume: 32, Issue:19 Topics: Adenosine; Animals; Carbon Radioisotopes; Cell Line; Cells, Cultured; Deoxyadenosines; Humans; Kinetics; Leukemia; Methionine; Mice; Neoplasms; Thionucleosides; Urinary Bladder Neoplasms	1983
Selective killing of human malignant cell lines deficient in methylthioadenosine phosphorylase, a purine metabolic enzyme. Proceedings of the National Academy of Sciences of the United States of America, 1981, Volume: 78, Issue:2 Topics: Adenosine; Azaserine; Breast Neoplasms; Cell Line; Cell Survival; Humans; Leukemia; Melanoma; Methotrexate; Neoplasms; Pentosyltransferases; Purine-Nucleoside Phosphorylase; Thionucleosides	1981
Growth inhibition of human tumor cells in soft-agar cultures by treatment with low levels of adenosine 5'-triphosphate. Cancer research, 1983, Volume: 43, Issue:9 Topics: Adenosine; Adenosine Diphosphate; Adenosine Monophosphate; Adenosine Triphosphate; Agar; Cell Division; Cell Line; Cell Survival; Culture Media; DNA Replication; Humans; Neoplasms	1983
Urine levels of N-[9-(beta-D-ribofuranosyl)purin-6-ylcarbamoyl]-L-threonine, N6-(delta 2-isopentenyl)adenosine, and 2'-O-methylguanosine as determined by radioimmunoassay for normal subjects and cancer patients. Cancer research, 1982, Volume: 42, Issue:12 Topics: Adenosine; Chromatography, High Pressure Liquid; Guanosine; Humans; Isopentenyladenosine; Neoplasms; Radioimmunoassay; Reference Values	1982
Comparison of serum and urinary levels of modified nucleoside, 1-methyladenosine, in cancer patients using a monoclonal antibody-based inhibition ELISA. The Tohoku journal of experimental medicine, 1995, Volume: 176, Issue:1 Topics: Adenosine; Adolescent; Adult; Aged; Antibodies, Monoclonal; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Middle Aged; Neoplasms; Reference Values	1995
Gas chromatography/mass spectrometric analysis of urinary nucleosides in cancer patients; potential of modified nucleosides as tumour markers. Rapid communications in mass spectrometry : RCM, 1993, Volume: 7, Issue:6 Topics: Adenosine; Biomarkers, Tumor; Female; Gas Chromatography-Mass Spectrometry; Guanosine; Humans; Inosine; Male; Neoplasms; Nucleosides	1993
Vitamin B6 and cancer: synthesis and occurrence of adenosine-N6-diethylthioether-N-pyridoximine-5'-phosphate, a circulating human tumor marker. Cancer research, 1996, Aug-15, Volume: 56, Issue:16 Topics: Adenosine; Animals; Biomarkers, Tumor; Humans; Hydrogen-Ion Concentration; Neoplasms; Pyridoxine; Rats	1996
Induction of cellular differentiation and apoptosis by signal transduction inhibitors. Advances in enzyme regulation, 1997, Volume: 37 Topics: Adenosine; Animals; Antineoplastic Agents; Apoptosis; Cell Differentiation; Cell Division; Formycins; Gene Expression Regulation, Neoplastic; Genes, abl; Humans; Hydroquinones; Molecular Structure; Neoplasms; Protein Tyrosine Phosphatases; Signal Transduction; Tubercidin; Tumor Cells, Cultured	1997
Adenosine and other low molecular weight factors released by muscle cells inhibit tumor cell growth. Cancer research, 1998, Jul-15, Volume: 58, Issue:14 Topics: Adenosine; Animals; Cell Cycle; Cell Division; Culture Media, Conditioned; Humans; Mice; Muscles; Neoplasms; Rats; Tumor Cells, Cultured	1998
Creatinine at the evaluation of urinary 1-methyladenosine and pseudouridine excretion. The Tohoku journal of experimental medicine, 1999, Volume: 188, Issue:2 Topics: Adenosine; Creatinine; Enzyme-Linked Immunosorbent Assay; False Positive Reactions; Female Urogenital Diseases; Humans; Kidney Diseases; Male Urogenital Diseases; Neoplasms; Pseudouridine	1999
The A3 adenosine receptor as a new target for cancer therapy and chemoprotection. Experimental cell research, 2001, Oct-01, Volume: 269, Issue:2 Topics: Adenosine; Administration, Oral; Animals; Antineoplastic Agents, Alkylating; Bone Marrow Cells; Cell Cycle; Cell Division; Cyclophosphamide; Granulocyte Colony-Stimulating Factor; Granulocyte-Macrophage Colony-Stimulating Factor; In Situ Hybridization, Fluorescence; Lung Neoplasms; Male; Mice; Mice, Inbred C57BL; Neoplasms; Neoplasms, Experimental; Protein Binding; Receptor, Adenosine A3; Receptors, Purinergic P1; Telomere; Tumor Cells, Cultured	2001
Modified nucleosides in urine: selective removal and analysis. Clinical chemistry, 1976, Volume: 22, Issue:9 Topics: Adenosine; Chromatography, Affinity; Glycols; Humans; Isomerism; Neoplasms; Ribonucleosides; RNA; Stereoisomerism; Uridine	1976
Hemolysis induced by 6-N-hydroxylaminopurine riboside, an adenosine analogue. Clinical pharmacology and therapeutics, 1975, Volume: 17, Issue:1 Topics: Adenosine; Adult; Bilirubin; Blood Cell Count; Breast Neoplasms; Dipyridamole; Erythrocytes; Female; Hemoglobins; Hemolysis; Humans; Hydroxylamines; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Neoplasms; Purines; Rectal Neoplasms; Reticulocytes; Time Factors	1975
Disturbance in the metabolism of 5'-methylthioadenosine and adenine in patients with neoplastic diseases, and in those with a deficiency in adenine phosphoribosyltransferase. Metabolism: clinical and experimental, 1991, Volume: 40, Issue:9 Topics: Adenine; Adenine Phosphoribosyltransferase; Adenosine; Adult; Aged; Deoxyadenosines; Female; Humans; Leukemia; Male; Middle Aged; Neoplasms; Osmolar Concentration; Thionucleosides	1991
Measurement of 5'-methylthioadenosine in patients with neoplasms. International journal of cancer, 1990, Jan-15, Volume: 45, Issue:1 Topics: Adenosine; Adult; Aged; Analysis of Variance; Chromatography, High Pressure Liquid; Deoxyadenosines; Female; Humans; Male; Middle Aged; Neoplasms; Remission Induction; Thionucleosides	1990
Preparation of a monoclonal antibody specific for 1-methyladenosine and its application for the detection of elevated levels of 1-methyladenosine in urines from cancer patients. Japanese journal of cancer research : Gann, 1988, Volume: 79, Issue:10 Topics: Adenosine; Antibodies, Monoclonal; Chromatography, High Pressure Liquid; Enzyme-Linked Immunosorbent Assay; Humans; Neoplasms; Radioimmunoassay	1988
Patterns of methionine auxotrophy in normal and neoplastic cells: the methionine independence of lymphocyte mitogenesis and low frequency of the methionine-dependent phenotype in human tumors. Cancer research, 1988, Dec-01, Volume: 48, Issue:23 Topics: Adenosine; Animals; Culture Media; Deoxyadenosines; Humans; Lymphocyte Activation; Methionine; Mice; Neoplasms; Phenotype; Thionucleosides; Tumor Cells, Cultured	1988
Differential antiproliferative actions of 2',5' oligo A trimer core and its cordycepin analogue on human tumor cells. International journal of cancer, 1985, Sep-15, Volume: 36, Issue:3 Topics: Adenine Nucleotides; Adenosine; Cell Division; Cell Line; Coformycin; Culture Techniques; Dose-Response Relationship, Drug; Drug Resistance; Humans; Neoplasms; Oligodeoxyribonucleotides; Oligonucleotides; Oligoribonucleotides; Pentostatin	1985
Bone marrow transplantation in immunosuppressed or congenitally immune deficient patients. Transplantation proceedings, 1973, Volume: 5, Issue:3 Topics: Adenosine; Aminohydrolases; Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow Cells; Bone Marrow Transplantation; Child; Cyclophosphamide; Graft vs Host Reaction; Histocompatibility Testing; Humans; Immunologic Deficiency Syndromes; Immunosuppression Therapy; Leukemia; Male; Metabolism, Inborn Errors; Mutation; Neoplasms; Thymus Gland	1973
[Adenosine deaminase. Molecular variability in human neoplasms]. Rinsho byori. The Japanese journal of clinical pathology, 1974, Volume: 22, Issue:10 Suppl Topics: Adenosine; Amidohydrolases; Humans; Molecular Weight; Neoplasms	1974
The occurrence of single-stranded DNA in the serum of patients with systemic lupus erythematosus and other diseases. The Journal of clinical investigation, 1973, Volume: 52, Issue:1 Topics: Adenosine; Animals; Antigen-Antibody Complex; Antigens; Arthritis, Rheumatoid; Cattle; DNA; DNA, Single-Stranded; Glomerulonephritis; Hemagglutination Inhibition Tests; Humans; Immunodiffusion; Leukemia; Lupus Erythematosus, Systemic; Methods; Neoplasms; Rabbits; Serum Albumin; Thymidine	1973
S-adenosylmethionine in human blood. Clinica chimica acta; international journal of clinical chemistry, 1971, Volume: 33, Issue:1 Topics: Adenosine; Adult; Child; Child, Preschool; Humans; Leukemia; Methionine; Methyltransferases; Neoplasms; Neuroblastoma; Radioisotope Dilution Technique; S-Adenosylmethionine	1971
Adenosine deaminase in gastric juice. Enzymologia, 1972, Jan-31, Volume: 42, Issue:1 Topics: Adenosine; Adolescent; Adult; Aminohydrolases; Carcinoma; Duodenal Ulcer; Gastric Juice; Gastritis; Humans; Hydrochloric Acid; Liver Diseases; Middle Aged; Neoplasms; Stomach Neoplasms; Stomach Ulcer	1972